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ABSTRACT 
The endoplasmic reticulum (ER) is a complex organelle whose primary function is 
concerned with protein folding and modification. However, occasionally unfolded proteins 
accumulate in the ER, causing ER stress. In these cases, the unfolded response (UPR) is 
activated in an attempt to restore ER homeostasis. There are three mammalian UPR signal 
transducers. IRE1α is the most ancient of these and has two functional domains. The RNase 
domain is often regarded as promoting cell survival via splicing of XBP-1 mRNA to 
generate the XBP-1(s) transcription factor. This domain has also been implicated in the 
RIDD pathway where ER-localised mRNAs are degraded. The kinase domain is thought of 
as proapoptotic due to its ability to activate the JNK signalling cascade.   
However, recent work highlighted a potential role for IRE1α kinase activity in cell survival. 
This project focussed on segregating cell fate decisions according to kinase and RNase 
functions. This was done by comparing MEFs expressing human WT-IRE1α to MEFs 
expressing a kinase-deficient IRE1α mutant, or a kinase- and RNase-dead form of IRE1α. 
Western blotting, qPCR analysis and electron microscopy were principally used to identify 
biochemical, transcriptional and physical differences between these cells. Western blot 
analysis highlighted a correlation between the loss of IRE1α kinase activity and increased 
expression of the proapoptotic marker, CHOP, during ER stress. Further strengthening this 
observation, an increase in mRNA levels of TRB3, which is a downstream target of CHOP 
was identified by qPCR. The latter technique also suggested that ERAD, the process by 
which misfolded ER lumenal proteins are degraded, was also compromised. Finally, electron 
micrographs clearly showed loss of the ability in cells expressing either IRE1α mutants to 
structurally organise the proliferating ER during stress. To conclude, the results strongly 
argue that lack of the kinase domain negatively influences ER physiology and gene 
expression when the UPR is active. Therefore, this study brings to attention the importance 
of IRE1α kinase activity for cytoprotection which, in turn, has major implications on the role 
of the UPR in several different diseases.  
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1.1: ER stress and the Unfolded Protein Response 
A defining feature of eukaryotic cells is the presence of a cell membrane and different 
membrane-bound organelles. One of these organelles is the endoplasmic reticulum (ER). 
The ER is a large, membranous organelle which serves as a store for calcium ions (Ca
2+
) and 
acts as a signalling platform. It is also responsible for synthesizing lipids and folding and 
modifying secretory and transmembrane proteins. If these proteins cannot be folded 
properly, maybe due to a mutation in their encoding gene, or a redox imbalance in the ER 
lumen, the ER becomes stressed and a response is elicited. This response is called the 
Unfolded Protein Response (UPR), which is activated to alleviate ER stress (Hussain and 
Ramaiah, 2007). This pathway has three principal outputs which are associated with trying 
to restore ER homeostasis: increased chaperone expression, translational attenuation, and 
upregulation of ER-associated degradation (ERAD) components and activity (reviewed in 
Lai et al, 2006). 
 
When unfolded or misfolded proteins accumulate in the ER lumen, they bind the ER-
resident chaperone, GRP78 (also known as BIP). As a result, BIP is titrated away from the 
three ER stress sensors: IRE1α, PERK and ATF6. IRE1α and PERK are also believed to 
interact directly with unfolded proteins (Gardner and Walter, 2001; Korennykh and Walter, 
2012) and oligomerisation and activation of these two signal transducers follows (Bertolotti 
et al., 2000). Upon activation, the RNase activity of IRE1α induces non-conventional 
splicing of an mRNA encoding a bZIP transcription factor (XBP-1) which in turn 
upregulates transcription of genes that help to relieve the unfolded protein load of the ER. 
PERK on the other hand, phosphorylates eIF2α to attenuate protein translation. This is 
thought to provide the ER with more time to clear the unfolded proteins before processing 
new polypeptides. Finally, ATF6 is translocated to the Golgi apparatus, where it undergoes 
cleavage. The cleaved product, known as ATF6(f), can then travel to the nucleus, where it 
changes gene expression alongside spliced XBP-1 (reviewed in Ron and Walter, 2007). 
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Figure 1.1: Early signalling events of the unfolded protein response. 
 
UPR signalling can be studied relatively easily as ER-stress can be artificially induced using 
several different drugs. One of these drugs is tunicamycin, which activates the UPR as it 
blocks N-linked glycosylation of polypeptides in the ER (Takatsuki et al., 1975) which are 
then unable to fold correctly. Thapsigargin is also regularly used, as it is a SERCA-pump 
inhibitor (Lytton et al., 1991) and thus protein folding cannot happen normally due to loss of 
ER calcium homoeostasis. DTT and subtilase AB5 are two alternative ER-stress inducing 
drugs which cause accumulation of unfolded proteins by inhibiting disulpide bond formation 
(Karlin and Bartels, 1966) and BIP inactivation (Paton et al., 2006), respectively. Whether 
or not a cell recovers from ER stress is dependent on many factors, and is the subject of 
research carried out worldwide. It is generally believed that persistent activation of the UPR 
will eventually lead to cell death, which plays a role in the pathogenesis of different human 
diseases (Kim et al., 2008). My project will focus on the signalling downstream of IRE1α, 
and how this influences cell fate decisions. 
 
1.2: Activation of IRE1α 
IRE1 is an ER-resident transmembrane protein which harbours both endoribonuclease 
(RNase) and kinase domains (Tabas and Ron, 2011). Early experiments showed that during 
ER stress, yeast Ire1p was necessary for transcription of BIP and PDI (Cox et al., 1993). 
Overexpression of either BIP, or PDI, which catalyses formation and isomerisation of 
disulphide bonds within proteins (Formenko and Gladyshev, 2003), was able to reduce UPR 
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signalling (Morris et al., 1997; Xu et al., 2005) suggesting ER homeostasis was being 
restored. Therefore, both proteins are thought to help alleviate ER stress, highlighting the 
protective role of IRE1. 
 
At this point, the mechanism of IRE1 activation and how it subsequently upregulated these 
chaperones was unknown. Later discoveries elucidated that this transmembrane protein 
became activated during ER stress by a process of homo-oligomerisation and trans-
autophosphorylation, with the latter process being fulfilled by the kinase activity of Ire1p 
itself (Shamu and Walter, 1996). In this study two Ire1p mutants were used: a C-terminally 
truncated form (‘tailless’) which still possessed the kinase domain, and the K702R mutant. 
The latter mutant had previously been shown to possess massively reduced kinase activity, 
whereas its close relative, K702A displayed no detectable kinase activity. The reason is 
presumed to be because mutation of this residue interferes with phosphotransfer ability 
(Mori et al., 1993). During ER stress, expression of ‘tailless’ Ire1p was able to increase the 
transcriptional response of the Ire1p-K702R mutant from 25% to 80% compared to WT 
Ire1p. If the K702R mutation was introduced into the truncated mutant, the observed 
‘rescue’ no longer occurred. Furthermore, the K702R mutant was found to be 
phosphorylated on specific serine residues when expressed with the truncated form of Ire1p. 
It was shown that the K702R mutant was unable to undergo phosphorylation unless 
expressed simultaneously with a kinase-active form of Ire1p. These data along with the 
finding that truncated Ire1p could complex with the full length form of this protein, lead to 
the conclusion that kinase activity of Ire1p was required for oligomerisation of this protein. 
In turn, trans-autophosphorylation of the subunits involved in the oligomer would result in 
downstream signalling. It was thus concluded that only after oligomerisation Ire1p is fully 
active for signalling (Shamu and Walter, 1996). The different aspects of how IRE1 functions 
in the UPR are discussed below. 
 
1.3: Structure and function of IRE1 
 
IRE1 is a type I transmembrane protein. Its N-terminus is located within the ER lumen and 
in yeast this was shown to interact with the ATPase domain of BIP (Todd-Corlett et al., 
2007). The kinase and RNase domains of IRE1 are located in the cytosolic C-terminus 
(reviewed in Schröder and Kaufman, 2005). There are several conserved amino acids in the 
kinase catalytic core of this protein, which if mutated are known to abolish kinase and/or 
RNase activities of this protein (Chawla et al., 2011; Lee et al., 2008; Mori et al., 1993; 
Tirasophon et al., 1998). The general consensus is that RNase activity, which is responsible 
for XBP-1 splicing, is stimulated by autophosphorylation of the activation loop, which is 
located in the protein kinase domain (Lee et al., 2008 and Figure 1.2). However, the ATP-
19 
 
competitive inhibitor, 1NM-PP1 has been demonstrated to activate the IRE1α RNase in 
mutants lacking phosphotransfer capacity (Papa et al., 2003). Hence, it would seem that 
kinase activity is actually unnecessary for activation of IRE1 by 1NM-PP1. 
 
Figure 1.2: Schematic showing the different domains of IRE1α. LD is the lumenal 
domain and TM is the transmembrane domain (figure from Korennykh et al., 2009). 
 
The two IRE1 residues of importance to this project are K599 and D711. The catalytic lysine 
at position 599 is required to enable the γ-phosphoryl transfer reaction (Hodgson and 
Schröder, 2011). Additionally, it is thought to be required for formation of a salt bridge with 
the E612 residue, which in turn would play a role in the active conformation of the kinase 
(Korennykh et al., 2011). It has been established that the point mutation formed by 
substituting this basic lysine residue to a non-polar alanine residue (K599A-hIRE1α) results 
in a form of IRE1α which lacks both RNase and kinase activity. It is hence unable to splice 
XBP-1 or undergo autophosphorylation (Tirasophon et al., 1998). 
 
K599A-hIRE1α was used alongside the D711A-hIRE1α mutant in this project. This residue 
is the conserved aspartate residue in all protein kinases, which is required for coordinating 
the (two) Mg
2+
 ions in the kinase catalytic core (Mori et al., 1993). This allows the 
triphosphate group of ATP to be appropriately placed in the nucleotide binding pocket. 
Therefore, mutating this aspartate to an alanine may inhibit phosphorylation due to 
misplacement of the triphosphate group. As can be seen in the appendix (figure A1.1), this 
mutant has preserved XBP-1 splicing capacity. Thus, the D711A-hIRE1α mutant has 
retained its RNase activity despite lacking kinase activity. By comparing these two mutants 
to the WT-hIRE1α, it can be elucidated whether or not the kinase domain is required for 
controlling certain aspects of cell survival downstream of the UPR being activated. 
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1.3.1: IRE1α endoribonuclease activity is responsible for XBP-1 splicing 
 
Results which were consistent with those regarding the expression of chaperone proteins 
during ER-stress (Cox et al., 1993) highlighted a correlation in yeast between activated Ire1p 
and UPR induction by a spliced bZIP transcription factor, Hac1p (Cox and Walter, 1996). 
Using Northern blotting, the Walter group showed that a 252 nucleotide intron had been 
removed from HAC1 mRNA. The splicing out of this intron essentially generates a form of 
HAC1 where the N-terminal DNA-binding domain is now adjacent to a C-terminal 
‘activation domain’. This event allows the translational block to be lifted, thus generating the 
active transcription factor, Hac1p (Mori et al., 2000). A similar system operates in 
mammalian cells, where IRE1α is able to splice the HAC1 mRNA equivalent, XBP-1. 
Translated XBP-1(s) is a more active transcription factor compared to XBP-1(u) and 
therefore it can proceed to effectively amplify basal chaperone expression levels generated 
by cleaved ATF6 (Yoshida et al., 2001). It is important to note however, that spliced XBP-1 
acts later compared to ATF6, and thus the target genes of these two transcription factors 
were not expected to overlap directly. This was indeed the case, and spliced XBP-1 was 
found to be required for upregulation of certain ERAD pathway components (Yoshida et al., 
2003). Although ATF6 has recently been proposed to play a role in transcription of some 
ERAD related genes (Shoulders et al., 2013), principal transcriptional control of these genes 
by XBP-1(s) highlights the anti-apoptotic nature of this route, as a more effective ERAD 
would presumably reduce the misfolded protein load in the ER lumen. 
 
1.3.2: The role of the IRE1α-XBP-1 branch in cell fate 
 
One would assume that loss of XBP-1 splicing would result in events that would make cell 
death more favourable, due to the fact there would be less transcriptional control over genes 
encoding chaperones and ERAD components. Loss of xbp-1 from embryonic liver cells 
correlated with the elevated levels of apoptosis observed in this model (Reimold et al., 
2000). By default, one would expect that knockout of IRE1α should also help favour 
apoptosis. Cell death does indeed occur in yeast, as growth assays display inhibition of 
survival in ire1Δ strains (Back et al., 2005). 
 
However, the mammalian pathway is much less simple. The Papa group used the I642G-
IRE1α mutant to investigate ER stress related cell fate decisions (Han et al., 2009). This 
mutant has an enlarged kinase active site pocket which is predicted to be accessible to the 
ATP-competitive drug, 1NM-PP1. Use of this drug supports XBP-1 splicing associated with 
active IRE1α whilst abolishing kinase-mediated phosphorylation (Papa et al., 2003). Using 
annexin V staining as a readout for cell death, it was demonstrated that ire1α-/- fibroblasts 
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showed much better survival after ER stress induction, compared to their WT counterparts. 
Although this initially seems to oppose the results obtained from the yeast system, this group 
was able to show that the activated I642G-IRE1α was able to further reduce the amount of 
cell death detected in the ire1 -/- cells (Han et al., 2009). These results support the role of 
XBP-1(s) in cell survival. 
 
It was later demonstrated that the ire1-/- fibroblasts were protected from ER-stress related 
cell death as caspase-2 upregulation and subsequent cleavage were unable to occur. 
Increased expression, but not cleavage of caspase-2 was observed in the 1NM-PP1-activated 
I642G-IRE1α cells. Only the WT-IRE1α cells showed caspase-2 cleavage. Thus, it was 
concluded that the presence of XBP-1(s) is separable from the ER stress-induced cell death 
pathway (Upton et al., 2012). 
 
Many groups have exploited XBP-1(s) to promote cell survival. By using an expression 
vector encoding the spliced XBP-1 form, it was demonstrated that the presence of this 
transcription factor caused a decrease in CHOP expression (Guo et al., 2012). CHOP, also 
known as GADD153, is understood to contribute to ER stress-related cell death (Marciniak 
et al., 2004) and thus downregulation of this protein protects cells from death. This is 
consistent with data published by Sado et al (2009) who noted that CHOP expression 
increased when inducing a Parkinson’s disease-like phenotype. They then successfully used 
adenoviral XBP-1 expression to rescue the neuronal cells from death. A separate group also 
demonstrated inhibition of cell death by sustained XBP-1 splicing. Interestingly, this was 
achieved by overexpression of the chaperone, Hsp72 (Gupta et al., 2010). In general, it 
seems this particular IRE1-associated route offers protection against apoptosis. 
 
1.3.3: IRE1α kinase activity leads to JNK activation 
Over a decade ago, the Ron group highlighted the association between IRE1α kinase activity 
and IRE1α-TRAF2 interaction. Using TRAF2 dominant negative mutants, they then went on 
to show that the formation of active phospho-JNK required WT TRAF2 (Urano et al., 2000). 
This evidence was reinforced by coimmunoprecipitation experiments which placed JNK 
activation downstream of IRE1α-TRAF2 complex formation (Nishitoh et al., 2002). It was 
elucidated that the specific MAP kinase cascade which leads to JNK activation uses the 
MAPKKK, ASK1. It is believed that IRE1α-TRAF2-ASK1 association into a heterotrimeric 
complex is dependent on ER-stress activation. Formation of this complex leads to JNK 
activation, which in turn can contribute to cell death (Nishitoh et al., 2002). This idea is 
supported by the fact that ASK1-interacting protein 1 (AIP1), which also binds directly to 
IRE1α, is required for cell death signalling via the JNK pathway (Luo et al., 2007). 
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1.3.4: The TRAF2-JNK arm encourages cell death 
 
It was demonstrated that the kinase-dead I642G-IRE1α mutant displays improved survival 
(Lin et al., 2007). As described above, this mutant has lost phosphotransfer potential but 
when bound to 1NM-PP1 has an active RNase (Han et al., 2008). This is suggestive of 
segregation between RNase and kinase functions and their roles in promoting life and death, 
respectively. This section discusses the process of cell death, followed by the relationship 
between this and JNK activation. 
 
The balance between cell life and death is dictated by the balance of Bcl-2 family members 
(Figure 1.3). Antiapoptotic members of this family are able to sequester proapoptotic ones, 
thus offering protection to the cell (Bassik et al., 2004). Conversely, proapoptotic proteins 
belonging to this family are able to initiate a caspase cascade, which culminate in cell death. 
 
The Bcl-2 proteins are thought to link the UPR to cell death. 13 years ago, it was found that 
the two key proapoptotic members, BAX and BAK, which are located in the mitochondrial 
membrane, potentiate ER stress signals (Wei et al, 2001). Both BAX and BAK are thought 
to oligomerise to create a pore in the mitochondrial membrane. This disrupts the normal 
calcium flux of this organelle, encouraging cell death (Eskes et al., 2000; Wei et al., 2000). 
However, calcium mobilisation associated with apoptosis is not only a feature of the 
mitochondria. BAX-deficient cell lines also show reduced calcium loss from the ER, 
associated with increased cell survival (Nutt et al., 2002). In a set of experiments where bax 
and bak double knockouts were reconstituted with a form of BAK targeted to the ER 
membrane, it was found that this Bcl-2 protein also controlled ER membrane potential 
(Zong et al., 2003). 
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Figure 1.3: The role of Bcl-2 protein family members in influencing cell fate. As stated in 
the text above, BAX and BAK are able to form a pore in the ER or mitochondrial 
membranes where they can alter calcium ion flux. At the ER membrane, calcium ion 
release is thought to be inhibited by the two anti-apoptotic proteins, Bcl-2 and Bcl-XL 
(Nutt et al., 2002; Wang et al.,2011). Bcl-2 impairs BAX/BAK pore formation at the 
mitochondrial membrane (Dlugosz et al., 2006). Conversely, tBid supports pore formation 
(Wei et al., 2000). 
Where proapoptotic Bcl-2 proteins become active, cell death ensues via caspase activation. It 
was demonstrated that ER-localised procaspase-12 was only cleaved and activated as a 
result of ER stress, when BAX and BAK were present (Zong et al., 2003). Despite the 
mechanism of caspase-12 activation being unclear, it has been suggested that BAX and 
BAK enhance IRE1α signalling via direct interaction (Hetz et al., 2006). This, in turn, may 
allow more effective recruitment of TRAF-2, which itself has been implicated in cleavage 
and subsequent activation of procaspase-12 (Yoneda et al., 2001). Alternatively, caspase-12 
has been proposed to be cleaved by calpains, which in turn are activated by release of 
calcium ions from the stressed ER (Tan et al., 2006). Whichever mechanism propagates 
cleavage of this caspase during ER stress, a caspase cascade is initiated and ends with the 
activation of the executioner caspase, caspase-3 (Morishama et al., 2004 and Figure 1.4). 
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Figure 1.4: Caspase cascade triggered during ER stress-mediated cell death. The exact 
input of TRAF2/BAX/BAK complex with IRE1α is unknown. 
 
So what makes JNK proapoptotic? In vitro kinase assays used in two different publications 
show that JNK is able to phosphorylate and activate proapoptotic BimL and BimEL 
isoforms (Lei and Davis, 2002; Putcha et al., 2003). The phosphorylation of BimL attenuates 
its sequestration by dynein light chain 1. This ‘free form’ of BimL is able to induce 
apoptosis, as shown by annexin-V staining (Lei and Davis, 2002). This cell death was found 
to be mediated by mitochondrial BAX, as only reconstitution of this protein into BAX 
knockout cells enabled cell death after Bim phosphorylation (Putcha et al., 2003). 
 
JNK also phosphorylates Bcl-2, which effectively silences its antiapoptotic function 
(Yamamoto et al., 1999). Thus, amongst its interaction with other proteins, Bcl-2 can no 
longer inhibit the oligomerisation of BAX in the mitochondrial membrane – a process 
thought to potentiate cell death (Mikhailov et al., 2001). This data was exploited by Bassik 
et al., in 2004, who utilised a non-phosphorylatable form of Bcl-2 to enforce its 
cytoprotective effects. 
 
However, it was later established that JNK also phosphorylates BAD, which subsequently 
releases Bcl-XL (Yu et al., 2005). This in turn may oppose proapoptotic BAX activity. These 
findings mean there is some debate about the contribution of JNK activation to ER stress-
induced cell death. To help resolve this debate, it should first be experimentally determined 
that it is specifically the IRE1α kinase activity that causes these changes downstream of ER 
stress, since many factors are known to activate JNK. 
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Figure 1.5: Summary of the role of phospho-JNK in apoptosis via Bcl-2 protein family 
members. 
 
1.3.5: IRE1α kinase: a role in cell survival? 
 
A different theory focussing on the IRE1 kinase activity and cell fate has recently been 
proposed in yeast. It was shown that an active kinase within Ire1p was required to complete 
the cellular recovery ‘circuit’ after ER-stress had been resolved, and may thus play a 
beneficial role (Rubio et al., 2011). The Walter group found that phosphotransfer 
incompetent Ire1p mutants were unable to recover from ER stress due to the fact that the 
RNase function was not ‘switched off’. This complies with the theory proposed by Chawla 
et al in 2011, who suggest yeast cell death was more likely if the Ire1p RNase was not 
properly deactivated by a fully functional kinase domain. 
 
1.3.6: Other functions of IRE1α endoribonuclease which influence cell survival: the 
RIDD pathway and beyond 
 
Suspicions about the specificity of the RNase function of IRE1α were raised when it was 
discovered that hIRE1α was able to cleave its own mRNA transcript in vivo (Tirasophon et 
al., 2000). This fact was exploited by Hollien and Weissman in 2006, who, by microarray 
analysis, found a particular collection of genes were downregulated during ER stress. The 
possibility that this was due to blocking transcription was eliminated by experiments using 
actinomycin D – a drug which inhibits RNA synthesis (Reich et al., 1961). The 
downregulation was instead found to be a result of mRNA cleavage by the endoribonuclease 
of IRE1α (Hollien and Weissman, 2006). 
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This degradation route was later referred to as the RIDD (regulated IRE1-dependent decay) 
function of IRE1α (Hollien et al., 2009). For the Weissman group the 1NM-PP1-activated 
I642G-IRE1α mutant (described in section 1.3.2) served as a tool enabling them to 
distinguish between different endonucleolytic activities of IRE1α. They observed that RIDD 
only occurred under conditions of ER stress. However, in the absence of ER stress, this 
mutant was still able to produce spliced XBP-1, suggesting that RIDD and ‘classical 
splicing’ are different despite both requiring the endoribonuclease function of IRE1α. This 
group concluded that since the majority of the mRNA transcripts targeted by RIDD normally 
passed through the ER for modification, RIDD activity may contribute to reducing protein 
load in the stressed ER, thus promoting survival (Hollien et al., 2009). 
 
A separate group’s findings also support the fact that XBP-1 splicing and mRNA 
degradation are separable. However they found that IRE1 must maintain its phosphotransfer 
capacity to activate RIDD, and therefore the I624G mutant would be insufficient. 
Furthermore, their data argues that this type of mRNA degradation correlates positively with 
ER stress-mediated apoptosis (Han et al., 2009). Further studies on the RIDD pathway need 
to be carried out in an attempt to reconcile the two models. 
 
Finally, recent work involved in IRE1α RNase-mediated cleavage of microRNAs seems to 
be gaining importance in terms of how this transmembrane protein influences cell death. 
One group reported that cleavage of one particular micro-RNA (miR-17) permitted the 
accumulation of TXNIP, which in turn was then able to engage with inflammatory 
machinery thus paving the way for cell death (Lerner et al, 2012). At the time, it was not 
known whether this was IRE1α specific cleavage, although a later study from the same 
laboratory discovered that IRE1α mediated cleavage of miR-17, amongst others, gave rise to 
an increase in the proapoptotic caspase-2 protein (Upton et al., 2012). These data point 
towards a multifactorial function of the endoribonuclease activity of IRE1α that may help 
and/or hinder cell life depending on several variables. 
 
1.4: The interaction between IRE1α and ERAD 
 
ER-associated degradation (ERAD) is a proteasomal degradation route used to eliminate 
proteins that are unable to undergo appropriate folding in the ER lumen. Mammalian cells 
normally have around 30,000 proteasomes, with the 26 S proteasome representing the best 
characterised of all the different types (Lodish et al., 2008). Recognition of proteasomal 
substrates precedes their retrotranslocation/dislocation out of the ER, probably via the Sec61 
pore (Nakatsukasa and Brodsky, 2009). Proteins can subsequently be targeted for 
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degradation by a process known as ubiquitination. Ubiquitin is activated courtesy of an E1 
enzyme. In this ATP-dependent reaction, ubiquitin is linked to a cysteine residue of the E1. 
The ubiquitin can then be transferred to an E2 ubiquitin-conjugating enzyme. In the final 
step, the E3 ubiquitin ligase binds both the target protein to be degraded and the E2. 
Addition of the ubiquitin ‘tag’ to the misfolded protein can then be conducted by the specific 
E3 ligase (Hershko and Ciechanover, 1998). Normally, several molecules of ubiquitin are 
added to the substrate forming a polyubiquitin chain. Once this process has been carried out, 
the protein is translocated to the proteasome where it is degraded by resident proteases 
(Lodish et al., 2008). 
 
 
Figure 1.6: Schematic highlighting the process of ERAD: the misfolded protein is targeted 
to the proteasome after addition of a K48 polyubiquitin chain. 
It was crucially established that there was an important interplay between the UPR and ER-
associated degradation (ERAD) where the two processes could compensate for one another 
(Travers et al., 2000). This fundamental study was used to demonstrate that the Ire1p-Hac1p 
pathway in yeast was required for effective proteasomal degradation of misfolded proteins 
via ERAD. It is known that in mammalian cells components of ERAD are upregulated upon 
UPR activation by XBP-1(s) and ATF6(f) transcription factors (Shoulders et al., 2013). 
 
HRD1 has been recognised as a key E3 ubiquitin ligase upregulated by the UPR to facilitate 
ERAD (Travers et al., 2000 and Shoulders et al., 2013). The precise role of HRD1 is 
intriguing as it was suggested there was a correlation between the presence of this protein 
and the disappearance of IRE1, leading one group to believe HRD1 (also known as 
synoviolin) was promoting proteasomal degradation of IRE1 (Gao et al., 2008). 
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ER-localised EDEM is believed to play an important role in ERAD, as it facilitates the 
degradation of glycoproteins. It was demonstrated that the IRE1α-XBP-1 branch of the UPR 
was solely responsible for transcriptionally upregulating this gene (Yoshida et al, 2003). 
This group also observed a correlation between a less responsive ERAD pathway and the 
absence of the XBP-1(s) transcription factor, further highlighting the relationship between 
the UPR and ERAD. 
 
Finally, HERP, whose function has not been fully characterised (reviewed in Bernasconi et 
al., 2013) has an N-terminal ubiquitin-like domain that has been proposed to function in the 
dislocation of polyubiquitinated proteins from the ER (Ma and Hendershot, 2004). What is 
known is that, unlike EDEM, it requires both ATF6 and XBP-1 pathways to converge to 
produce the maximal transcriptional output (Ma and Hendershot, 2004).  
 
These three genes represent a subset of ERAD components which require IRE1α 
endoribonuclease to generate XBP-1(s) to drive their full expression. The capability of 
ERAD to degrade unfolded proteins from within the ER lumen presumably renders it 
‘protective’ in terms of the UPR. Indeed, it is well known that inhibition of the proteasome 
by MG132 increases ER stress-induced cell death (Lee et al., 2003; Amanso et al., 2011; 
Williams et al., 2013). However, it has been difficult to identify exactly which ERAD 
components are essential for mammalian cell survival. A likely reason for this is probably 
due to functional redundancy within the system. For example, it is now believed that there 
are over 20 ER-localised E3 ligases which may target substrates for degradation from the ER 
(Neutzner et al., 2011).  
 
1.5: The relationship between IRE1α and autophagy 
 
Apart from ERAD, autophagy is the other cellular degradation route and it has been 
implicated in both cell survival and death (Kundu and Thompson, 2008). It involves the 
delivery of polypeptides and entire organelles to the lysosome, where they can subsequently 
be broken down (Lodish et al., 2008). The process of autophagy involves the formation of a 
membrane which is able to form the autophagosome. This in turn fuses to the lysosome 
forming the mature lysosome, or autolysosome, which contains an acidic lumen harbouring 
several digestive hydrolases (Aredia et al., 2012). There are three types of autophagy: 
macroautophagy, microautophagy and chaperone-mediated autophagy, each of which is 
considered to be part of the protein quality control system within eukaryotic cells. Several 
links between autophagy and the UPR have been postulated.  
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Autophagy begins with an event known as nucleation, where the phagophore is formed. It is 
thought that the ER is able to provide membrane to help generate this structure (Tooze and 
Yoshimori, 2010). In the presence of the ATG16 homodimer, the ATG5-ATG12 complex is 
believed to control extension of this structure (Mizushima et al., 2003). This complex is also 
thought to target and encourage conversion of LC3-I to LC3-II by addition of 
phosphatidylethanolamine in the growing phagophore membrane (Mizushima et al., 2001; 
Fujita et al., 2008) This, in turn, further aids the elongation and completion of the 
phagophore (Xie et al., 2008) which encompasses cargoes such as protein aggregates. Upon 
completion of the phagophore, the double-membranes vesicle, known as the autophagosome 
is formed. 
 
Early studies in 2006 indicated that the kinase activity of IRE1α was required to promote 
autophagosome formation, via an undefined TRAF2-JNK signalling cascade. This also 
correlated with an increase in cell survival (Ogata et al, 2006). To determine this, a truncated 
IRE1α mutant lacking the RNase domain was compared to the K599A-hIRE1α mutant, 
which lacks both RNase and kinase activities. Only the K599A-hIRE1α mutant displayed a 
decrease in autophagic activity. JNK inhibition and introduction of a dominant negative 
form of TRAF2 displayed similar effects. Using the knowledge that Bcl-2 is a JNK 
phosphorylation substrate (Bassik et al., 2004) and that the uncoupling of Bcl-2 from Beclin-
1 could be required for activation of autophagy (Pattingre et al., 2005), the mechanism for 
how JNK promotes autophagy has been elucidated (Wei et al., 2008). Using both jnk1
-/-
 and 
jnk2
-/-
 MEFs, it was demonstrated that JNK1 was required to mediate the phosphorylation 
and subsequent release of Bcl-2 from Beclin-1 under conditions of stress. This free Beclin-1 
was then able to bring about the autophagic response (Wei et al., 2008). These data all infer 
that kinase function is beneficial to the cell via the autophagic route.  
 
Despite the above evidence, a separate group demonstrated that a functional kinase domain 
actually impaired autophagy, and consequentially led to the accumulation of mutant 
huntingtin (Lee et al., 2011). For these experiments, autophagy was measured using a 
doubly fluorescent form of LC3, alongside accumulation of p62. These studies may comply 
with a model concerning mTORC1. This complex inhibits autophagy and was shown to 
stabilise the IRE1α-TRAF2-JNK arm (Kato et al., 2012).  
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Controversy over the regulation of autophagy by the IRE1α-XBP-1 arm also exists. Whilst 
overexpressing the spliced form of this transcription factor did not alleviate accumulation of 
mutant huntingtin in SH-SY5Y cells (Lee et al., 2011), the conversion of unspliced XBP-1 
(XBP-1(u)) to spliced XBP-1 (XBP-1(s)) correlated with the clearance of misfolded 
rhodopsin in photoreceptor cells (Chiang et al., 2011). On the other hand, knockdown of 
XBP-1 using short hairpin RNA showed an increase in autophagy and cell survival in a 
familial ALS motor neuron-like model (Hetz et al., 2009).  
 
The role of each of the IRE1α arms in controlling degradation processes is likely to be 
complex and dependent on a number of variables, such as severity of stress and cell type. It 
is likely that both autophagy and ERAD play an important role in the UPR, and that these 
two processes are not mutually exclusive. For example, although a damaged proteasome 
would undoubtedly compromise the cells’ ability to recover from the stress of unfolded 
proteins, it has been shown that lysosomal degradation is able to share some of the burden 
when ERAD is blocked chemically (Chiang et al., 2011). 
 
1.6: How does IRE1α affect the physiology of the ER? 
 
The ER is a very plastic compartment and forms a complex network of interconnected 
tubules and sheets. Interest regarding the morphology and biogenesis of the ER has recently 
been building and could help provide an alternative and complementary mechanism for the 
UPR to restore homeostasis to this organelle. Using fibroblasts, Sriburi et al., (2004) 
demonstrated that retroviral expression of the spliced form of XBP-1 induced an increase in 
the levels of phosphatidylcholine and phosphatidylethanolamine. These two lipids are 
located within the membranes of intracellular structures (Lykidis and Jackowski., 2001). 
This correlated with the observed increase in size and volume of the ER seen in electron 
micrographs. They proceeded to analyse aspects of the Kennedy pathway, which is 
responsible for producing a large proportion of cellular phosphatidylcholine. It was 
discovered that the activities of both the rate-limiting enzyme and the enzymes involved in 
the final stage of the pathway were both higher in cells expressing spliced XBP-1 compared 
to cells transfected with an empty control vector (Sriburi et al., 2004).  
 
The same group later elucidated that increased translation of the α isoform of the rate-
limiting choline cytidylyltransferase (CCT) downstream of XBP-1(s) expression was, at 
least, partially responsible for the synthesis of ‘excess’ ER membrane lipids (Sriburi et al., 
2007). The dependence of ER proliferation and expansion on the spliced transcription factor 
downstream of IRE1α RNase activity was also discovered in yeast (Schuck et al., 2009). By 
blocking the splicing of HAC1 mRNA, the ER became disorganised and ‘tangled’. 
31 
 
 
The importance of the change in ER morphology during the UPR is highlighted in 
mammalian cells, as it was reported that there was a degree of redundancy between 
XBP-1(s) and ATF6α(f). Overexpression of an ATF6α fragment was able to increase ER 
volume independently of XBP-1(s), however, the stage of the Kennedy pathway affected 
was different compared to the changes induced by the latter mentioned transcription factor 
(Bommiasamy et al., 2009).  
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1.7: Final remarks 
 
This introduction has highlighted the crucial role of IRE1α in cell fate decisions. ER stress-
mediated cell death has gained recent importance as it is known to play a role in several 
diseases, including Parkinson’s disease and diabetes (Kim et al., 2008; Scheuner and 
Kaufman, 2007). Restoring ER homeostasis whilst avoiding the apoptotic pathway is the key 
to finding therapeutic targets to help treat disease. First though, many remaining questions 
regarding UPR signalling must be answered. This project attempted to elucidate whether 
IRE1α kinase activity contributes to cell survival independent of its endoribonuclease 
function. Different techniques were used to try and answer how the kinase activity was 
achieving this, in order to further understand the complexity of this signalling pathway.  
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1.8: Hypotheses and objectives: 
 
A former PhD student in the Schröder lab, Dr. Louise Sutcliffe, generated three Flp-In T-
Rex MEF cell lines encoding, WT-hIRE1α, D711A-hIRE1α or K599A-hIRE1α, in an ire1α-/- 
background. It was demonstrated that there were increased PARP-1 cleavage levels in the 
mutants (figure A1.2) when tetracycline was added to induce expression of the different 
forms of hIRE1α (see section 2.3 and figure 2.1). MTT tests carried out over 48 h of 
tunicamycin treatment showed similar decreases in viability in both mutants compared to the 
WT-hIRE1α, which was more able to survive ER stress (figure A1.2). For the latter 
experiment 100 ng/ml of the ER-stressor, tunicamycin was used despite the fact that much 
higher concentrations of this drug have been used (Urano et al., 2000; Nishitoh et al., 2002). 
The low concentration of tunicamycin used in this project allows the protective function of 
the kinase activity to be uncovered as ER stress is less severe. 
From these data, it was proposed that IRE1α kinase activity protects from cell death 
downstream of UPR activation. This kinase domain may control this by a number of 
mechanisms which include: upregulation of ERAD and/or autophagy, control of the RIDD 
pathway, and change in gene expression. The following aims were proposed to test these 
ideas: 
 
1a) Comparison of levels of apoptotic cell death markers between WT-hIRE1α, D711A-
hIRE1α, and K599A-hIRE1α cells to establish and confirm previous results suggesting 
kinase activity protects cells from ER stress. This will be done by Western blotting against 
PARP-1 and caspase-3 cleavage. 
b) Since JNK activation is implicated in ER stress related cell death, characterisation of this 
protein by analysing total JNK and phospho-JNK forms from cell lysates will follow. 
c) Characterisation of the status of eIF2α phosphorylation and CHOP activation downstream 
of PERK signalling will be analysed using Western blotting. 
2) Quantitative RT-PCR will be carried out to obtain a partial transcript profile of the WT-
hIRE1α and mutant cells. The genes being analysed can be separated into genes induced by 
the UPR, and genes whose mRNA is cleaved by the RIDD pathway (Hollien et al., 2009). 
This may help address which mRNAs are induced in the different cell lines as a result of the 
UPR being activated and whether or not RIDD functions in the D711A-hIRE1α cells.  
3) Preparation and characterisation of plasmids encoding ATF6, mCherry-GFP-LC3b, and 
ERAD substrates. The first plasmid will allow the study of changes in ATF6 activity in the 
different cell lines. The mCherry-GFP-LC3b plasmid will enable the question regarding 
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whether autophagy is defective in the mutant cells to be answered. Finally, it will be able to 
be determined whether there are any changes in ERAD activity between the three cell lines, 
by using plasmids encoding ERAD substrates. For these experiments, [
35
S]-methionine pulse 
chase experiments will be carried out following transient transfection.   
4) It is possible that its kinase activity may play a role in the proliferation and/or 
organisation of the ER during the UPR. Transmission electron microscopy will be used to 
analyse untreated and treated cell lines, to estimate the average width of the ER. ER-tracker 
will also be used to obtain an estimate for the volume of the ER.  
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Chapter 2 
 
Materials and Methods 
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2.1: List of antibiotics, reagents and chemicals 
Name Product Number Company 
25 % glutaraldehyde R1012 Agar Scientific, Stansted, 
UK 
5xFirst Strand Buffer Y02321 Invitrogen, Paisley, UK 
5xgreen GoTaq®Flexi Buffer M891A Promega, Southampton, UK 
Acetic acid (HOAc) A/0360/PB17 ThermoFisher, 
Loughborough, UK 
Agar 100 Resin kit R1031 Agar Scientific, Stansted, 
UK 
Agarose (electrophoresis grade) MB1200 Melford, Ipswich, UK 
Ampicillin A0104 Melford, Ipswich, UK 
β-Mercaptoethanol M-6250 Sigma-Aldrich, Gillingham, 
UK 
Blasticidin S·HCl in HEPES buffer B1105 Melford, Ipswich, UK 
Bovine serum albumin A2153-50G Sigma-Aldrich, Gillingham, 
UK 
Bromophenol blue 11439 Sigma-Aldrich, Gilliangham, 
UK 
Complete mini protease inhibitors 11836 153 001 Roche, Welwyn Garden 
City, UK 
DAPI D9642 Sigma-Aldrich, Gillingham, 
UK 
dATP  R0141 ThermoFisher, 
Loughborough, UK 
dCTP  R0151 ThermoFisher, 
Loughborough, UK 
DEPC A0300574 Acros Organics, 
Loughborough, UK 
D-Glc G/0500/61 Fisher Scientific, 
Loughborough, UK 
dGTP  R0161 ThermoFisher, 
Loughborough, UK 
DMSO D5879-100ML Sigma-Aldrich, Gillingham, 
UK 
DTT (0.1M for reverse transcription) Y00147 Invitrogen, Paisley, UK 
dTTP R0171 ThermoFisher, 
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Loughborough, UK 
EDTA D/0700/53 ThermoFisher, 
Loughborough, UK 
ER-Tracker™ Red E34250 Invitrogen, Paisley, UK 
Ethanol E/0650DF/25 ThermoFisher, 
Loughborough, UK 
Ethidium bromide E1510-10ML Sigma-Aldrich, Gillingham, 
UK 
Fish gelatin G7765 Sigma-Aldrich, Gillingham, 
UK 
Glycerol G/0650/17 ThermoFisher, 
Loughborough, UK 
Glycine BP381-1 ThermoFisher, 
Loughborough, UK 
Glycogen RNA-grade R0551 ThermoFisher, 
Loughbourough, UK 
Hygromycin B 40052 Calbiochem, Nottingham, 
UK 
LB-Agar LENNOX LBX0202 Formedium Ltd, Hunstanton, 
UK 
LB-Broth LENNOX LBX0102 Formedium Ltd, Hunstanton, 
UK 
Lead nitrate C008 EMScope, Ashford, UK 
Methanol M/4000/PC17 ThermoFisher, 
Loughborough, UK 
MgCl2 (25mM for PCR) A351H Promega, Southampton, UK 
Na2EDTA·2H2O D/0700/53 ThermoFisher, 
Loughborough, UK 
Oligo(dT)15 (50 μM) C1101 Promega, Southampton, UK 
Paraformaldehyde R1018 Agar Scientific, Stansted, 
UK 
Pepstatin A BIMI2205 Apollo scientific, Stockport, 
UK 
PhosSTOP 04906837001 Roche, Welwyn Garden 
City, UK 
Potassium hydroxide pellets P/5600/53 ThermoFisher, 
Loughborough, UK 
Propan-2-ol P/7490/17 ThermoFisher, 
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Loughborough, UK 
RNasein® ribonuclease inhibitor N221A Invitrogen, Paisley, UK 
Sodium cacodylate R1102 Agar Scientific, Stansted, 
UK 
Sodium chloride S/3120/65 ThermoFisher, 
Loughborough, UK 
Sodium citrate 10242 BDH, Poole, UK 
Sodium deoxycholate D6750 Sigma-Aldrich, Gillingham, 
UK 
Sodium dodecyl sulphate BPE116-500 ThermoFisher, 
Loughborough, UK 
Sodium hydroxide S/4920/53 ThermoFisher, 
Loughborough, UK 
Tetracycline 87130 Sigma-Aldrich, Gillingham, 
UK 
Trichloroacetic acid (TCA) T4885-500G Sigma-Aldrich, Gillingham, 
UK 
Tris (hydroxymethyl) methylamine T/3710/60 ThermoFisher, 
Loughborough, UK 
Triton X-100 282103-5G Sigma-Aldrich, Gillingham, 
UK 
Tunicamycin 645380 Calbiochem 
Tween 20 P1379-500ml Sigma-Aldrich, Gillingham, 
UK 
Uranyl acetate 102088 BHD, Poole, UK 
 
2.2: List of cell culture chemicals 
Note that all chemicals used for cell culture were sterile-filtered and only opened under 
sterile conditions in a microbiolgical safety cabinet which was cleaned with 70% (v/v) 
ethanol. If necessary, filter sterilisation was carried out using a 0.2 m sterile filter and 
syringe.  
Name Product Number Company 
0.25% (w/v) Trypsin-EDTA 
Solution 
T4049-100 ml Sigma-Aldrich, Gillingham, UK 
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DMEM high glucose  D5671 (500 ml) Sigma-Aldrich, Gillingham, UK 
DMEM high glucose w/o L-
glutamine w/ sodium pyruvate 
LM-D1112/500 Biosera, Uckfield, UK 
Dulbecco's phosphate 
buffered saline (PBS) 
D857 (500 ml) Sigma-Aldrich, Gillingham, UK 
Fetal bovine serum S1830 Biosera, Uckfield, UK 
L-glutamine G7513-100 ml Sigma-Aldrich, Gillingham, UK 
Penicillin-streptomycin, 
solution stabilised, sterile-
filtered, suitable for cell 
culture 
P4333-100 ml Sigma-Aldrich, Gillingham, UK 
Tetracycline-free fetal bovine 
serum 
FB-1001/500 Biosera, Uckfield, UK 
Trypan blue solution 0.4% 
(w/v) 
T8154 (100 ml) Sigma-Aldrich, Gillingham, UK 
 
2.3: List and description of cell lines used in cell culture 
Cell type Genotype Source  
MEF ire1α
-/-
 MEF stable Flp-In T-Rex 
IRE1α/Tet transfected cells hIRE1α 
Schröder Lab, Durham 
University, UK 
 
MEF ire1α
-/-
 MEF stable Flp-In T-Rex 
IRE1α/Tet transfected cells hIRE1α-
D711A 
Schröder Lab, Durham 
University, UK 
 
MEF ire1α
-/-
 MEF stable Flp-In T-Rex 
IRE1α/Tet transfected cells hIRE1α-
K599A 
Schröder Lab, Durham 
University, UK 
 
HEK293   Cann Lab, Durham University, 
UK 
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The ire1α-/- MEFs were received from the Kaufman lab and generation of the three stable 
MEF cell lines listed above was carried out by Dr. Louise Sutcliffe. Initially, the 
pFRT/LacZeo plasmid was transfected into the cells, introducing the FRT site and the zeocin 
resistance gene. Once positive cells had been selected with zeocin, the cells were transfected 
with pcDNA6/TR. This plasmid encodes the gene for the tetracycline repressor (TR) and the 
blasticidin resistance gene. After selection with blasticidin, these cells were co-transfected 
with pcDNA5-FRT-TO-hIRE1α and pOG44. The former plasmid encodes the tetracycline 
operator (TO), hIRE1α and the hygromycin resistance gene, and the latter expresses Flp 
recombinase. This enzyme allows the exchange of the zeocin resistance gene with the open 
reading frame of the pcDNA5 plasmid. Again, cells were selected, this time with 
hygromycin. This procedure was carried out with pcDNA5-FRT-TO-hIRE1α, pcDNA5-
FRT-TO-D711A-hIRE1α and pcDNA5-FRT-TO-D711A-hIRE1α. Thus, the Flp-In system 
allowed stable integration of the three forms of the hIRE1α gene into the MEF genome. 
 
Figure 2.1: The pcDNA5/FRT/TO-hIRE1α vector from Sutcliffe, 2012. 
Tetracycline binds the tetracycline repressor. This causes a conformational change in the tet 
repressor and it thus dislocates from the tetracycline operator, allowing expression of 
hIRE1α. This way, the role of hIRE1α can be closely studied, as its expression can be finely 
controlled using tetracycline and also because there are no ‘background’ effects from 
endogenous IRE1α. 
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2.4: List of commercially available kits 
Name Product Number Company 
Amersham
TM
 ECL
TM 
Western 
Blotting Detecting Reagents 
RPN2009 ThermoFisher, Loughborough, 
UK 
Criterion
TM
 TGX
TM 
Precast 
Gels 4-20% 
567-1094/95 Bio-Rad, Hemel Hempstead, 
UK 
DC
TM
 Protein Assay reagent A 500-0113 Bio-Rad, Hemel Hempstead, 
UK 
DC
TM
 Protein Assay reagent B 500-0114 Bio-Rad, Hemel Hempstead, 
UK 
DC
TM
 Protein Assay reagent S 500-0115 Bio-Rad, Hemel Hempstead, 
UK 
EndoFree® Plasmid Maxi Kit 
(10) 
13262 Qiagen, Manchester, UK 
EZ-RNA Kit (Solution A & B) K1-0120 Geneflow, Lichfield, UK 
GeneRuler™ 1 kb DNA Ladder SM0311 ThermoFisher, Loughborough, 
UK 
GeneRuler™ DNA Ladder Mix SM0331 ThermoFisher, Loughborough, 
UK 
GoTaq® qPCR MasterMix A6002 Promega, Southampton, UK 
jetPRIME  114-07 Polyplus transfection™, 
Illkirch, France 
PageRuler™Plus Prestained 
Protein Ladder 
26619 ThermoFisher, Loughborough, 
UK 
Pierce® ECL Plus Western 
Blotting Substrate 
32132 ThermoFisher, Loughborough, 
UK 
Precision 2xreal-time PCR 
MasterMix with SYBR Green 
Precision PrimerDesign, Southampton, 
UK 
Precision FAST 2xreal-time 
PCR MasterMix with SYBR 
Green 
 Precision-R PrimerDesign, Southampton, 
UK 
Restore
TM
 Western Blot 
Stripping Buffer 
21059 ThermoFisher, Loughborough, 
UK 
RunBlue SDS Precast Gels 4-
12% 10cmx10cm 
NXG41212/27 Expedeon, Manchester, UK 
Wizard®SV Gel and PCR 
Clean-Up System 
A9282 Promega, Southampton, UK 
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2.5: List of Escherichia coli strains 
Name Genotype Source 
DH5α F- Ф80lacZΔM15 Δ(lacZYA-
argF)U169  recA1 endA1 
hsdR17(rk
-
 , mk
+
) phoA  
supE44 thi-1 gyrA96 relA1 λ- 
Agilent, Stockport, UK 
XL10-GOLD Tet
r
 Δ(mcrA)183Δ(mcrCB-
hsdSMR-mrr)173 endA1 
supE44 thi-1 recA1 gyrA96 
relA1 lac Hte [F’ proAB 
lacI
qZ ΔM15 Tn10 (Tetr) Amy 
Cam
r
] 
Agilent, Stockport, UK 
 
2.6: List of plasmid maps 
 
Figure 2.2: Plasmid map for the mCherry-GFP-LC3b construct. The restriction sites of 
the enzymes used for diagnostic digest characterisation are shown. The oligonucleotide 
used to sequence this plasmid is marked (H8428) and these sequences can be found in the 
list of oligonucleotides in section 2.8. The ORF encoding murine LC3b is highlighted in 
red. Other ORFs are coloured yellow, whereas promoters are blue. 
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Figure 2.3: Plasmid map of pREP9-NHK-α1AT. The oligonucleotides used to sequence 
this plasmid are marked (H8833 and H8834) and these sequences can be found in the list 
of oligonucleotides insection 2.8. The point mutation (T237A) and the deletion (ΔTC) are 
also highlighted. The ORF for the Hong Kong null α1-antitrypsin is shown in red. Other 
ORFs are coloured yellow, whereas promoters are blue and origins are green. 
 
Figure 2.4: Plasmid map of pcDNA3-TCRα. The oligonucleotides used to sequence this 
plasmid are marked (H8428 and H8832) and details of these can be found in list 2.8. The 
ORF encoding TCRα is highlighted in red. Other ORFs are coloured yellow, whereas 
promoters are blue and origins are green. 
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Figure 2.5: A plasmid map of pCl-neo-RI332-6xHA. The restriction sites of the enzymes 
used for diagnostic digest characterisation are shown. The ORF for RI332 is coloured red, 
whereas other ORFs are yellow. Promoters and origins are blue and green, respectively. 
 
2.7: List of enzymes 
Name Product Number Company 
BssHII 11168851001 Roche, Welwyn Garden City, 
UK 
EcoRI ER0271 ThermoFisher, Loughborough, 
UK 
GoTaq® DNA Polymerase M830B Promega, Southampton, UK 
NotI ERO591 ThermoFisher, Loughborough, 
UK 
PstI ER0611 ThermoFisher, Loughborough, 
UK 
RNaseA R-4875 Sigma-Aldrich, Gillingham, 
UK 
SalI ER0641 ThermoFisher, Loughborough, 
UK 
Superscript® III Reverse 
transcriptase 
56575 Invitrogen, Paisley, UK 
XhoI ER0691 ThermoFisher, Loughborough, 
UK 
XmaI R01805 NewEngland BioLabs, Ipswich, 
UK 
 
  
Lane: 1            2            3
*1,200 
base-pairs
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2.8: List of oligonucleotides 
Primers were all ordered lyophilised and were diluted in 1xTE (1 part 10 x TE buffer, 9 parts 
sterile H2O) buffer to a concentration of 100 μM. This was used as a stock concentration 
from which 10 μM working dilutions were prepared using RNase and DNase-free water. 
List of oligonucleotides, where F = forward and R = reverse. The annealing temperature is 
generally, approximately 5°C below the lowest melting temperature of each of the primer 
pairs. PCR and qPCR were used to optimise annealing temperatures using mouse cDNA. 
Inventory 
Number 
Purpose Sequence Annealing 
temp/°C 
H8428 pcDNA3 5’ primer CAAAATCAACGGGACTTTCC 50 
H8778 CHOP F mouse TCTTGAGCCTAACACGTCGAT 55 
H8779 CHOP R mouse CGTGGACCAGGTTCTGCTTT 55 
H8780 GADD34 F mouse TCTCTTCCAGGTGGCCTTCTA 55 
H8781 GADD34 R mouse GAAGTGTACCTTCCGAGCTT 55 
H8784 
RAMP4 F mouse 
GAAGAAAAGGCGTCGGTAGG 50 
H8785 RAMP4 R mouse CTAGGGCATCGAACATCAGG 50 
H8786 ERO1L-α F mouse GCGGACCAAGTTATGAGTTCC 55 
H8787 ERO1L-α  R mouse GAAACAGGCACATTCCAACC 55 
H8792 GRP94  F mouse TAGAAAAGGCTGTGGTGTCG  55 
H8793 GRP94 R mouse GGGTGTCTAGGATTGATTTCG  55 
H8794 p58
IPK 
 F mouse CGGGAAGGCTTAGAGAAAGC 55 
H8795 p58
IPK 
 R mouse GAAATTATCTGGATGCCACTGC 55 
H8796 EDEM1 F mouse TGGAAAGCTTCTTTCTCAGC 55 
H8797 EDEM1 R mouse ATTCCCGAAGACGTTTGTCC 55 
H8798 HERP F mouse TGATGAGATAAACCGAGACTGG 55 
H8799 HERP R mouse CCTCTGTCTGAACGGAAACC 55 
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H8802 HGSNAT F mouse CTGCTTTGCCTTCTTCATCC 55 
H8803 HGSNAT R mouse TCTTTGTGTGACTGCTCATCC 55 
H8804 BLOS1 F mouse GTTGGTGGATCACCTCAACG 55 
H8805 BLOS1 R mouse TCCCCAATTTCCTTAAGTGC 55 
H8808 PDGFRB  F mouse CATCATCCCCTTACCTGACC 55 
H8809 PDGFRB R mouse CTTGCTGTGGCTCTTCTTGG 55 
H8810 PMP22 F mouse GCCAGCTCTTCACTCTCACC 69 
H8811 PMP22 R mouse GATGTAGGCGAAGCCATAGG 69 
H8812 COL6a1 F mouse CTGGGCCAGATGAGTGTGAG 55 
H8813 COL6a1 R mouse CATCCTTGCTCAACCGGTCA 55 
H8814 EPHRINB2 F mouse AATCACGGTCCAACAAGACG 55 
H8815 EPHRINB2 R mouse AATAAGGCCACTTCGGAACC 55 
H8818 SRp20 F mouse GGCGCAGATCCCCAAGAAG 55 
H8819 SRp20 R mouse TTTGCAAACTGGTCTTCTATTTCC 55 
H8820 TRIM16 F mouse TCAAGTGTCTGCCATTGTCC 55 
H8821 TRIM16 R mouse GTGGTGTTGGTGACCTTGC 55 
H8824 ERdj4  F mouse GGGGCGCACAGGTTATTAGA 65 
H8825 ERdj4 R mouse TTTGATTTGTCGCTCTGAGGC 65 
H8826 BiP F mouse GTGTGTGAGACCAGAACCGT 55 
H8827 BiP R mouse TCCTTCTTGTCCTCCTCCTCGG 55 
H8832 pcDNA3 3' primer GGCACCTTCCAGGGTCAAGG 60 
H8833 pREP9 5' primer GGACGAACCACTGAATTCCG   55 
H8834 pREP9 3' primer  GGTTACAAATAAAGCAATAGC 50 
H8944 HEDJ F mouse CCTCATCGGGACTGTGATCG 55 
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H8945 HEDJ  R mouse CTTGGGGGTCATCAGGGTTC 55 
H8952 HRD1 F mouse TCTTCCACTGCCGCATCG 55 
H8953 HRD1 R mouse CCATGGTCATCAGAATGGCG 55 
H8954 GALNT10 F mouse AGGCCTGATAAGGACCCGAA 55 
H8955 GALNT10 R mouse ATTGGGCACACGATGGTCTT 55 
H8956 ERO1L-β F mouse AAACCTTCCGGAGAACAGCC 55 
H8957 ERO1L-β R mouse TGTGCTGCAACAACGCTTTA 55 
H8960 MAP7d1 F mouse CAGCTCCCCTGGACGTAAGA 55 
H8961 MAP7d1 R mouse CTGCGATTTCTACTGGGGGA 55 
H8962 TRB3 F mouse TTTGGAACGAGAGCAAGGCA 55 
H8963 TRB3 R mouse CCACATGCTGGTGGGTAGG 55 
 
2.9: List of primary and secondary antibodies 
Primary antibodies used for Western blotting. In general dilutions were made in 5% (w/v) 
fat-free milk solution. If the antibody was specific to a phospho-form, then the dilutions 
were made in 5% w/v BSA solution. In the ‘host’ column, R = rabbit, M = mouse and G = 
goat. In the ‘clonality’ column, M = monoclonal and P = polyclonal. 
1° AB Host Clonality Supplier Product 
no. 
Dilution MW/kDa 
anti-HA 
(mouse)  
R P Sigma-
Aldrich, 
Gillingham, 
UK 
H6908 1:1000 Dependent on 
tag 
BIP R P Abcam, 
Cambridge, 
UK 
ab-53068 1:500 78 
Caspase-
12 
R P Cell 
Signalling, 
Hitchin, UK 
2202 1:1000 42,55 
Caspase-3 R M Cell 9665 1:1000 17,19,35 
48 
 
Signalling, 
Hitchin, UK 
CHOP Mo M Cell 
Signalling, 
Hitchin, UK 
2895 1:1000 27 
eIF2α R P Santa-Cruz, 
Heidelberg, 
Germany 
sc-11386 1:1000 36 
GAPDH Mo M Sigma-
Aldrich, 
Gillingham, 
UK 
G8795 1:20,000 37 
Human 
TcRα 
G P Santa-Cruz, 
Heidelberg, 
Germany 
sc-31275 1:200 34 
Human 
α1AT 
G P Source 
Bioscience, 
Nottingham, 
UK 
GTX2763 1:2000 52 
IRE1α R M Cell 
Signalling, 
Hitchin, UK 
3294 1:1000 130 
JNK R M Cell 
Signalling, 
Hitchin, UK 
9258 1:1000 46,54 
LC3B R P Cell 
Signalling, 
Hitchin, UK 
2775 1:1000 14,16 
PARP-1 R P Cell 
Signalling, 
Hitchin, UK 
9542 1:1000 116,89 
p-eIF2α R P Cell 
Signalling, 
Hitchin, UK 
9721 1:1000 38 
p-IRE1α R M Epitomics, 
Cambridge, 
UK 
pS724 1:1000 110 
p-JNK R M Cell 4668 1:1000 46,54 
49 
 
Signalling, 
Hitchin, UK 
 
The dilutions for all the secondary antibodies were made in a 5% (w/v) fat-free milk 
solution. 
Secondary 
Antibody 
Host Supplier Product 
number 
Dilution 
Anti-goat Mouse ThermoFisher, 
Loughborough, UK 
31400 1:20,000 
Anti-mouse Goat ThermoFisher, 
Loughborough,  UK 
31432 1:20,000 
Anti-rabbit Goat Cell Signalling, Hitchin, UK 7074S 1:1000 
Anti-rabbit Donkey ThermoFisher, 
Loughborough, UK 
31458 1:20,000 
 
2.10: Solutions and buffers 
Type I laboratory H2O was used to make the following solutions. This is defined as having: 
resistivity of less than 18 Ω-cm; total organic content of less than 10 parts per billion; less 
than 10 bacterial CFU/ml; and less than 0.03 EU/ml. Here, CFU stands for ‘colony forming 
unit’ and EU is ‘endotoxin units’. 
The autoclave cycle was at 121°C for 20 min at 1 atm. 
Name of 
buffer/solution 
Composition Quantity Recipe 
0.2 N NaOH + 
1% (w/v) SDS 
0.2 N NaOH 
1% (w/v) SDS 
500 ml 4 g NaOH and 5 g SDS were 
dissolved in ~450 ml H2O. H2O was 
then added to a final volume 500 ml. 
This solution was stored in a 
polyethylene bottle. 
1 M Tris·HCl 
(pH 8.0) 
1 M Tris·HCl (pH 
8.0) 
 60.57 g Tris were dissolved in ~ 400 
ml DEPC-H2O. The pH was adjusted 
with concentrated HCl. DEPC-H2O 
was added to a volume of 500 ml. 
The solution was then autoclaved. 
10 mg/ml 
tetracycline 
10 mg/ml 
tetracycline 
10 ml 100 mg tetracycline were dissolved 
in ~9 ml EtOH. EtOH was added so 
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as the total volume was 10 ml. After 
filter sterilisation 1 ml aliquots were 
placed into brown 1.5 ml 
microcentrifuge tubes and stored at 
-20°C. 
10 mg/ml 
tunicamycin 
10 mg/ml 
tunicamycin in 
DMSO 
1 ml 1 ml DMSO was added to 10 mg 
tunicamycin and mixed until 
dissolved. 50 μl or 100 µl aliquots 
were stored at -20°C. 
10 x SDS-
PAGE buffer 
1.92 M glycine 
0.248 M Tris 
10 g/l SDS 
1 l 144.13 g glycine, 30.03 g Tris and 
10.00 g SDS were dissolved in 900 
ml H2O to ~ 900 ml. Once 
completely dissolved, H2O was 
added to a total volume of 1 l.  
10 x DNA gel 
electrophoresis 
sample loading 
buffer 
20% (w/v) Ficoll 
400 
0.1 M EDTA 
1% (w/v) SDS 
2.5 g/l 
bromophenol blue 
50 ml 35 ml of H2O were added to 10 g 
Ficoll 400, 125 mg bromophenol 
blue, and 10 ml 0.5 M EDTA (pH 
8.0). After dissolving, the volume 
was adjusted to 45 ml with H2O and 
the solution was autoclaved. 5 ml of 
10% (w/v) SDS were then added. 
10 x semi-dry 
transfer buffer 
121.1 g Tris base 
144.13 g Glycine 
1 l 900 ml H2O were used to dissolve the 
Tris base and glycine. After the 
constituents had dissolved, the final 
volume was adjusted to 1 l. 
10 x TBS 24.2 g Tris base 
80 g NaCl 
1 l H2O was used to dissolve the Tris 
base and NaCl and the pH was 
adjusted to 7.6 using conc. HCl. 
10 x TE (pH 
8.0) 
100 mM Tris·HCl 
(pH 8.0) 
10 mM EDTA 
4 l 400 ml 1 M Tris·HCl (pH 8.0) were 
mixed with 80 ml 0.5 M EDTA. H2O 
was added to a total volume of 4 l 
and the solution was then autoclaved. 
100% (w/v) 
Trichloroacetic 
acid 
100% (w/v) 
trichloroacetic acid 
100 ml 100 g trichloroacetic acid was 
dissolved in ~80 ml H2O. H2O was 
then added to make 100 ml total 
volume. 
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2 mM dNTPs 2 mM dATP 
2 mM dCTP 
2 mM dGTP 
2 mM dTTP 
1 mM Tris·HCl 
(pH 8.0) 
 
1 ml 910 μl H2O and 10 μl 100 mM 
Tris·HCl (pH 8.0) were mixed 
together. The following were then 
added: 20 μl 100 mM dATP, 20 μl 
100 mM dCTP, 20 μl 100 mM dGTP, 
and 20 μl 100 mM dTTP.  
30% (v/v) 
glycerol 
30% (v/v) glycerol 500 ml 189 g glycerol was dissolved in H2O 
400 ml, and mixed well by stirring. 
The remaining H2O was added and 
the solution was autoclaved. 
4% (w/v) PFA 4% (w/v) PFA 100 ml 90 ml of PBS was added to 4 g of 
PFA powder. The solution was 
heated to 60°C and 1 M NaOH was 
added dropwise until the PFA 
powder had dissolved. The pH was 
then adjusted to 7.4. PBS was added 
to achieve a final volume of 100 ml. 
16% (w/v) 
PFA 
16% (w/v) PFA 50 ml 50 ml H2O was added to 8 g PFA. 
This was heated to 60-65 °C until the 
solution turned milky white. 1 N 
NaOH was added dropwise while 
stirring, until the solution cleared. 
This was then cooled to room 
temperature prior to use. 
5 M KOAc, pH 
4.8 
5 M KOAc, pH 4.8 500 ml 147.5 ml HOAc was placed in a 
bottle and H2O was added to a 
volume of ~ 450 ml. The pH was 
adjusted to 4.8 using KOH pellets 
while cooling in an ice/H2O bath. 
H2O was then added to a final 
volume of 500 ml and autoclaved. 
50 mg/ml 
ampicillin 
50 mg/ml 
ampicillin 
50 ml 2.5 g ampicillin was dissolved in 40 
ml H2O, and then a further 10 ml 
H2O was added. The solution was 
filter sterilized and stored in 1.0 ml 
aliquots at -20°C. 
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50 mM D-Glc, 
25 mM 
Tris·HCl (pH 
8.0), 10 mM 
EDTA 
50 mM D-Glc 
25 mM Tris·HCl 
(pH 8.0) 
10 mM EDTA 
50 ml 2.50 ml 1 M D-Glc, 1.25 ml 1 M 
Tris·HCl (pH 8.0), 1.00 ml 0.5 M 
EDTA and 45.25 ml H2O were mixed 
together and stored at 4°C. 
50 x TAE 2 M Tris·HOAc 
0.1 M EDTA 
pH ~ 8.5 
 
1 l 242 g Tris, 57.1 ml HOAc and 37.2 g 
Na2EDTA·2H2O were added together 
and mixed. H2O was added to a total 
volume of 1 l. 
6 x SDS-PAGE 
sample buffer 
350 mM Tris·HCl, 
pH 6.8 
30% (v/v) glycerol 
10% (w/v) SDS 
0.5 g/l 
bromophenol blue 
2% (v/v) β-
mercaptoethanol 
10 ml 3.50 ml 1 M Tris·HCl, 3.78 g 
glycerol, 1.00 g SDS, 500 μl 10 g/l 
bromophenol blue and 200 μl β-
mercaptoethanol were added 
together. 
9 ml H2O were added to these 
constituents. The solution was 
dissolved overnight if necessary. H2O 
was added to a final volume of 10 
ml. 
DEPC-H2O H2O 1 l 1 ml DEPC was added to 1 l type I 
laboratory H2O and stirred 
vigorously for 30 min at room 
temperature. The solution was 
autoclaved. 
LB Broth 2% (w/v) LB broth  20 g LB powder was vigorously 
stirred into 1 l H2O until it had 
dissolved. The solution was then 
autoclaved. 
PBG 1% (w/v) BSA 
0.5% (w/v) fish 
gelatin 
100 ml 90 ml PBS was added to 1 g BSA 
and 0.5 g fish gelatin. The pH was 
then adjusted to 7.4 and the final 
volume was adjusted to 100 ml using 
PBS. 
RIPA buffer 
 
50 mM Tris·HCl, 
pH 8.0 
150 mM NaCl 
1% (v/v) Triton X-
10 ml 0.5 ml 1M Tris·HCl pH 8.0, 0.3 ml 5 
M NaCl, 0.1 ml Triton X-100, 0.5 ml 
10% (w/v) sodium deoxycholate, and 
0.1 ml 10% (w/v) SDS were added 
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100 
0.5% (w/v) sodium 
deoxycholate 
0.1% (w/v) SDS 
 
together. 8.5 ml H2O were then 
added to the mixture. The solution 
was stored at 4°C. 
 
One Roche CompleteMini protease 
inhibitor tablet and one Roche 
phosSTOP phosphatase tablet were 
dissolved in this solution 
immediately before use. 
TBST 
 
24.2 g Tris base 
80 g NaCl 
1 ml Tween 20 
1 l The salts were added together, ~900 
ml H2O were added and the solution 
was stirred. The pH was adjusted to 
7.6 using HCl. 1 ml Tween 20 was 
added and H2O was added to a final 
volume of 1 l. 
 
2.11: List of specialist equipment 
Name Product Number Company 
24 well plate Adherent 83.1836 Sarstedt, Leicester, UK 
6 well plate Adherent 83.1839 Sarstedt, Leicester, UK 
CellView™ Cell Culture Dish, 
Glass-Bottomed 
627965 Greiner, Stonehouse, UK 
DNA Engine® Thermal Cycler N/A Bio-Rad, Hemel Hempstead, UK 
PVDF Transfer Membrane 
(0.45μm pore size) 
RPN303F ThermoFisher, Loughborough, UK 
Rotor-Gene Q N/A Qiagen, Manchester, UK 
Tissue Culture dish 83.1802 Sarstedt, Leicester, UK 
Tissue culture flask 175 
Adherent  
83.1812 Sarstedt, Leicester, UK 
Tissue culture flask 75 
Adherent  
83.1811 Sarstedt, Leicester, UK 
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2.12: Protocols 
2.12.1: Cell Culture (Davis, 2002) 
2.12.1.1: Preparation of DMEM culture media and culture conditions 
Reagents (See list 2.2 for details) 
 L-glutamine solution 
 Tetracycline-free FBS 
 High-glucose DMEM (without glutamine, with sodium pyruvate) 
A 500 ml solution of DMEM with 4.5 g/l D-glucose, 10% (v/v) FBS, 2 mM L-glutamine, 
110 mg/l pyruvate was prepared. This was done by adding 50 ml FBS and 5 ml 200 mM L-
glutamine to 445 ml DMEM.  
Please note that any reference to DMEM/culture medium specifically means DMEM, high 
glucose, +10% FBS, +2 mM glutamine, unless otherwise stated. Revival of any of the three 
MEF cell lines was carried out using this medium and antibiotics (hygromycin and 
blasticidin·HCl) were added 24 h later to achieve final concentrations of 100 μg/ml and 10 
μg/ml, respectively. All cells were grown in the 37°C incubator with a humidified, 5% CO2 
atmosphere. These cell culture conditions are assumed when referring to the CO2 incubator, 
unless stated otherwise. 
2.12.1.2: Cell revival 
9 ml warmed DMEM medium were pipetted into a 75cm
2
 adherent cell culture flask. The 
cells were taken from the liquid N2 tank and immediately placed into a 37°C water bath. 500 
μl of medium was pipetted into the cell vial when its contents had started to thaw. The 
mixture was pipetted up and down a few times. 500 μl of this mixture were pipetted into the 
culture flask. The process of adding medium to the cells being thawed was repeated at least 
another two times so as to dilute the DMSO in the freeze mix, thus preventing cell damage. 
The contents of the vial were then all transferred into the flask. The flask was placed in the  
CO2 incubator for approximately 24 h, after which any necessary antibiotics were added. 
2.12.1.3: Trypsinisation of cells 
The DMEM medium was placed in a 37°C water bath for 30 min prior to passaging the 
cells. The medium from the adherent cell culture was aspirated. The cells were gently 
washed with 10 ml sterile PBS. Film trypsinisation was then carried out by covering the 
cells evenly using 2 ml of 0.25% (w/v) trypsin-EDTA, and then removing the trypsin. The 
cells were incubated in the CO2 incubator for 3 min after which they were suspended in 10 
ml culture medium. Depending on the desired seeding density, a specific volume was then 
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transferred into a fresh flask containing new media. Antibiotics were added accordingly to 
the flask which was then transferred to the CO2 incubator. The final volume in the flask was 
10 ml for a 75 cm
2
 flask, and 25 ml for a 125 cm
2
 flask.  
2.12.1.4: Cell counting with a Neubauer chamber (haemocytometer) 
The haemocytometer was first cleaned using 70% (v/v) ethanol. Using a 10 μl pipette, a few 
drops of water were placed on the mounting supports either side of the grooves. The glass 
cover slip was carefully positioned over the area which contained the water drops and the 
counting grids.  
 
Figure 2.6: Basic schematic depicting a Neubauer chamber and the position of the cover 
slip.  
A 1:1 ratio of trypan blue solution : cell suspension was made in a 1.5 ml microcentrifuge 
tube. Approximately 10 μl of sample was loaded underneath the cover slip, onto the loading 
groove. Each of the two counting grids were visualised using the 4 x objective lens of a 
microscope. The cells within a square of area 0.04 mm
2
 were counted on both of the 
counting grids and the average number of cells was calculated. 
The number of cells per ml was then calculated using the following equation: 
Number of cells per ml = Average number of cells · 10
4 
· 2 
In this equation, 2 takes into consideration the dilution factor created as a result of mixing 
the given volume of cell suspension with an equal volume of trypan blue solution.  
2.12.1.5: Generation of frozen cell stocks 
Cells were grown until they reached 95% confluency. The above protocol for passaging cells 
was followed up to and including the trypsinisation stage. The cells were then resuspended 
in a volume of 90% (v/v) FBS, 10% (v/v) DMSO. The volume of freeze mix was determined 
by the number of cryotubes to be filled, with 1 ml of freeze mix per cryotube. For cells 
Mounting supports
Cover slip
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grown in a T75 flask, 4 ml freeze mix were used. The cell suspension was transferred into 
the cryotubes and these were placed in the -80°C storage in an insulated container (CoolCell, 
BioCision) to slow the rate of freezing. The vials were removed from the container the 
following morning and transferred to storage in a liquid nitrogen freezer.  
2.12.1.6: Treatment of MEFs 
Cells were seeded at 15% confluency on a 10 cm plate. To induce expression of human 
IRE1α, each of the three MEF cell lines were treated with 1 g/ml tetracycline. A 10 mg/ml 
tetracycline stock solution in ethanol was diluted tenfold in absolute ethanol. This 1 mg/ml 
tetracycline solution was diluted 1:1000 in culture media to yield the final concentration of 1 
g/ml. The culture media containing tetracycline was then added to the cells. Control 
cultures received the same volume of absolute ethanol added to the media. This tetracycline 
dilution was only stored for a week at -20°C due to its photosensitivity.  
 
Similarly, 100 μl of the stock of 1 mg/ml tunicamycin was added to 900 μl DMSO. Thus, 
when 1 μl of this 100 ng/μl concentration was pipetted into 1 ml media, the final 
concentration of 100 ng/ml was achieved. This media was then added to the cells. As a 
control, cells were treated with the same volume of DMSO in culture media.  
 
2.12.1.7: Transfection of HEK293T cells 
Cells were seeded at around 30% confluency in a 6-well plate and allowed to adhere and 
double in number over approximately 24 h. The volume required for 2 μg plasmid DNA was 
calculated and added to 200 μl of jet-PRIME buffer. 4 μl of jet-PRIME was then added to 
the mixture and centrifuged briefly using a benchtop centrifuge. It was then incubated at 
room temperature for 10 min before 200 μl were added to each well. 200 μl of a mixture 
containing only jet-PRIME buffer and jet-PRIME transfection agent were added to control 
wells so as any background expression of the gene in question could be taken into account. 
The cells were placed in the 37°C CO2 incubator and 4 h later the media was refreshed. 
Lysates were collected after 3 washes in 1 ml PBS using 100 μl RIPA buffer, 24 and 48 h 
after the media had been changed. Protein expression of the transiently transfected gene was 
analysed by Western blotting.   
2.12.1.8: Protein extraction  
Reagents 
 Phosphate buffered saline (PBS) 
 10ml ice-cold RIPA buffer (containing 1 Complete mini protease inhibitor cocktail 
tablet, and 1 phosSTOP phosphatase inhibitor cocktail tablet) 
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The media was removed from the plates and the cells were gently washed with 3x1 ml room 
temperature PBS. For protein extraction the plates were placed on ice, 100 μl RIPA buffer 
were added to the plates and evenly spread by gently using a cell scraper.  After about 2 min 
the surface of the plate was thoroughly scraped using the blade-edge of a cell scraper, to 
collect the cell lysate at one end of the plate. The lysates were transferred into a 1.5 ml 
microcentrifuge tube and stored at -80°C.  
 
The protein samples were thawed and then centrifuged at 13,000 g for 15 min at 4°C. The 
supernatant containing the protein was transferred into a fresh 1.5 ml microcentrifuge tube 
prior to carrying out a protein assay.  
2.12.1.9: RNA isolation (GeneFlow) 
Reagents 
 EZ-RNA Solution A (contains guanidine thiocyanate) 
 RNA-grade pipette tips and 1.5 ml microcentrifuge tubes were used 
For RNA extraction, 500 μl of EZ-RNA Solution A were added to the plates. A pipette tip 
was used to dislodge the cells from the plate using the lysis buffer. The samples were 
collected in RNase-free 1.5 ml microcentrifuge tubes and stored at -80°C.  
 
After thawing the samples in EZ-RNA Solution A, 500 μl of EZ-RNA Solution B was 
added. Each sample was inverted vigorously for 15 s to mix the contents. The mixtures were 
incubated at room temperature for 10 min before being centrifuged at 12,000 g for 15 min at 
4°C. 500 μl ice-cold isopropanol were added to fresh tubes. The supernatant which formed 
as a result of centrifugation was added to the isopropanol. The mixtures were shaken. At this 
stage, the samples were either stored overnight at -20°C, or at -80°C for 1 h or longer before 
the remainder of the protocol was carried out. Storage at these low temperatures was 
particularly useful if the amount of RNA harvested was believed to be low, as it helped to 
increase the final yield. 
  
0.5 μl of 20 mg/ml RNA-grade glycogen was added to aid RNA precipitation. The samples 
were then centrifuged at 12,000 g for 10 min 
*1
 at 4°C. The supernatant was discarded using 
a pipette. 1 ml of 75% (v/v) EtOH in DEPC water was added and the samples were gently 
shaken. Again, one was able to store at -20°C at this stage, especially if cDNA synthesis was 
not going to follow immediately.  
 
The final stage of the protocol consisted of a centrifugation step at 7,500 g for 5 min 
*2
 at 
4°C. The supernatant was discarded carefully using a pipette. The samples were left to air-
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dry for about 20 min at RT. 20 μl DEPC water was added to each RNA pellet and the 
preparations were incubated in a heat block at 55°C for 10 min before being stored at -80°C 
for future use. 
 
Note, to improve RNA yields centrifugation 
*1
 should be carried out at 16,000 g for 30 min, 
and centrifugation
*2
 at 16,000 g for 15 min. 
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2.12.2: Protein chemistry  
 
2.12.2.1: Preparation of a standard curve for use in protein assay 
 
100 μl of 20 mg/ml BSA stock were added to 900 μl RIPA buffer. 500 μl of this 2 mg/ml 
dilution were added to 500 μl RIPA buffer to create a 1 mg/ml dilution. The process of 
adding 500 μl of the most recently created dilution to 500 μl RIPA buffer was repeated, 
creating the serial dilutions of 0.5 mg/ml, 0.25 mg/ml, 0.125 mg/ml and 0.0625 mg/ml. 
 
2.12.2.2: Protein assay (Bio-Rad) 
Using RIPA buffer 1:5 dilutions of the protein samples were made in separate 1.5 ml 
microcentrifuge tubes. In a 96-well plate, 5 μl RIPA buffer was loaded as the blank sample. 
5 μl of each of the standard curve dilutions and the protein samples were loaded into wells. 
Each sample including the blank was in duplicate.  
 
A solution containing 5 ml DC
TM
 Protein Assay reagent A and 100 μl of DCTM Protein 
Assay reagent S was made. This was shaken vigorously prior to use to ensure that DC
TM
 
Protein Assay reagent S had not precipitated out. 25 μl of this solution were added to each 
well. 200 μl DCTM Protein Assay reagent B were subsequently added to each well. The plate 
was incubated at room temperature for 15 min on a shaker. Using the SpectraMAX 190 plate 
reader and version 5.3 of the SoftMaxPro software, the absorbance values at 750 nm were 
determined against the standard dilutions to generate protein concentrations of the samples.  
 
2.12.2.3: TCA (trichloroacetic acid) protein precipitation 
1 volume of 20% (v/v) TCA was added to 1 volume of protein sample and mixed. This was 
incubated on ice for 30 min. The protein sample was centrifuged at 12,000 g, for 15 min at 
4°C. The supernatant was carefully discarded, thus leaving a white pellet behind. 200 μl 
10% (v/v) TCA were added ad the pellet was resuspended. This mixture was centrifuged at 
12,000 g for 5 min at 4°C. The supernatant was again carefully discarded. The step 
involving the addition of 200 μl 10% (v/v) TCA was repeated. 200 μl 100% (w/v) EtOH 
were added. Here the pellet turned from white to transparent. The susepsnion was 
centrifuged at 12,000 g for 5 min at 4°C. The supernatant was discarded. The EtOH wash 
step was repeated. The samples were left to air-dry for 20 min to allow the EtOH to 
evaporate. The pellets were resuspended in 20 μl SDS-PAGE buffer. Note that upon addition 
of SDS-PAGE buffer, if the sample turned from blue to yellow, 0.5 M Tris HCl (pH 9.4) 
was added in 0.5μl increments to neutralise any remaining TCA. 
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2.12.2.4: Western Blotting 
Solutions to prepare 
 1 x Semi-dry transfer buffer (18 parts sterile water, 2 parts 10 x transfer buffer, 1 
part MeOH) 
 1 x TBST (1 part 1 x TBS, 9 parts sterile water, 1 ml TWEEN 20 for every litre) 
 5% w/v milk (10 g skimmed milk powder was dissolved in 200 ml 1 x TBST) 
Gel electrophoresis 
The appropriate amount of 6 x SDS-PAGE loading buffer was added to the protein samples 
so as the final concentration was 1 x SDS-PAGE. These mixtures were boiled for 5 min at 
100°C. As the samples were cooling, the precast gel was placed into a tank, which was 
subsequently filled with the appropriate running buffer. The wells of the gel were washed 
with running buffer. The protein samples were loaded against 10 μl of pre-dyed protein 
ladder (Figure 2.2) and the gel was run at a voltage specified by the manufacturer, until the 
band representing 10 kDa in the protein ladder was almost at the bottom of the gel. 
 
Figure 2.7: A depiction of the composition of the PageRuler™Plus Prestained Protein 
Ladder used for Western blotting. Product details can be found in list 2.4. 
For each gel, 1 PVDF membrane (0.45 μm pore size) and 8 pieces of filter paper were cut to 
dimensions equal to those of the gel. The membrane was incubated at room temperature on a 
shaker in MeOH for 1 min. The membrane and filter papers were then incubated at room 
temperature in 1xsemi-dry transfer buffer for 15 min. Simultaneously, the gel was washed in 
1xsemi-dry transfer buffer for 15 min.  
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Semi-dry transfer  
Four pieces of drained filter paper were placed on the clean surface of a Semi-dry transfer 
machine. A 50 ml tube was used to roll across this paper to remove any air-bubbles. The 
membrane was placed on top of this filter paper. The gel was then carefully transferred onto 
the membrane, followed by the four remaining pieces of filter paper. The Falcon tube was 
re-used to remove any more air bubbles. The lid of the machine was carefully lowered onto 
the stack. The appropriate current density was set to correspond to 2 mA/cm
2
.  
 
Figure 2.8: Layout of filter papers, gel and membrane in the transfer machine. 
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Antibody immunoblotting 
Once the transfer had completed, the membrane was washed quickly in 1 x TBST and was 
then blocked in 5% (w/v) fat-free milk. This step was carried out either at room temperature 
for 1 h, or at 4°C, overnight. The membrane was then washed 3x5 min 1 x TBST. It was 
then cut along the 70 kDa band so as each half could be probed for a different protein. The 
membrane was transferred into a 50 ml falcon tube. A minimum volume of 3 ml 5% (w/v) 
fat-free milk was pipetted into the falcon tube and a specific amount of primary antibody 
was added to achieve the recommended concentration (see list 2.8). The falcon tube was 
placed on a roller at 4°C, overnight.  
 
The following day, the membrane was removed from the falcon tube and washed 3x5 min 1 
x TBST. It was then inserted into a fresh 50 ml falcon tube and secondary antibody was 
added to 5% (w/v) fat-free milk in a ratio which would produce the recommended antibody 
concentration (see list 2.8). The falcon tube was placed on a roller for 1 h at room 
temperature. The membrane was then washed in 3x5 min 1 x TBST before being placed into 
an exposure cassette. A solution of room temperature ECL or ECL+ was made according to 
product instructions to cover the surface of the membranes. A 5 min incubation stage in the 
dark followed.  
 
A piece of photographic film was positioned on top of the membrane and the cassette was 
closed. In a dark room, the film was normally exposed for about 1 min before being 
developed. Following exposure times were determined by the intensity of the bands seen 
after this exposure. 
  
2.12.2.5: Stripping of membranes 
The membrane was removed from the cassette and washed in 3x5 min 1xTBST. Enough 
Restore
TM
 Western Blot Stripping Buffer was added to cover the membrane in a tray. The 
membrane was incubated with the stripping buffer at room temperature for 15 min on a 
shaker. The membrane was then washed in 3x5 min 1 x TBST and was stored in a minimal 
volume of 1 x TBST at 4°C until required for further probing and imaging.  
  
63 
 
2.12.3: Molecular Biology – methods for RNA and DNA 
2.12.3.1: RNA quantitation 
In a 96-well plate, a 1:50 dilution of each RNA sample was made using 2 μl RNA and 98 μl 
DEPC water. All samples were in duplicate. Using the SpectraMAX 190 plate-reader and 
the Warburg-Christian analysis (Warburg and Christian, 1942) on version 5.3 of the 
SoftMax Pro program, the RNA concentrations were calculated against the DEPC water 
blank.  
2.12.3.2: Reverse transcription (Invitrogen) 
For this reaction, (N+1) master mixes were made up for N samples. 
Reagents per sample 
 1μl 10 mM RNA dNTPs 
 1μl 50 μM oligo(dT)15 primer 
 4μl 5xfirst strand buffer 
 1 μl 0.1 M DTT 
 1 μl 40 U/μl RNaseIN 
 1 μl 200 U/ml SuperScript III Reverse Transcriptase 
The volume containing 1.5-5 μg RNA was calculated and pipetted into each PCR tube. 2 μl 
of the first master mix containing 10 mM dNTPs and 50 μM oligo(dT)15 primer were added 
to this. A total volume of 11 μl was achieved by adding the appropriate amount of sterile, 
nuclease-free water. The PCR tubes were centrifuged for a few seconds to collect all the 
liquid at the bottom. The tubes were placed in the PCR machine and incubated at 65°C for 5 
min, followed by 5 min incubation at 4°C. To each tube 7 μl of the second master mix 
containing 5 x first strand buffer, 0.1 M DTT, 40 U/μl RNaseIN, and 200 U/ml SuperScript 
III reverse transcriptase were added. The PCR tubes were centrifuged for another few 
seconds. The tubes were placed in the PCR machine, and a program was selected to heat the 
samples to 50°C for 1 h and then to 70°C for 15 min to inactivate the reverse transcriptase. 
The synthesized cDNA was stored at 4°C or -20°C for long-term use. 
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2.12.3.3: Primer Design 
Primer3 and Primer-BLAST were used to design primers with the following parameters: 
 PCR product of 120-150 base-pairs 
 Primer length between 18 and 22 nucleotides 
 Primer GC content ≥50% 
 Primers flanking an exon-exon junction 
 Intron length of 1000 base-pairs between the 2 exons 
 Annealing temperature between 50°C and 65°C 
 No mismatch bases 
 Primers specific to Mus musculus  
 Primers to amplify mRNA splice variants 
Primers were diluted in 1xTE buffer to a stock concentration of 100 μM. These primer 
solutions were further diluted using sterile water, to a 10 μM working concentration.  
2.12.3.4: Polymerase Chain Reaction (PCR) (Reed et al., 2013) 
Reagents per sample 
 2.5 μl 10 μM forward primer 
 2.5 μl 10 μM reverse primer 
 5 μl 5xGreen GoTaq® Reaction Buffer 
 1.5 μl 25 mM MgCl2 
 1.25 μl 2 mM dNTPs 
 1.25 μl 1:10 mouse cDNA dilution 
 0.25 μl Taq Polymerase (5 U/μl) 
 10.75 μl sterile water 
The reagents were mixed together in a PCR tube, with the primers being added last to avoid 
primer-dimer formation. The total volume per tube was 25 μl. The tubes were loaded into 
the PCR machine and a 35 cycle program similar to the one below was run: 
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Table 1.1: Cycling conditions for the Thermal Cycler PCR machine. 
Number 
of cycles 
Temperature/°C Time Description 
1 94 5 min Initial denaturation 
35 
94 15 s 
Cycle of denaturation, 
annealing and elongation 
55 20 s 
72 30 s 
1 72 5 min Final elongation 
 
The annealing temperature was changed according to primer specifications. Once the 
program had finished, the samples were loaded alongside a 1kB DNA ladder on a 1% (w/v) 
agarose gel which contained an ethidium bromide concentration of 500 μg/l. The gel was run 
at 10 V per cm length of the gel.  
2.12.3.5: qPCR with PrimerDesign FAST 2xMasterMix (with SYBR green) 
For this reaction, (N+1) master mixes were made up for N samples. 
Reagents 
 5 μl 1:10 cDNA dilution 
 10 μl FAST 2xqPCR Master Mix  
 0.6 μl 10 μM forward primer 
 0.6 μl 10 μM reverse primer 
 3.8 μl sterile nuclease-free water 
A master mix containing all reagents excluding the cDNA was prepared and kept on ice. 5 μl 
of the cDNA were added to the qPCR tubes in triplicate followed by 15 μl of the mixture. 
These tubes were kept on ice at all times. The tubes were loaded into the qPCR machine and 
the following program was run.  
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Table 2.2: Cycling conditions for qPCR program on the Rotor-Gene Q using the FAST 
2xqPCR MasterMix. The annealing temperature of 55°C is used here as a general 
annealing temperature, although this is, of course, dependent on the primers being used. 
Number 
of cycles 
Temperature/°C Time Description 
1 95 1 min 
Enzyme activation and 
denaturation 
40 
95 5 s 
Cycle of denaturation, 
annealing and elongation 
55 5 s 
72 10 s 
1 55-95 N/A Melt curve production 
 
Note that most of the qPCR data obtained for this thesis was done using the FAST 2xqPCR 
MasterMix from PrimerDesign. However, some data was obtained using the standard 
2xqPCR MasterMix (Primer Design) or the Promega MasterMix kit. There were shown to 
be no differences in terms of data output, between these three kits (data not shown). The 
recipe for the former is the same as above, however the cycling conditions did vary: 
Table 2.3: Cycling conditions for qPCR program on the Rotor-Gene Q using the 2xqPCR 
MasterMix. The annealing temperature of 55°C is used here as a general annealing 
temperature, although this is, of course, dependent on the primer being used. 
Number 
of cycles 
Temperature/°C Time Description 
1 95 10 min 
Enzyme activation and 
denaturation 
40 
95 15 s 
Cycle of denaturation, 
annealing and elongation 
55 30 s 
72 20 s 
1 55-95 N/A Melt curve production 
 
The recipe for the Promega kit was as follows: 
 5 μl 1:10 cDNA dilution 
 7.5 μl GoTaq® qPCR MasterMix  
 0.45 μl 10 μM forward primer 
 0.45 μl 10 μM reverse primer 
 1.6 μl sterile nuclease-free water 
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When using the Promega kit, 5 μl cDNA were added to the tubes in triplicate, followed by 
10 μl master mix. 
The cycling conditions which accompanied this kit were as follows: 
Table 2.4: cycling conditions for qPCR program on the Rotor-Gene Q using the GoTaq® 
qPCR MasterMix. The annealing temperature of 55°C is used here as a general annealing 
temperature, although this is, of course, dependant on the primers being used. 
Number 
of cycles 
Temperature/°C Time Description 
1 95 10 min Initial denaturation 
40 
95 15 s Cycle of denaturation, 
annealing and elongation 55 60 s 
1 55-95 N/A Melt curve production 
 
2.12.3.6: Agarose gel electrophoresis of DNA 
150 ml of 1 x TAE buffer were added to 1.5 g of agarose powder in a conical flask. The 
mixture was heated at full power in a microwave, until all the powder had dissolved. 7.5 μl 
ethidium bromide (10 mg/ml stock concentration) were added to the solution once the flask 
had cooled enough to touch. The final concentration of ethidium bromide was thus 500 μg/l. 
The mixture was stirred gently and poured into a gel cast. The comb was then added 
carefully. Once the agarose gel had set, it was placed in a gel tank filled with 1 x TAE, and 
the comb was removed. 10 x loading buffer was added to the samples (PCR products or 
digest plasmids). These were loaded into the wells of the gel alongside a 1kB DNA ladder 
which served (figure 2.5) as a reference marker. The voltage was set to 5 V per cm length of 
the gel. The gel was then photographed under a UV transilluminator (302 nm wavelength, 32 
W) to analyse the DNA fragments. 
 
Figure 2.9: GeneRuler™ DNA Ladder Mix SM0331 (left) and SM0311 (right) used to 
determine fragment sizes on agarose gels. 
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2.12.4: Molecular biology - Escherichia coli methods 
2.12.4.1: Preparation of LB ampicillin plates 
35 g of LB-agar were suspended in 1 l of distilled water. The solution was autoclaved after 
being stirred. Once it had cooled to around 50°C, ampicillin was added so as a concentration 
of 50 µg/ml was achieved. ~25 ml of the solution was poured into each culture plate. The 
agar was left to solidify and then stored at 4°C. 
 
2.12.4.2: Revival of Escherichia coli strains 
 
The vial of bacterial cells was transferred from the -80°C storage to a small container of 
liquid nitrogen. Once removed from this container, a pipette tip was used to scrape clumps 
of frozen cells from the vial. A flamed inoculating loop was then used to streak the 
individual colonies out from one another. The plate was then incubated at 37°C overnight. 
 
2.12.4.3: Escherichia coli transformation (adapted from Inoue et al., 1990) 
After dissolving the plasmids in an appropriate amount of 1 x TE buffer, a 50 μl aliquot of 
competent bacterial cells (DH5α or XL10-GOLD) were added using a wide-orifice pipette 
tip. That was then mixed by very gently flipping the tube. These preparations were left on 
ice for 30 min. The vials containing DH5α cells were then heat-shocked at 42°C for 90 s 
whereas those containing XL10-GOLD cells were heat-shocked at 42°C for 42 s. All vials 
were then incubated on ice for 2 min. 1 ml LB broth was then added to each sample. The 
preparations were transferred to 12 ml culture tubes and then incubated at 37°C in a shaker 
at 240 rpm for 1 h. 
 
200 μl of the DH5α suspension were pipetted onto LB ampicillin plates and spread using a 
sterile spreader. This process was repeated for the XL10-GOLD suspensions but using only 
50 μl. The remaining suspensions were centrifuged at 17,000 g for 1 min at room 
temperature. Most of the supernatant was removed, leaving about 100 μl behind. The cell 
pellet was resuspended in this volume and spread onto LB ampicillin plates.  
 
2.12.4.4: Inoculation of E. coli colonies 
A bacterial colony was lifted off the plate using a sterile toothpick, which was handled using 
flamed forceps. The toothpick was then placed into a culture tube containing 4 ml LB broth 
and 100 μg/ml ampicillin. The tube was incubated at 37°C in a shaker at 240 rpm overnight. 
It was ensured that the tube caps were not fully closed to allow respiration to occur.  
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2.12.4.5: Generation of E. coli stock cultures 
1 ml culture inoculation was added to 1 ml 30% (w/v) glycerol in a cryotube. Mixing was 
carried out by pipetting up and down. The culture was then placed in liquid nitrogen before 
being transferred to -80°C.  
2.12.4.6: Miniprep of plasmid DNA from transformed Escherichia coli (Birnboim and Doly, 
1979) 
1.5 ml of saturated overnight culture were placed in a 1.5 ml microcentrifuge tube. The 
remaining culture was stored in the refrigerator at 4°C.The microcentrifuge tubes were 
centrifuged at 14,000 g for 1 min at room temperature. The supernatant was removed 
carefully using a pipette, and discarded. The process of centrifugation and removal of the 
supernatant was repeated. 
 
100 μl of 50 mM D-Glc, 25 mM Tris·HCl (pH8.0), 10 mM EDTA were added to the cell 
pellet. These samples were resuspended by vortexing and then incubated at room 
temperature for 5 min. 200 μl 0.2 N NaOH, 1% (w/v) SDS were added to the tubes. The 
samples were mixed by inverting the tubes between 4 and 6 times. It was ensured that the 
samples were not vortexed from this point onwards, to avoid the chromosomal DNA being 
sheared. The samples were incubated on ice for 5 min. 150 μl of ice-cold 5M KOAc (pH  
4.8) was added and the tubes were inverted 4-6 times to mix the contents. The samples were 
placed on ice for another 5 min.  
 
The tubes were centrifuged at 14,000 g for 3 min at 4°C. The resulting supernatant 
containing the plasmid was transferred into a fresh microcentrifuge tube. 0.8 ml of 100% 
(v/v) EtOH was added to the tubes, which were then inverted 2-3 times. This was followed 
by a 2 min incubation at room temperature. The samples were centrifuged at 14,000 g for 1 
min at room temperature. The supernatant was discarded.  
 
1 ml of 70% (v/v) EtOH was added to each sample. This was followed by another 
centrifugation at 14,000 g for 1 min at room temperature. The supernatant was discarded. 
The tubes were centrifuged at 14,000 g for a final 10-15 s at room temperature, and any 
remaining liquid was carefully removed using a pipette. The pellets in the tubes were air-
dried for 15 min to allow the EtOH to evaporate. 30 μl 1 x TE (pH 8.0), 0.3 mg/ml RNase A 
were added to the pellets. These preparations were stored at 4°C. 
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2.12.4.7: Diagnostic digest of plasmid DNA 
Firstly, the program pDRAW32 was used to choose which enzyme/s would be most suitable 
for confirming the plasmid’s identity by diagnostic digest. 
For each clone of each plasmid a1.5 ml microcentrifuge tube containing 2 μl miniprep 
solution, 0.5 μl restriction enzyme, 2 μl restriction enzyme buffer and 15.5 μl sterile water 
was prepared. Each 1.5 ml microcentrifuge tube containing a 20 μl final reaction volume 
was transferred into a 37°C water bath for 1 h and then placed on ice. An undigested control 
was also prepared using 2 μl miniprep solution and 8 μl sterile water. The appropriate 
volume of 10 x loading dye was added to the control samples and digests so as the final 
concentration was 1 x agarose loading dye. The products were run on a 1 % agarose gel as 
described in 2.12.3.6. 
2.12.4.8: Promega Wizard® SV Gel and PCR Clean-up System (DNA purification) 
The column was placed into the collection tube. All of the miniprep was transferred into the 
assembly and incubated for 1 min at room temperature. Each sample was centrifuged at 
13,000 g for 1 min at room temperature. The liquid in the collection tube was discarded.  
 
375 ml 95% (v/v) ethanol were added to 75 ml membrane wash solution and then the 
minicolumn was washed with 700 μl membrane wash solution. The above centrifugation 
step was repeated and the liquid was discarded. The minicolumn was then washed in 500μl 
membrane wash solution and then centrifuged at 13,000 g for 5 min at room temperature. 
When the collection tube was emptied this time, care was taken so as the bottom of the 
minicolumn was not wetted with the flow through. The samples were then centrifuged at 
13,000 g for 1 min at room temperature.  
 
The minicolumn was carefully transferred to a clean 1.5 ml microcentrifuge tube. 50 μl of 
nuclease-free water were applied directly to centre of the minicolumn whilst ensuring not to 
touch the membrane with the pipette tip. Each sample was incubated at room temperature for 
1 min and then centrifuged at 13,000 g for 1 min at room temperature. The minicolumn was 
then discarded and the microcentrifuge tube containing the purified DNA was stored at 4°C.  
 
2.12.4.9: MAXIprep DNA preparation (Qiagen) 
4 ml of inoculation culture (see 2.12.4.4) were added to ~500 ml of LB broth in a flask and 
placed in a 37°C shaker (240 rpm) overnight.  This culture was centrifuged at 6,000 g for 15 
min at 4°C. The supernatant was carefully poured off. At this stage the pellet can be stored at 
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-20°C. 20 ml of buffer P1, containing 100 μg/ml RNase A, were used to resuspend the pellet, 
and after this mixture had been split equally into 2 tubes, each one was placed on ice.  
Protocol followed for each mixture: 
Buffer P2 was checked for precipitation. 10 ml of this buffer were added to each mixture, 
which was then incubated at room temperature for 5 min. A viscous, non-homogenous liquid 
formed. Whilst the incubation step was taking place, one QIAfilter Maxi Cartridge was 
prepared per sample. To do this, a cap was screwed onto the outlet nozzle of a cartridge. 
This was then placed in a rack. 10 ml of pre-chilled buffer P3 were added to the mixture and 
was inverted 4-6 times. 
 
The lysate was poured into the barrel of the QIAfilter Maxi Cartridge and incubated at room 
temperature for 10 min. The cap was then removed from the nozzle and the plunger was 
gently inserted into the cartridge. Pressure was applied to the plunger and the cell lysate was 
filtered into a 50 ml tube. 2.5 ml of Buffer ER were added to the filtered lysate. The tube 
was inverted around 10 times and then incubated for 30 min on ice. 
 
1 QIAGEN-tip 500 per lysate sample was equilibriated by applying 10 ml Buffer QBT. This 
passed through the column by gravity flow. The filtered lysate was then poured into the 
QIAGEN-tip and was allowed to enter the resin by gravity flow. The QIAGEN-tip was then 
washed with 2x30 ml of Buffer QC. The DNA was eluted using 15 ml of Buffer QN and 
collected in a fresh tube which had been placed underneath the QIAGEN-tip. To the eluted 
DNA, 10.5 ml of room temperature isopropanol were added and mixed by inversion. This 
mixture was centrifuged at 15,000 g for 30 min at 4°C. Care was taken not to dislodge the 
DNA pellet as the supernatant was being poured away. The pellet was washed with 5 ml of 
endotoxin-free, room temperature 70% (v/v) EtOH. This was centrifuged at 15,000 g for 10 
min at 4°C. The supernatant was again carefully discarded. Any remaining EtOH was 
removed with a pipette. The pellet was air-dried for approximately 10 min (longer if 
required) and was dissolved in a suitable volume (about 50 μl) of endotoxin-free Buffer TE. 
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2.12.5: Microscopy 
2.12.5.1: TEM processing for cells grown in culture flasks 
Solutions prepared prior to protocol 
 Double strength fixative 
-12.5 ml 16% (w/v) paraformaldehyde 
-10 ml 25% (w/v) glutaraldehyde 
-25 ml 0.2 M sodium cacodylate buffer 
 
 Single strength fixative 
-25 ml double strength fixative (see above for recipe) 
-25 ml 0.1 M sodium cacodylate buffer 
 
 Epon recipe (to mix with propylene oxide for final infiltration) 
-20 ml Agar100 epoxy resin 
-DDSA (dodecenyl succinic anhydride) hardener 
-MNA (methyl nadic anhydride) hardener 
-BDMA (benzyldimethylamine) accelerator 
An equal volume of double strength fixative to cell culture medium was added to the flasks 
and incubated at room temperature for 5-10 min. After this the fixative was poured off, 10 
ml single strength fixative were added to cover the cells. The flasks were incubated at room 
temperature for 1 h with shaking. The cells were then washed three times in 0.1 M sodium 
cacodylate for 5 min.  
The cells were washed in 1 ml cacodylate buffer and removed from the flask surface using a 
cell scraper. They were then transferred into a 1.5 ml microcentrifuge tube. The cells were 
centrifuged at 1,000 g for 5 min. The supernatant was removed and the pellets were ‘post-
fixed’ for 1 h in 1% (w/v) osmium cacodylate in 0.1 M cacodylate buffer. In some of the 
samples (for example: the tunicamycin treated K599A cells) the pellet was very small and 
therefore a 1000 g spin for 3 min was carried out. The supernatant was pipetted off and the 
pellet was washed in 0.1 M sodium cacodylate buffer.  
 
The pellet was gently touched with a cocktail stick to test whether or not it easily 
fragmented. Providing the pellet remained intact, it was transferred to a glass vial and 
dehydrated through a series of alcohol additions. This step was carried out in the 1.5 ml 
microcentrifuge tube if the pellet was not intact.  
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Alcohol dehydration steps 
 3x5 min 50% (v/v) ethanol washes 
 3x5 min 70% (v/v) ethanol washes 
 3x5 min 95% (v/v)ethanol washes 
 3x10 min 100% (w/v) ethanol washes 
The mixture was then infiltrated three times with a mixture of 100% (w/v) alcohol:propylene 
oxide (50:50), with each infiltration lasting 10 min. Another three 10 min infiltration steps 
were carried out using propylene oxide. Each sample underwent a final infiltration using a 
mixture of propylene oxide:resin (50:50) for 1 h to overnight with the lids open. 
2.12.4.2: Sectioning and analysis of cells in resin 
Ultrathin sections of the cells embedded in the resin were cut using a Leica Reichert Ultracut 
S ultramicrotome. These were then picked up onto a 200 mesh copper grids and stained 
using 1% (w/v) alcoholic uranyl acetate and Reynold’s lead citrate (Reynold, 1963) for 10 
min each. They were examined using a Hitachi H-7600 transmission electron microscope. 
Electronmicrographs were taken on an AMT Orca-ER digital camera (Deben). 
2.12.5.3: Immunofluorescence 
The cells for this experiment were cultured on glass cover slips placed in the wells of a 24-
well plate. 
Preparation: 
A section of parafilm was cut and stretched over a glass square to provide a platform upon 
which the glass cover slips could rest. This was then placed on top of some wet tissue paper 
in the bottom of a plastic box to ensure that the cover slips did not become dry during the 
incubation steps described below. The entire box was lined with tin foil making it 
impenetrable to light. The primary and secondary antibodies were added to thawed PBG in 
1.5 ml microcentrifuge tubes (see table 2.5 and 2.6 for dilutions) , then placed on ice.  
Fixing process: 
The medium was removed from the wells containing the glass cover slips. The cells were 
washed twice using 1ml of ice-cold PBS. After the second wash, the PBS was not aspirated 
off the wells. 12 µl drops of ice-cold 4% (w/v) paraformaldehyde (PFA) were pipetted onto 
the parafilm in the incubation box. The cover slips were removed carefully using fine 
tweezers and dabbed gently onto dry tissue paper to remove any excess PBS. They were then 
placed ‘face-down’ (cells facing down) onto the drops of PFA in the incubation box. The lid 
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of the box was replaced and the cover slips were incubated with PFA at room temperature 
for 15 min. 
Permeabilisation process: 
After the fixing stage was complete, the cover slips were placed into a 24-well plate 
containing PBS, ensuring they were now ‘face-up’ (cells facing up). They were washed 
twice in 1 ml ice-cold PBS. At this stage, the cover slips can be stored in PBS at 4ºC. 
10 µl drops of 0.5% (w/v) Triton X-100 (dissolved in PBS) were added to the parafilm in the 
incubation box, and the cover slips were positioned on top, as before. The lid was replaced 
and the cover slips were incubated at room temperature for 10 min.  
Blocking process: 
The cover slips were replaced into the wells (again ensuring they were ‘face-up’) and 
washed once in 1 ml of ice-cold PBS. This time, 10 µl drops of 0.5% (w/v) fish gelatin in 
PBS were added to the parafilm layer. As before, the cover slips were transferred into the 
box and incubated at room temperature for 15 min.  
Antibody staining and mounting slides: 
Table 2.5: Primary antibodies for immunofluorescence. Dilutions were made in PBG. 
Name Host Clonality Supplier and Product Number Dilution 
Emerin (4G5) Mo M Abcam (ab-49499) 1:200 
Sun-1 (282) R P Karakesisoglou lab collection 1:200 
Nesprin-2 (pAbK1) R P  Karakesisoglou lab collection 1:200 
 
Table 2.6: Secondary antibodies used for immunofluorescence. Dilutions were made in 
PBG. 
Name Host 
Supplier and 
Product Number Conjugated dye Dilution 
Anti-mouse IgG Donkey Invitrogen A-21202 Alexa Fluor® 488 1:2000 
Anti-rabbit IgG Goat Invitrogen A-11011 Alexa Fluor® 568 1:2000 
 
10 µl drops of primary antibody were added to the parafilm in the incubation box. The cover 
slips were transferred directly from the blocking step onto the primary antibody and 
incubated at room temperature for 1 h. Afterwards, the cover slips were replaced in the wells 
and washed three times with 1 ml ice-cold PBS. 10 µl drops of the secondary antibody were 
added to the parafilm layer and the cover slips were incubated for another h at room 
temperature. During this time, the mounting media was thawed.  
75 
 
The cover slips were again replaced in the wells and were given five washes in 1 ml ice-cold 
PBS. Approximately 7 µl of mounting media was added to a slide for each cover slip. The 
cover slips were dabbed gently on tissue paper as above and lowered ‘face down’ onto the 
solution on the slides. These were placed flat in a slide box and stored in the fridge to dry 
overnight before being imaged. 
2.12.5.4: Confocal microscopy (visualisation of the ER) 
MEFs were seeded onto 9.6 cm
2
 glass-bottomed plates to allow visualisation under the 
confocal microscope. There were given 24 h to adhere to the plate, followed by 24 h of 
tetracycline treatment. Tunicamycin was then added and the cells were taken down to image 
as soon as it was noticed they were beginning to detach from the surface of the plate. This 
was done to avoid not being able to visualise the cells due to them completely detaching 
from the plate as a result of apoptosis.  
1 μl of ER-Tracker™ Red (pre-dissolved in DMSO) was added per ml of culture media and 
left to incubate in the dark at 37°C for approximately 10 min. The media was then replaced. 
The cells were then visualised using the Zeiss 510 Meta CLSM inverted microscope. The 
lipophilic dye stains the ER red by binding sulphonylurea receptors of the potassium channel 
in the ER membrane (Invitrogen). Making sure the settings of the microscope were constant 
between taking images, approximately 10 pictures of each cell and treatment were taken. 
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Chapter 3 
 
The protein expression profile of 
WT, D711A and K599A human 
IRE1α in mammalian cells during 
ER stress 
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3.1: Rationale for studying protein expression in the three cell lines 
Several proteins induced by the UPR have been implicated in both cell life and death. As 
discussed in chapter 1, XBP-1 splicing, courtesy of the IRE1α RNase domain, has been 
shown to play an integral role in the cytoprotective component of the UPR (Gupta et al., 
2010; Han et al., 2008; Sado et al., 2009; Lin et al,., 2009, Reimold et al., 2000). Regarding 
kinase activity of IRE1α, some groups demonstrated it is responsible for aiding cell death 
mechanisms via JNK activation (Nishitoh et al., 2002; Urano et al., 2000). However, a 
separate group more recently suggested the kinase’s principal function in terms of yeast cell 
fate, was to control the state of the endoribonuclease and thus has at least some protective 
function (Rubio et al., 2011). The MTT and PARP-1 cleavage in the appendix show that the 
D711A-hIRE1α and K599A-hIRE1α mutants undergo cell death before the WT-hIRE1α 
cells, raising the possibility that the kinase activity of hIRE1α is important for cell survival. 
This project was hence designed to bring certain mechanisms via which the kinase may 
dictate cell fate decisions to attention, principally by comparing transcription and protein 
levels, and ER physiology during ER stress in the three cell lines. 
The differences in protein levels were investigated in this chapter. Many of the proteins 
analysed have been demonstrated to play a role in ER stress-induced cell death. Since the 
K599A-hIRE1α cells have a compromised cytoprotective response (Figure A1.3), the cell 
death markers should be elevated in this mutant. By comparing the D711A-hIRE1α response 
to the one seen in the WT-hIRE1α and K599A-hIRE1α cells, some light should be shed onto 
the role the kinase plays in cell life decisions downstream of UPR activation. 
To validate activation and expression of human IRE1α, phospho-IRE1α and IRE1α were 
probed for. BIP was also imaged so as to confirm that ER stress induction was taking place 
as expected. Proteins involved in UPR-mediated cell death include caspase-12, caspase-3 (an 
executioner caspase activated downstream of caspase-12 cleavage), PARP-1, phospho-JNK 
and CHOP (Kim et al., 2006). All of these were analysed by Western blotting. To evaluate 
whether or not there are differences in protein translation potential, phospho-eIF2α and total 
eIF2α were probed for. LC3 was also analysed, so as to help indicate differences in the 
autophagic programme between the three difference cell lines. 
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3.2: Differences in protein expression in the three MEF cell lines 
Using the culture conditions described in chapter 2, phospho-IRE1α and IRE1α proteins 
were probed for to confirm the tetracycline-inducible expression system was working as 
expected. Western blotting confirmed that human IRE1α was induced after 4 h of 
tetracycline treatment in all three cell lines, and expression reached a maximum after 10 h of 
this treatment, independent of the presence of tunicamycin. A low level of IRE1α 
phosphorylation was observed in the WT-hIRE1α samples after 4 h of induction, suggesting 
that overexpression had caused dimerisation and subsequent autophosphorylation of this 
UPR signal transducer in the ER membrane. There was a large increase in phospho-IRE1α 
expression between 4 and 10 h of tetracycline addition, which was maintained throughout 
the remainder of the time course and again was independent of tunicamycin treatment. The 
antibody used against phospho-IRE1α specifically detects phosphorylation of the S724 site 
on hIRE1α. Phosphorylation of this particular site was not observed in either of the mutant 
cell lines, confirming impaired kinase activity.  
  
Figure 3.1: Western blot showing levels of IRE1α and its phospho-form from WT-
hIRE1α, D711A-hIRE1α and K599A-hIRE1α MEF lysates. – and + indicate absence or 
presence of the appropriate drug, respectiely. Cells treated with tetracycline were 
harvested after 4 h, then after 6, 24 and 48 h of combined tetracycline and DMSO 
treatment. ER-stressed cells were harvested after 6, 24, and 48 h of combined tetracycline 
and tunicamycin treatment. GAPDH was used as the loading control. Figure A3.2 
represents the repeat obtained. 
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Figure 3.2: Graphical representation of the Western blot in Figure 3.1. The bands were 
quantified using ImageJ and phospho-IRE1α/IRE1α was calculated. The error bars show 
the standard error. An unpaired t-test was carried out and the confidence limits were set to 
95%. There was no significant difference between the tetracycline-only and the 
tetracycline and tunicamycin treated cells in the WT-hIRE1α.  
BIP was also used as a positive control to highlight induction of ER-stress. Since a protocol 
for the BIP/GRP78 antibody had not been established, ECL+ was initially used to visualise 
the bands on the PVDF membrane. This gave a very smeary blot at the molecular weight 
predicted for this protein. However, the second time the treatment course was run, only ECL 
was used, and this showed much clearer, more distinct bands in all three cell lines. In the 
WT-hIRE1α and D711A-hIRE1α cells there was a large upregulation of BIP 24 h after ER-
stress induction. This increase was slightly less impressive in the K599A-hIRE1α mutant, 
which is consistent with Western blotting carried out in XBP-1 knockout MEFs by Lee et 
al., 2003. However, this is not consistent with what was observed by Tirasophon et al (2000) 
who observed no differences in BIP induction between WT and ire1α-/- cells. Therefore, 
after obtaining a repeat for these data, it may be useful to compare BIP mRNA and protein 
levels in ire1α-/- cells and K599A-hIRE1α cells.  
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Figure 3.3: Western blot showing levels of BIP from hIRE1α WT-hIRE1α, D711A-
hIRE1α and K599A-hIRE1α MEF lysates. – and + indicate absence or presence of the 
appropriate drug, respectively. Cells treated with tetracycline were harvested after 4 h, 
then after 6, 24 and 48 h of combined tetracycline and DMSO treatment. ER-stressed cells 
were harvested after 6, 24, and 48 h of combined tetracycline and tunicamycin treatment. 
GAPDH was used as the loading control. 
To address any differences in cell fate between the three different cell lines, caspase activity 
was investigated. Caspase activation is known to occur downstream of ER stress (Yoneda et 
al., 2001). One way of assessing caspase activity is by analysing PARP-1 cleavage, as 
PARP-1 is a target of active caspases (Oliver et al., 1998 and Lazebnik et al., 1994). As 
expected, PARP-1 cleavage levels were elevated in all cell lines after 24 h of ER-stress, and 
increased further after 48 h (Figure 3.8 and 3.9). In both repeats, it was apparent that the 
PARP-1 cleaved fragment was the most abundant in the K599A-hIRE1α mutant. Since 
PARP-1 is a marker of apoptosis, these data suggest that cell death was most advanced in 
this cell line. Compared to the WT-hIRE1α, the D711A-hIRE1α mutant only displayed very 
slightly higher levels of PARP-1 cleavage that was not statistically significant. These results 
imply that the kinase- and RNase-dead mutant was most compromised. 
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Figure 3.4: Western blot showing the ratio of cleaved PARP-1 to total PARP-1 from WT-
hIRE1α, D711A-hIRE1α and K599A-hIRE1α MEF lysates. The arrow represents the 
cleaved fragment. – and + indicate absence or presence of the appropriate drug, 
respectively. Cells treated with tetracycline were harvested after 4 h, then after 6, 24 and 
48 h of combined tetracycline and DMSO treatment. ER-stressed cells were harvested 
after 6, 24, and 48 h of combined tetracycline and tunicamycin treatment. GAPDH was 
used as the loading control. Figure A3.3 represents the repeat obtained. 
  
Figure 3.5: Graphical representation of the Western blot  in Figure 3.4. The bands were 
quantified using ImageJ and cleaved PARP-1/total PARP-1 was calculated. The error 
bars show the standard error. An unpaired t-test was carried out and the confidence limits 
were set to 95%. * p = 0.0472 (WT-hIRE1α tunicamycin treated vs K599A-hIRE1α 
tunicamycin treated).  
As with PARP-1, caspase-3 cleavage was increased in each of the cell lines when ER stress 
was induced. Consistent with the highest levels of PARP-1 cleavage in the K599A-hIRE1α 
mutant, caspase-3 cleavage was also highest in this cell line (Figure 3.10 and 3.11). These 
observations from the K599A-hIRE1α mutant are consistent with published data, where 
forced activation of the RNase domain increased cell viability (Han et al., 2008; Lin et al., 
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2009). It would appear that activation of this caspase was intermediate in the D711A-
hIRE1α mutant, however, another repeat is required to validate these data. This may help 
explain why the D711A-hIRE1α cells die before the WT-hIRE1α cells, as was seen when 
observing cells in tissue culture using light microscopy (data not shown). 
  
Figure 3.6: Western blot showing the ratio of caspase-3 cleavage to total caspase-3 form 
from WT-hIRE1α, D711A-hIRE1α and K599A-hIRE1α MEF lysates. – and + indicate 
absence or presence of the appropriate drug, respectively. Cells treated with tetracycline 
were harvested after 24 and 48 h of combined tetracycline and DMSO treatment. ER-
stressed cells were harvested after 24 and 48 h of combined tetracycline and tunicamycin 
treatment.  
  
Figure 3.7: Graphical representation of the Western blot image in Figure 3.6. The bands 
were quantified using ImageJ and cleaved caspase-3/total caspase-3 was calculated. 
Unfortunately, there was not enough time to optimise the Western blotting conditions for 
caspase-12, which is upstream of caspase-3 cleavage (reviewed in Lai et al., 2007). It was 
found that if the primary antibody was incubated at room temperature for 4 h after 
incubation at 4°C overnight, then the image seen in figure 3.12 was obtained. Here the 
‘upper’ bands were observed to be just above the 55 kDa mark, and the lower bands were 
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very slightly below this mark. Since the predicted molecular weights of the uncleaved and 
cleaved caspase-12 are 55 and 42 kDa respectively, it is possible that the top band may be 
non-specific. Another reason this may also be true is because if the top bands did represent 
the uncleaved caspase-12 form, then it suggests that there was as much caspase-12 cleavage 
in the WT-hIRE1α untreated cells as there was in the K599A-hIRE1α tunicamycin treated 
cells (48 h). Further research needs to be conducted to prove that the lower band is 
uncleaved caspase-12. Loading a larger amount of protein onto the gel and increasing film 
exposure times will help identify the lower band. 
  
Figure 3.8: Western blot showing the ratio of caspase-12 cleavage to total caspase-12 
form from WT-hIRE1α, D711A-hIRE1α and K599A-hIRE1α MEF lysates. – and + 
indicate absence or presence of the appropriate drug, respectively. Cells treated with 
tetracycline were harvested after 4 h, then after 6, 24 and 48 h of combined tetracycline 
and DMSO treatment. ER-stressed cells were harvested after 6, 24, and 48 h of combined 
tetracycline and tunicamycin treatment.  
CHOP
-/-
 MEFs are protected against cell death downstream of the UPR being activated 
(Zinszner et al., 1998) and this protein is often used as marker of ER stress-induced 
apoptosis. It was hypothesized that expression of this protein would be the lowest in the WT 
cells. From initial observation of the Western blot, it seemed as though CHOP was most 
upregulated in the K599A-hIRE1α mutant, followed by D711A-hIRE1α and finally WT-
hIRE1α (Figure 3.13). This was expected since endoribonuclease activity of IRE1α confers 
cytoprection through XBP-1. It also correlated well with figure A3.4. However, upon 
normalisation to GAPDH, a different pattern emerged, where the highest levels of CHOP 
were in the D711A-hIRE1α mutant after 24 h of ER stress induction.  Since the K599A-
hIRE1α mutant should, in theory, be most compromised, and because the CHOP qPCR data 
supported this idea (figure 4.3), it is possible that the loading control conditions require 
further optimisation. It could be that a 1:20,000 dilution of the GAPDH antibody is too weak 
for such an abundant protein and thus probing for GAPDH should be repeated with a higher 
concentration of this antibody. 
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Figure 3.9: Western blot showing CHOP activation from WT-hIRE1α, D711A-hIRE1α 
and K599A-hIRE1α MEF lysates. – and + indicate absence or presence of the appropriate 
drug, respectively. Cells treated with tetracycline were harvested after 4 h, then after 6, 24 
and 48 h of combined tetracycline and DMSO treatment. ER-stressed cells were harvested 
after 6, 24, and 48 h of combined tetracycline and tunicamycin treatment. GAPDH was 
used as the loading control. 
 
Figure 3.10: Graphical representation of the Western blot image in Figure 3.9. The bands 
were quantified using ImageJ and normalised against GAPDH. 
Since translation of CHOP mRNA occurs downstream of the PERK-peIF2α-ATF4 branch 
(Ohoka et al., 2005) it was expected that the phospho-eIF2α expression profile would show 
a similar pattern relative to that observed for CHOP expression. However, this was not the 
case, and it was the WT-hIRE1α which consistently displayed the highest levels of phospho-
eIF2α during ER stress (Figure 3.15 and 3.16). More data will need to be obtained to 
determine the significance of these findings. This phenomenon may contribute to the earlier 
death of the mutant cells before the WT-hIRE1α. It is known that phosphorylation of the 
eIF2α subunit blocks general (but not all) mRNA translation into protein (Harding et al., 
2000) reducing the rate of translocation of new proteins into the ER lumen. Conversely, 
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dephosphorylation of this subunit restarts polypeptide production and it has been shown that 
inhibiting this reaction using salubrinal increases cell viability (Boyce et al., 2005). It may 
be informative to use salubrinal in conjunction with cell death assays, such as MTT, to 
determine whether any of the three cell lines displayed better survival as a result of this 
treatment during ER stress.  
 
Figure 3.11: Western blot showing eIF2α and its phospho-form from WT-hIRE1α, 
D711A-hIRE1α and K599A-hIRE1α MEF lysates. – and + indicate absence or presence 
of the appropriate drug, respectively. Cells treated with tetracycline were harvested after 4 
h, then after 6, 24 and 48 h of combined tetracycline and DMSO treatment. ER-stressed 
cells were harvested after 6, 24, and 48 h of combined tetracycline and tunicamycin 
treatment. Figure A3.5 represents the qualitative repeat obtained. 
 
Figure 3.12: Graphical representation of the Western blot in Figure 3.11. The bands were 
quantified using ImageJ and phospho-eIF2α/total eIF2α was calculated. 
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JNK phosphorylation should also indicate differences in cell viability (see Chapter 1), 
however, it was found that levels did not change dramatically during ER-stress. There was 
only a real increase in phospho-JNK after 6 h tetracycline addition, independent of cell line 
and independent of whether tunicamycin was added or not. The disappearance of the 
phospho-JNK signal at 24 h tetracycline treatment was also consistent across the three cell 
lines. There is a small increase in the intensity of the 54 kDa phospho-JNK form (uppermost 
band of the top panel in Figure 3.17) after 48 h tunicamycin treatment. Again, this does not 
differ between each of the cell lines and does not indicate as strong an expression as 6 h 
tetracycline treatment. Overall, one can conclude that using 100 ng/ml tunicamycin to 
induce ER stress, does not elicit a different response in terms of JNK activation in either 
WT-hIRE1α, D711A-hIRE1α or K599A-hIRE1α cells.  
 
Figure 3.13: Western blot showing JNK and its phospho-form from WT-hIRE1α, D711A-
hIRE1α and K599A-hIRE1α MEF lysates. – and + indicate absence or presence of the 
appropriate drug, respectively. Cells treated with tetracycline were harvested after 4 h, 
then after 6, 24 and 48 h of combined tetracycline and DMSO treatment. ER-stressed cells 
were harvested after 6, 24, and 48 h of combined tetracycline and tunicamycin treatment. 
Figure A3.7 represents the qualitative repeat obtained.  
Finally, since autophagy is known to play a role in determining cell fate decisions, LC3 
conversion was analysed. Lipidation of LC3-I to LC3-II is thought to signify whether or not 
autophagy is taking place and can simply be detected by Western blotting. It was 
hypothesised that autophagy may have been compromised in the mutant cell lines, therefore 
contributing to their earlier cell death phenotype compared to the WT cells. However, figure 
3.18 and 3.19 indicate the lowest conversion in the WT-hIRE1α cells during ER stress. 
Further experimentation is required to validate the significance of these data and to 
determine the autophagic state in each of the cell lines, since it was recently found that LC3 
conversion could in fact indicate a blockage in the process of autophagy (Xavier et al., 
2008). 
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Figure 3.14: Western blot showing conversion of LC3-I (19 kDa) to LC3-II (17 kDa) from 
WT-hIRE1α, D711A-hIRE1α and K599A-hIRE1α MEF lysates. – and + indicate absence 
or presence of the appropriate drug, respectively. Cells treated with tetracycline were 
harvested after 4 h, then after 6, 24 and 48 h of combined tetracycline and DMSO 
treatment. ER-stressed cells were harvested after 6, 24, and 48 h of combined tetracycline 
and tunicamycin treatment. GAPDH was used as the loading control. 
   
Figure 3.15: Graphical representation of the Western blot image in Figure 3.14. The 
bands were quantified using ImageJ and lipidated LC3/total LC3 was calculated. 
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3.3: Discussion 
In summary, the highest PARP-1 cleavage was observed in the K599A-hIRE1α cells. 
However, there were repeatable differences detected in CHOP expression and 
phosphorylation of the eIF2α subunit in the D711A-hIRE1α cells compared to their WT 
counterparts. These results suggest that IRE1α kinase activity does play some role in 
determining cell fate of these ER-stressed MEFs.  
Analysing both PARP-1 cleavage and caspase-3 activation, the K599A-hIRE1α cells appear 
to be most compromised in terms of cell fate downstream of ER stress. However, the lack of 
statistical significance in PARP-1 cleavage between the WT-hIRE1α and D711A-hIRE1α 
MEFs does not conclude that cell death does not happen earlier in the latter cells. PARP-1 
cleavage analysed in this project is only a marker of apoptosis (Gobeil et al., 2001) and 
therefore, one cannot rule out that the D711A-hIRE1α cells may be dying via the necrotic 
route or another cell death mechanism. Krysko et al., 2008, describe a set of methods, which 
together can be used to discriminate between apoptosis and necrosis. It would be interesting 
to determine whether these different cell lines were dying by taking different cell death 
pathways, as it would help characterise the role of IRE1α kinase activity. 
It does, however, seem as though the kinase domain plays some role in cross-talk between 
IRE1α and PERK. It would be useful to show that the differences in phospho-eIF2α 
observed between the mutants and WT-hIRE1α are due to PERK activation by using PERK 
knockout MEFs, as three other proteins are able to phosphorylate eIF2α (referenced in 
Boyce et al., 2005). Additonally, one cannot rule out that the differences in eIF2α 
phosphorylation are due to differential induction of one of the eIF2α phosphatases.  
Supporting the idea of cross-talk between IRE1α and PERK, it does appear that the D711A-
hIRE1α mutant is more susceptible to cell death due to CHOP upregulation. To further 
support the observation that CHOP levels are elevated in the D711A-hIRE1 MEFs, it 
would be useful to show an increase in expression of TRB3 in D711A-hIRE1α by Western 
blotting. This death-inducing protein is downstream of CHOP (Ohoka et al., 2005), and 
TRB3 mRNA expression was found to be upregulated in D711A-hIRE1α expressing cells by 
qPCR analysis (Chapter 4). 
Similar to eIF2α, the phosphorylation status of JNK is dependent on multiple stress 
pathways (Lui and Lin, 2005). Since there were no differences in JNK phosphorylation 
when the three cell lines were treated with tunicamycin, it would be informative to check 
whether the response was any different using other ER stress inducing drugs, such as 
thapsigargin, subtilaseAB5 or DTT. Of course, the appropriate concentration of these drugs 
would first have to be optimised to generate similar levels of ER stress compared to 100 
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ng/ml tunicamycin. However, some of these results could be difficult to interpret not least 
because JNK responds to different cellular stresses, but also because of off-target effects of 
drugs. 
Finally, autophagy is a likely candidate which could help account for the differences in cell 
death observed. Due to the fact that there seemed to be more lysosomal structures in the 
WT-hIRE1α cells (See Figure 5.4) it would seem there was an increased autophagic 
response in the WT-hIRE1α cell compared to the mutants (Ogata et al., 2006). However, the 
upregulation of CHOP and its downstream target, TRB3 (see Chapter 4) in the mutant MEFs 
suggests there should be an increased autophagic response, since TRB3 inhibits the 
Akt/mTORC autophagic-blocking route (Salazar et al., 2009). This would also be consistent 
with the report which concluded that IRE1α kinase activity blocked autophagy (Lee et al., 
2011). In which cells autophagy is effective in needs to be answered using the mCherry-
GFP-LC3b reporter construct, which was used by Lee et al., in 2011. Use of this plasmid has 
been shown to differentiate between autophagosomes and mature lysosomes, with the green 
luminescence produced by the GFP becoming less intense in the lower pH environment of 
the lumen of the mature lysosome (Pankiv et al., 2007). Further research must be conducted 
to elucidate whether autophagy is beneficial or detrimental in this particular model system.   
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Chapter 4 
 
Investigating the transcriptional 
profile and the RIDD pathway as 
part of the UPR in WT, D711A and 
K599A human IRE1α mouse 
embryonic fibroblasts  
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4.1: Rationale for studying changes in gene induction between the three cell lines 
It is well established that when the UPR is activated in mammalian cells, both spliced 
XBP-1 and cleaved ATF6 serve as two of the primary transcription factors to upregulate a 
large number of genes. It has been proposed that ATF6 is actually required to upregulate 
XBP-1, which can then undergo splicing by IRE1 (Yoshida et al., 2001). These two 
transcription factors are principally involved in trying to restore homeostasis within the ER 
(Lai et al., 2006). The subset of genes that were analysed by qPCR in this project, can be 
segregated into those which contribute to cell death, those which reside in the ER lumen 
(most of which have chaperone or co-chaperone activity) and those which contribute to 
ERAD.  
Early work on the transcriptional profile of IRE1 demonstrates that the Ire1p-Hac1p 
pathway is required for induction of genes such as KAR2, which is the yeast homolog of BIP 
(Cox and Walter, 1996). In addition, BIP expression was more recently shown to be 
dependent on XBP-1 splicing in fruitfly cells (Hollien and Weissman, 2006). However, in 
mammalian systems, the UPR seems to have deviated from this and probably relies on more 
than one transcription factor. Several groups have attempted to characterise which genes are 
strictly dependent on either XBP-1, ATF6, or a combination of these two (Lee  et al., 2003, 
Yamamoto et al., 2007, Adachi  et al., 2008 and Shoulders et al., 2013). Subsequently, a 
large amount of Northern blot, microarray and proteomics analyses have been carried out 
highlighting the importance of the IRE1α RNase domain in the transcriptional program of 
the UPR. However, very few studies have been dedicated to investigating whether or not the 
kinase activity of this transmembrane protein has any influence on which genes are 
expressed. For this reason qPCR analysis was carried out on the three MEF cell lines to help 
characterise in what ways the kinase-dead mutant might be transcriptionally deficient.  
Apart from IRE1α and ATF6, the PERK branch is also associated with upregulation of 
certain genes via the phospho-eIF2α pathway. It is understood that although phosphorylation 
of this subunit of the eIF2 complex attenuates general translation, translation of mRNAs 
which harbour upstream open reading frames (uORFs) is induced (Kozak, 2002). In 
mammalian cells, one of these targets is the ATF4 transcription factor, which harbours two 
of these uORFs (Vattem and Wek, 2004). In 2011, it was shown that ATF4 along with a 
dimerisation partner, is capable of causing the transcription of CHOP, a protein whose 
function is mainly linked to cell death (Badiola et al., 2011). CHOP is a transcription factor 
which is responsible for the dephosphorylation of eIF2α via upregulation of GADD34. 
GADD34 can then direct the phosphatase activity of PP1 towards phospho-eIF2α (Brush et 
al., 2003). Dephosphorylation of this subunit means that protein translation is now free to 
restart and therefore the lumen of the ER can become full of newly synthesised polypeptides 
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before actually recovering from the original stress. This is one reason for linking CHOP 
upregulation with ER stress –related apoptosis.  
  
Another mechanism hypothesised to encourage cell death downstream of CHOP involves 
TRB3. TRB3 mRNA expression was shown to follow CHOP expression in two separate 
studies (Ohoka et al., 2005 and Shang et al., 2010). CHOP cooperates with ATF4 to engage 
with the TRB3 promoter and cause its transcription (Ohoka et al., 2005). Exactly how TRB3 
contributes to cell death is unknown, however one group suggested it inhibits the prosurvival 
function of Akt by binding it (Du et al., 2003). This is supported by a publication which 
shows that the TRB3 mediated Akt inhibition can drive the cell into apoptosis by increasing 
autophagic activity (Salazar et al., 2009).  
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CHOP (eg: ATF4)
CHOP 
heterodimer
Active CHOP 
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P
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nucleus
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p38
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eIF2α P eIF2α
Increase in protein 
synthesis and ER stress
 
Figure 4.1: Illustration of the result of CHOP activation. 
 
Due to the fact that CHOP plays a role in ER stress determined cell fate, this gene and 
downstream GADD34 and TRB3 were also analysed by qPCR. This was done in order to 
understand whether compromising the function of human IRE1α caused an over-
compensatory response downstream of PERK.  
 
The main hypothesis for the differences in transcription between WT-hIRE1α, D711A-
hIRE1α and K599A-hIRE1α cells, is that the latter mutant is likely to have either decreased 
or elevated levels of transcript in comparison to the WT-hIRE1α. This would be due to lack 
of XBP-1(s), or over-compensation by  ATF6(f), respectively. Alternatively, other UPR 
transcription factors could also play a role. The K599A-hIRE1α may display no 
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transcriptional differences, indicating that XBP-1(s) is not necessary for effective 
transcription of the gene under investigation. The principal objective of carrying out this 
qPCR analysis was to find evidence for differences between the WT-hIRE1α and D711A-
hIRE1α cells, so as to help understand how the latter mutant is compromised. The level of 
involvement of the kinase domain for the transcription of each gene will be apparent 
depending on whether its profile is more similar to that of the WT-hIRE1α or the K599A-
hIRE1α cells.   
 
4.2: The changes in expression of induced genes between WT-hIRE1α and mutant 
MEFs 
Each qPCR was set up on the RotorGeneQ real-time PCR machine and the data were 
analysed on the accompanying software. It was ensured that all primers were tested in 
reactions which did not contain any template cDNA, so as to ensure primer dimers or any 
contaminant were not responsible for the peak seen in the melt curve. All data presented 
here were normalised to the housekeeping gene β-actin. For normalising, the 2-ΔΔCt method 
was used, as only the relative gene expression was of interest, rather than the absolute copy 
number (Livak and Schmittgen, 2001). The three MEF cell lines were treated using the time 
course described below. 
 
Figure 4.2: Flow chart indicating the treatments for the control and ER-stressed cells. 
The blue text highlights the treatments for the control cells, and the purple and black 
routes highlight the treatments for the tetracycline-only treated cells and the ER-stressed 
cells, respectively. Cells were incubated in a CO2 incubator at 37°C. Details of chemical 
concentrations can be found in Chapter 2. 
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4.2.1: Induced genes whose function is associated with cell death 
It was hypothesised that at least one of the mutants would display a higher level of CHOP 
expression relative to the WT, since partial or full loss of IRE1α function should 
compromise the cell during ER stress. As it can be seen from figure 4.3, CHOP expression 
was induced in all three cell lines after 24 h of ER stress induction. There was a smaller 
increase in transcripts between 24 and 48 h tunicamycin treatment. Any differences between 
the WT-hIRE1α and D711A-hIRE1α were not significant. The fold change in CHOP during 
ER stress in the K599A-hIRE1α mutant was consistently seen to be at least double the 
induction levels in the WT-hIRE1α and D711A-hIRE1α cells. Despite this, the p value 
obtained when comparing the WT-hIRE1α and K599A-hIRE1α using an unpaired t-test, was 
0.0563. This falls just outside the 95% confidence limits, and therefore a repeat is required 
to validate the significance of these findings. The difference between the D711A-hIRE1α 
and K599A-hIRE1α cells was significant, indicating that loss of the RNase activity in 
addition to loss of kinase activity leads to increased levels of this death-inducing protein. 
However, what is observed in the K599A-hIRE1α mutant does not correlate with what was 
observed in the original publication regarding the transcriptional potential of XBP-1(s) in 
MEFs (Lee et al., 2003). This group did not observe any changes in the levels of CHOP 
between WT-hIRE1α and XBP-1 deficient MEFs. This could be due to the fact that the cells 
were treated with 100 ng/ml tunicamycin for 48 h, rather than 10 μg/ml for 16 h (as they 
were in the publication). This high concentration of tunicamycin would elicit a much 
stronger ER stress response, which may mask the prosurvival branch of the UPR. 
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Figure 4.3: CHOP expression profile determined by qPCR analysis using Rotor-Gene Q 
software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and + indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h. The time shown is the number of h that ER-stress was induced. 
Error bars show standard error. An unpaired t-test was performed. * p = 0.0563 (WT-
hIRE1α vs K599A), ** p = 0.0087 (D711A-hIRE1α vs K599A-hIRE1α). The average Ct 
value error was ± 0.24. 
These results suggest that the K599A-hIRE1α mutation may be responsible for causing 
earlier cell death via the CHOP route. Despite the fact that upregulation of CHOP is 
classically thought of being downstream of the PERK pathway, the upregulation seen in the 
qPCR data might be the cause of enhanced levels of ATF6 (Yoshida et al., 2000). One 
would expect both PERK and ATF6 to be upregulated in the K599A-hIRE1α cells to 
compensate for the loss of the transcriptional potential of IRE1α. Two separate groups 
demonstrated that CHOP is under regulation of ATF6(f), as well as the PERK-ATF4 branch 
(Ma et al., 2002 and Okada et al., 2002). Therefore, hyperactivation of ATF6 and /or PERK 
may be responsible for the differences seen in the K599A-hIRE1α mutant. 
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Figure 4.4: GADD34 expression profile determined by qPCR analysis using Rotor-Gene 
Q software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and + 
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of h that ER-stress was 
induced for. The average Ct value error was ± 0.15. 
  
Figure 4.5: TRB3 expression profile determined by qPCR analysis using Rotor-Gene Q 
software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and + indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h. The time is the number of h that ER-stress was induced for. The 
average Ct value error was ± 0.74. 
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CHOP is known to induce expression of GADD34 and TRB3 (Marciniak et al., 2004; Ohoka 
et al., 2005). Based on the CHOP expression profile, it was hypothesized that both GADD34 
and TRB3 levels would be similar in the ER stress-induced WT-hIRE1α and D711A-hIRE1α 
cells, and highest in the K599A-hIRE1α-IRE1α MEFs. However, figure 4.4 argues that the 
levels of the GADD34 gene are upregulated to a very similar fold induction (>6) in all three 
cell lines treated with tunicamycin for 24 h. After 48 h of ER stress, the levels of this gene 
had diminished somewhat, but still displayed at least a 4-fold induction compared to the 
untreated cells. The slightly higher fold induction in the K599A-hIRE1α mutant treated 
MEFs could be a result of the higher CHOP expression, although a repeat would be required 
to validate this. The reason GADD34 levels might not rise as dramatically as expected in the 
K599A-hIRE1α mutant might be due to the fact that even though CHOP expression is the 
highest, it might not become dimerised and/or phosphorylated. These two processes are 
required to render CHOP a fully capable transcription factor (Zinzsner et al., 1998 and 
Wang and Ron, 1996). For this reason it might be beneficial to study the phospho-p38 
pathway by Western blot analysis, as this is believed to be responsible for CHOP 
phosphorylation (Wang and Ron, 1996). 
 
However, in support of the GADD34 qPCR profile obtained, in 2008, Adachi et al., saw no 
fluctuations in levels of GADD34 parallel to changes in CHOP expression, which suggests 
there may be another transcription factor controlling this gene. The presence of an 
alternative transcription factor may also explain why the TRB3 expression pattern did not 
correlate with that observed for CHOP. As expected, there was an increase in TRB3 
expression in each of the cell lines undergoing ER stress (figure 4.5). However, contrary to 
what was hypothesized based on the CHOP profile, the highest expression of TRB3 was 
actually in the D711A-hIRE1α mutant, where after 48 h of tunicamycin treatment, there was 
almost an 18-fold induction of this mRNA compared to the untreated cells. Levels of TRB3 
mRNA seemed to be at their lowest in WT-hIRE1α, where expression compared to the 
untreated cells was maintained at ~5-fold induction during the time course of ER stress-
inducing treatment. After 24 h, K599A-hIRE1α cells induced this gene to a similar level, 
however after 48 h of induction levels were intermediate between the WT-hIRE1α and the 
D711A-hIRE1α cells. A repeat for these data is obviously required, however the differences 
between the WT cells and those expressing the D711A form of hIRE1α warrants full 
characterisation of this mutant by microarray, or RNA sequencing experiments. It is 
believed the TRB3 pathway within the UPR will provide an interesting route to study the 
function of IRE1α kinase activity in cell fate, due to its potential role in ER physiology and 
autophagy (see discussion).  
 
  
98 
 
4.2.2: Induced genes associated with ER luminal localisation 
 
As discussed earlier, BIP is induced by the UPR, and its transcript levels were therefore 
hypothesized to increase upon tunicamycin addition. Indeed, as it can be seen in figure 4.6, 
there was a ~20 fold induction of this gene in the WT, after 24 h of ER stress. In the D711A-
hIRE1α mutant, there was almost the same increase in levels of this transcript, however the 
decrease between 24 and 48 h of treatment was less striking than in the WT-hIRE1α cells. 
On the other hand, 24 h after activation of ER-stress in the K599A-hIRE1α mutant saw 
almost a 45-fold increase compared to the untreated sample. This drastic increase could be 
due to differences in BIP mRNA stability and/or an over-compensatory effect by a 
transcription factor, such as ATF6α. The latter idea is supported by several laboratories who 
demonstrate that this chaperone is dependent on the ATF6α(f) transcription factor 
(Yamamoto et al., 2007, Adachi et al., 2008, and Shoulder et al., 2013). However, although 
most publications focus on the transcriptional potential of XBP-1(s) and ATF6(f), Scheuner 
et al., 2001 showed that phosphorylation of eIF2α was required for complete BIP 
expression. For this reason, one must not rule out the PERK pathway for gene regulation. 
 
  
Figure 4.6: BIP expression profile determined by qPCR analysis using Rotor-Gene Q 
software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and + indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h. The time is the number of h that ER-stress was induced for. The 
average Ct value error was ± 0.48. 
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The chaperone, GRP94, and co-chaperone, p58
IPK
,were hypothesized to be induced by 
tunicamycin treatment, as they are both targets of the UPR (Lee et al., 2003). Figures 4.7 
and 4.8 highlight that both genes display the same pattern in terms of induction. As 
expected, both were strongly activated in the WT-hIRE1α cells after 24 h of tunicamycin 
treatment, compared to the untreated samples. In both cases, the expression dropped after 48 
h, more dramatically in the GRP94 profile, compared to the one of p58
IPK
. Strikingly, the 
levels of induction in the D711A-hIRE1α were almost identical to those present in WT-
hIRE1α cells for both genes. This is suggestive of the fact that IRE1α kinase does not 
contribute to the control of these genes. Both genes show a comparatively low induction in 
K599A-hIRE1α compared to the two other cell lines, implying that IRE1α endoribonuclease 
function is necessary for full induction of this ER-resident chaperone.  
  
Figure 4.7: GRP94 expression profile determined by qPCR analysis using Rotor-Gene Q 
software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and + indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h. The time is the number of h that ER-stress was induced for. The 
average Ct value error was ± 0.14. 
Other laboratories imply that the ATF6(f) transcription factor would be able to induce this 
gene in the absence of XBP-1 (Lee et al., 2003; Shoulders et al., 2013). However, from the 
qPCR data displayed above, the significance of other transcription factors in the regulation 
of this gene during ER stress needs to be investigated. It is possible that the GRP94 qPCR 
data output is a combinatorial effect of the kinase and RNase functions being absent, 
although a repeat is required to support this argument. 
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The higher relative induction of p58
IPK
 compared to GRP94 in the K599A-hIRE1α mutant 
suggests that another transcription factor plays a significant role in the upregulation of the 
former gene in the absence of XBP-1(s). Both Mori (2007) and Wiseman (2013) groups 
suggest that this co-chaperone promoter is accessed by both ATF6 and XBP-1 and therefore 
ATF6 alone may be able to promote expression levels noted in the K599A-hIRE1α mutant. 
What is interesting is that p58
IPK
 may play a role in controlling polypeptides being 
translocated into the ER. These polypeptides can be degraded before fully entering the 
lumen during ER stress (Oyadomari et al., 2006) and p58
IPK
 may therefore assist in the 
ERAD program. Investigating its potential role at the interface between the UPR and ERAD 
and exactly how it is transcriptionally regulated could provide insight into the future 
elucidation of IRE1α signalling. 
  
Figure 4.8: p58
IPK
 expression profile determined by qPCR analysis using Rotor-Gene Q 
software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and +  
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of h that ER-stress was 
induced for. The average Ct value error was ± 0.15. 
ERO1L-α and ERO1L-β are both responsible for reoxidizing mammalian protein disulphide 
isomerise (PDI). PDI introduces and isomerises disulphide bonds and is therefore thought to 
assist with protein folding (Sitia and Braakman, 2003). The yeast homolog was originally 
found to be upregulated downstream of the Ire1p-Hac1p pathway (Travers et al., 2000) and 
therefore it was hypothesised that ER stress could induce its upregulation. The qPCR 
analysis shown in figure 4.9 suggests that IRE1α kinase activity dramatically impacts the 
transcriptional control for the ERO1L-α gene, as the transcript levels from the D711A-
hIRE1α cells were decreased in comparison to WT-hIRE1α. The fold change in the WT cells 
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reached a maximum of ~7 after 48 h of ER stress, whereas in the D711A-hIRE1α expressing 
cells, maximal fold induction was only about half of this value. This was only marginally 
higher than the induction of this gene in the K599A-hIRE1α mutant. The differences 
displayed here justify that full characterisation of the D711A-hIRE1α mutant by microarray 
analysis or RNA sequencing should be carried out in order to begin determining the role of 
the kinase in transcriptional control in the UPR. 
  
Figure 4.9: ERO1L-α expression profile determined by qPCR analysis using Rotor-Gene 
Q software. FAST 2xreal-time PCR MasterMix with SYBR Green was used . – and + 
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of h that ER-stress was 
induced for. The average Ct value error was ± 0.19. 
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Figure 4.10: ERO1L-β expression profile determined by qPCR analysis using Rotor-Gene 
Q software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and + 
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of h that ER-stress was 
induced for. The average Ct value error was ± 1.11. 
 
As it can be seen from figure 4.10, the ERO1L-β gene displays a different profile to ERO1L-
α. Due to the abolishment of XBP-1(s) in the K599A-hIRE1α mutant, it was predicted that 
there would be little induction of this gene compared to the WT-hIRE1α and D711A-
hIRE1α mutant (Sriburi et al., 2007 and Shoulders et al., 2013). This was indeed the case, 
however, the D711A-hIRE1α mutant displayed massively elevated levels of this gene. 
Perhaps this is due to the fact that it was less able to induce ERO1L-α, and therefore hyper-
activation of this gene was a result of compensating for this loss. Again, this probes for 
further investigation into the IRE1α kinase domain. 
 
Lee et al., 2003 suggest that ERDJ4 transcription is completely reliant on XBP-1 splicing. 
The profile below, obtained for co-chaperone ERDJ4 was largely in agreement with what 
has been published, as the levels of transcript in the WT-hIRE1α cells after 24 h tunicamycin 
treatment were approximately ~14 times the untreated control. The fold induction in both 
mutants were greatly reduced in comparison. However the comparatively small increases of 
ERDJ4 transcript in both tunicamycin-treated mutants, suggest that another transcription 
factor apart from XBP-1(s) may play a role in expression of this gene (albeit a much less 
effective one). What is interesting is that again the kinase activity seems to be important in 
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ensuring this gene is expressed, as the levels of transcription reached by the D711A-hIRE1α 
mutant are essentially equal to those in the K599A-hIRE1α mutant. This strengthens the 
argument that full characterisation of the former mutant is required to help understand its 
role in gene induction. 
  
Figure 4.11: ERDJ4 expression profile determined by qPCR analysis using Rotor-Gene Q 
software. GoTaq® qPCR MasterMix with SYBR Green was used to obtain these data. – 
and + indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of h that ER-stress was 
induced for. The average Ct value error was ± 0.23. 
4.2.3: Induced genes which are associated with regulating ERAD 
Synoviolin or HRD1 is an indispensable E3 ubiquitin ligase for the ERAD protein quality 
control system. Travers et al., 2000 found it to be upregulated as a consequence of Ire1p-
Hac1p activation and more recently it was identified as being reliant on XBP-1 for its 
transcription in mammalian cells (Shoulders et al., 2013). It was therefore hypothesized that 
its upregulation in the K599A-hIRE1α cells would be compromised during ER stress. In 
figure 4.12, HRD1 was shown to be heavily downregulated to roughly half the fold 
induction in both mutants, compared to the WT-hIRE1α cells treated for 24 h with 
tunicamycin. A qualitative repeat was obtained for these data, and in both cases it appears 
there may be a very slight increase in the D711A-hIRE1α response relative to the K599A-
hIRE1α. The response from the latter mutant complements the above mentioned studies, 
although other transcription factors must be available to achieve the smaller increases in 
response to ER stress induction. The results also heavily implicate IRE1α kinase in the 
transcriptional mechanism involved in activating this gene.  
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Figure 4.12: HRD1 expression profile determined by qPCR analysis using Rotor-Gene Q 
software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and + indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h. The time is the number of h that ER-stress was induced for. A 
qualitative biological repeat was obtained for this gene (Figure A4.26). The average Ct 
value error was ± 0.23. 
EDEM1 is proposed to recognise structures to be retrotranslocated for ERAD and Yoshida et 
al., 2003 showed that IRE1α deficient MEFs were unable to induce EDEM1 mRNA, even 
though the active fragment of ATF6 was present under ER stress. This is supported by the 4-
fold induction of this gene after induction of the UPR in the WT-hIRE1α, and also the lower 
levels sustained in the K599A-hIRE1α mutant. Again, it seems as though transcription 
factors other than XBP-1(s) do play a role in regulating this gene, and candidates such as 
ATF6 and ATF4 should be questioned. More importantly, it seems as though the kinase 
domain may be vital for the full transcriptional activation of the EDEM1 gene, as expression 
levels in the D711A-hIRE1α mutant are intermediate between the WT-hIRE1α and K599A-
hIRE1α cells. 
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Figure 4.13: EDEM1 expression profile determined by qPCR analysis using Rotor-Gene 
Q software. FAST 2xreal-time PCR MasterMix with SYBR Green was used.  – and + 
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of h that ER-stress was 
induced for. The average Ct value error was ± 0.23.  
HEDJ, also known as ERDJ3, is mainly regarded as a co-chaperone for BIP as it stimulates 
its ATPase activity. Additionally, it has been postulated that it may play a role in ERAD by 
binding unfolded polypeptides chains to be targeted for degradation (Jin et al., 2009). The 
potential link to ERAD encouraged the hypothesis that this gene would show a similar 
profile to HRD1 and EDEM1. Despite this, figure 4.14 shows that HEDJ is actually 
expressed almost identically in all three cell lines. After 24 h, levels of transcripts reach 
approximately a 4.5 fold induction compared to the untreated cell lines. Each displays a 
small decrease in transcript after 48 h of ER stress, however, the downregulation in both of 
the mutants is greater than in the WT-hIRE1α. In accord with this, the Wiseman laboratory 
(2013) showed that by inducing either XBP-1(s), ATF6, or both, resulted in almost equal 
increases in HEDJ upregulation. This proposed redundancy is supported by Sriburi et al., 
2004, who essentially saw the same protein upregulation of ERDJ3 in ATF6α(373) or 
XBP-1(s) transduced cells. This enforces the idea that the HEDJ profile is a result of 
XBP-1(s) and ATF6(f) having the same capabilities regarding activation of this gene. 
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Figure 4.14: HEDJ expression profile determined by qPCR analysis using Rotor-Gene Q 
software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and + indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h. The time is the number of h that ER-stress was induced for. The 
average Ct value error was ± 0.23. 
HERP is the final gene that was analysed and that is UPR-regulated for ERAD purposes. It 
has been postulated that all three branches of the UPR are able to cause an upregulation of 
this gene (Ma and Hendershot, 2004). It was shown that apart from ATF6(f) and XBP-1(s) 
binding the ERSE sites in the HERP promoter, ATF4 (downstream of the PERK-phospho-
eIF2α branch) was able to complex with the composite site in this promoter. Consistently, 
they found the constitutively inactive eIF2α mutant (S51D) was able to generate an increase 
in both HERP mRNA and protein levels. Therefore, it was proposed that HERP upregulation 
might be similar in each of the cell lines treated with tunicamycin. Despite the fact there was 
no difference between the WT-hIRE1α and D711A-hIRE1α profiles, the K599A-hIRE1α 
mutant showed a much higher induction (~14 fold) after 24 h tunicamycin treatment. It is 
possible that ATF6 and ATF4 cause a higher upregulation of HERP in K599A-hIRE1α 
compared to the other two cell lines in order to try and compensate for the loss of other 
ERAD components. Further experimentation would be needed to validate this idea. 
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Figure 4.15: HERP expression profile determined by qPCR analysis using Rotor-Gene Q 
software. FAST 2xreal-time PCR MasterMix with SYBR Green was used. – and + indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h. The time is the number of h that ER-stress was induced for. The 
average Ct value error was ± 0.16. 
4.3: Rationale for studying the RIDD pathway: 
A report in Science in 2006 gave evidence for a subset of mRNAs whose degradation was 
dependent on the presence of IRE1 (Hollien and Weissman, 2006). The presented data 
suggested that an internal cleavage site in these mRNAs was present to differentiate them 
from other mRNAs that do not get degraded, such as BIP. Consistent with data published 
recently (Gaddam et al., 2012) it was also demonstrated that the signal sequence targeting 
these mRNAs for cotranslational translocation into the ER, seemed to be required for this 
repression (Hollien and Weissman, 2006). 
As explained in Chapter 1, the Weissman group used human IRE1α stably transfected MEFs 
to show that this RIDD pathway was sustained under ER stress provided the RNase was also 
functional. Additionally, they suggested this was maintained by using the 1NM-PP1 
sensitized I642G IRE1α mutant, in which IRE1α kinase activity is abolished (Hollien et al, 
2009). Similar data was published by the Papa group at around the same time. However, in 
these experiments, mRNA degradation did not occur as part of the UPR when the I642G 
mutant was active (Han et al. 2009). These two groups had opposing ideas as to how this 
degradation route affected cell fate, with the Weissman group proposing this would relieve 
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the burden on the ER, and the Papa group suggesting there was a positive correlation with 
apoptosis. 
From these data it was hypothesized that RIDD substrates should not undergo degradation in 
ER-stressed K599A-hIRE1α mutants due to lack of RNase activity. Since this project was 
designed to find other potential functions associated with the IRE1kinase domain, 
determining any differences between the RIDD pathway outputs of the WT-hIRE1α and 
D711A-hIRE1α cells could help answer this. Since endoribonuclease activity is maintained, 
the D711A-hIRE1α cells may display a similar RIDD profile to what was is observed in the 
WT-hIRE1α cells. However, if the Papa group is correct, and full kinase function is required 
for an effective RIDD, then this mutant may mirror what is found for the K599A-hIRE1α 
mutant.  
4.4: Results and discussion for analysis of the RIDD pathway by qPCR 
The genes examined in the context of the RIDD pathway were those published by Hollien et 
al., in 2009.  
Table 4.1: List of RIDD target genes and their localisation as proteins, adapted from the 
Hollien et al., paper in 2009. 
Gene corresponding to RIDD target Localisation of protein 
HGSNAT Lysosomal membrane 
BLOS1 Cytosol 
SCARA3 ER/Golgi apparatus membrane 
PDGFRB Plasma membrane 
PMP22 Extracellular matrix 
COL6 Extracellular matrix 
EPHRINB2 Plasma membrane 
MAP7d1 Cytoskeleton 
SRP20 Spliceosome 
TRIM16 Cytosol 
GALNT10 Golgi apparatus membrane 
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Primers were designed to recognise the genes listed in Table 4.1 and tested in ordinary PCR 
first. Once they had also been tested for specificity using mouse cDNA (derived from pre-
adipocytes and adipocytes) in the RotorgeneQ, they were finally checked for primer-dimer 
formation using a no template control. As with the induced genes, the raw data were 
normalised to ACTB, and the quantitation was carried out using the 2
-ΔΔC
t method (Livak and 
Schmittgen, 2001). Initial experiments did show evidence for degradation in the WT-
hIRE1α samples, upon induction of ER-stress. This was observed for the following genes: 
BLOS1, PDGFRB, TRIM16, COL6, EPHRINB2, SRP20 and GALNT10. MAP7d1 mRNA 
was only marginally reduced after 48 h ER-stress induction. Data were not generated for 
HGSNAT, SCARA3 and PMP22 due to time limitations.  
As can be seen from figures 4.16 and 4.17 (and figures A4.28-A4.33)  there is evidence for 
elevation of transcript levels in the K599A-hIRE1α mutant relative to the WT-hIRE1α in 
COL6, EPHRINB2, GALNT10, PDGFRB, SRP20 and TRIM16 genes. All but the latter two 
genes still showed a decrease in the level of transcript upon induction of ER stress compared 
to the untreated K599A-hIRE1α. This suggests that the RIDD pathway is not fully abolished 
in these cells despite the lack of IRE1α endoribonuclease activity. Only SRP20 and TRIM16 
transcripts were increased during ER-stress compared to the untreated K599A-hIRE1α. 
Increased levels of SRP20 transcript (Figure 4.17) seem to be the most significant, and a 
biological repeat was obtained for this gene. The profile does suggest that the kinase may 
play a role on effective degradation of SRP20. However, by observing the small increase 
seen at the end of the time course in WT-hIRE1α cells, one would have to question how 
much of was what found was simply a consequence of the length of ER stress induction. 
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Figure 4.16: TRIM16 expression profile determined by qPCR analysis using Rotor-Gene 
Q software. 2xreal-time PCR MasterMix with SYBR Green was used. – and + indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h. The time is the number of h that ER-stress was induced for. The 
average Ct value error was ± 0.30. 
  
Figure 4.17: SRP20 expression profile determined by qPCR analysis using Rotor-Gene Q 
software. 2xreal-time PCR MasterMix with SYBR Green was used.  – and + indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h.  The time is the number of h that ER-stress was induced for. A 
qualitative biological repeat was obtained for this gene (Figure A4.33). The average Ct 
value error was ± 0.22. 
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Despite several attempts, no other data was generated which demonstrated a loss of RIDD in 
the K599A-hIRE1α expressing cells. From the data shown in this thesis it is difficult to 
speculate a role for the kinase activity of hIRE1α in this pathway, as the profiles for the 
different proposed RIDD transcripts are very variable. In general it seems as though this 
mutant is less effective in carrying out the RIDD function, however repeats are required to 
validate this observation. 
It may be advisable to repeat this set of experiments using primers that have been redesigned 
to anneal closer to the 5’ end of the genes. Most of the primers designed in this project 
annealed slightly closer to the 3’ end than the 5’ end. Therefore, if the cleavage site of the 
mRNA in question was upstream of the primer annealing site, it is possible that the 3’ end of 
the mRNA may have been reverse transcribed if it had not been immediately degraded. 
Reverse transcription would have been able to take place as the oligo(dT)s would have still 
annealed to the polyA tail of mRNA, creating a starting template for the reverse transcriptase 
enzyme. Thus, the primers would have generated the expected PCR product despite the fact 
that mRNA cleavage may have taken place. 
The role of the kinase domain in RIDD can unfortunately not be deduced from these studies, 
as from the data presented, it is still possible that some mRNAs require an active IRE1α 
kinase for degradation, whereas other do not. The RIDD pathway could indeed be less 
defined than originally portrayed by both Han and Hollien groups, and mRNAs may be 
subject to cleavage dependent on their proximity to IRE1α. This has in fact been proposed 
for Schizosaccharomyces pombe (Kimmig et al., 2012). If this is true, then qPCR analysis of 
single genes cannot be used to study RIDD activity, and microarray and/or RNA sequencing 
will be required. 
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4.5: Discussion 
As previously discussed, the main objective was to find any differences between the WT-
hIRE1α and the D711A-hIRE1α cells in terms of their transcriptional output. Changes in the 
cell lines expressing the kinase and RNase-dead form of IRE1α were to be expected due to 
loss of the XBP-1(s) transcription factor and/or overcompensatory effects by ATF6. The 
data obtained by qPCR analysis do indeed demonstrate that the kinase activity of IRE1α is 
required for a full transcriptional response. The HRD1 and EDEM1 profiles suggest that 
both mutants may have a diminished ERAD response. This, along with the fact that kinase 
function also seemed to be necessary for effective transcription of the ER-resident co-
chaperone ERDJ4, and ERO1L-α  provides a mechanism by which the kinase-activity of 
IRE1α may contribute to keeping the cell alive once the ER stress has been induced. These 
differences justify full characterisation of the transcriptional role of the kinase by using 
microarray and RNA sequencing in each of the three cell lines. Pulse-chase labelling and 
immunoprecipitation for known ERAD substrates will help confirm loss of control of ERAD 
in the D711A-hIRE1α cells. 
Another line of interest in the D711A-hIRE1α mutant is the upregulation of TRB3. TRB3 is 
known to inhibit Akt (Salazar et al., 2009) which in turn is required for function of VCP/p97 
(Vandermoere et al., 2006). Knockdown of VCP, which is an AAA-ATPase involved in 
proteasomal degradation, correlated with the phenotype of dilated ER, as visualised by 
electron microscopy (Wócjik et al., 2006). As will be shown in the following chapter, the 
D711A-hIRE1α mutant displays very similar features to that seen in the Wócjik publication. 
Theoretically, elevated TRB3 levels may render VCP/p97 non-functional via Akt in the 
D711A-hIRE1α cells, thus leading to a drastic change in ER phenotype. Using qPCR and 
Western blotting to investigate the relationship between IRE1α kinase and ER phenotype 
could lead to discovering a novel mechanistic pathway relating the two. It may also help 
delineate the cell death route taken when IRE1α lacks kinase activity.  
 
Returning to the data obtained, it was noted that differences were seen between the mRNA 
and protein expression levels of BIP. This is probably due to differences in protein 
translation in the three cell lines. Therefore the activities of phospho-eIF2α should be 
analysed using Western blotting at a series of close time points. Pulse-labelling could be 
used alongside this Western blotting to help determine levels of protein synthesis. 
Ribosomal profiling may also be utilised to establish the ratio of monosomes to polysomes 
to determine levels of translation.  
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Finally, the RIDD pathway should next be analysed using primers which anneal to the 5’ 
end of the genes under investigation. It is hypothesised that RIDD activity will be lost in the 
K599A-hIRE1α cells compared to the WT-hIRE1α. If these experiments are successful, it 
may also be useful to carry out the same analyses using xbp-1
-/-
 MEFs, in order to 
demonstrate that the RIDD pathway is separable from XBP-1 splicing, as shown in Hollien 
et al., 2009. 
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Chapter 5 
 
The differences in ER physiology 
between WT, D711A and K599A 
human IRE1α mouse embryonic 
fibroblasts  
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5.1: Rationale for investigating changes in ER physiology 
The Walter group reported that hac1Δ mutants displayed normal ER characteristics when ER 
stress was not induced in yeast. However, by analysing the localisation of Rtn1 (an ER 
membrane protein) after 2 h DTT treatment, they showed that the ER became disorganised 
and that there was relatively more smooth ER compared to rough ER (Schuck et al., 2009). 
Earlier studies performed, using mammalian fibroblasts showed that XBP-1(s) transduction 
into cells resulted in an increased ER surface area and volume (Sriburi et al., 2004). It was 
also noted that this transduction correlated with increased activity of cytidylyltransferase 
(CCT). This enzyme is regarded as the rate-limiting factor in the Kennedy pathway 
(illustrated below), which produces phosphatidylcholine and phosphatidylethanolamine, 
both of which are required for ER membrane biogenesis. This group later demonstrated that 
the most efficient upregulation of these membrane components was by over-expression of 
XBP-1(s) and not the CCT enzyme. It is therefore thought that the product of IRE1α RNase 
activity is responsible for generating a greater ER surface area via increased output of the 
Kennedy pathway and that this is most likely achieved by upregulation of the CCT enzyme 
alongside other cofactors (Sriburi et al., 2007). 
 
Figure 5.1: Schematic outlining the steps of the Kennedy Pathway. ATP: adenosine 
triphosphate, ADP: adenosine diphosphate, CTP: cytidine triphosphate, CDP: cytidine 
diphosphate, DAG: diacylglycerol, CMP cytidine monophosphate.  
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A similar phenomenon compared to that observed in yeast was observed in pancreatic acinar 
cells. In cells lacking XBP-1, the ER was unable to develop normally in comparison to the 
WT-hIRE1α cells. It was also observed that the defectively formed ER contained granules 
within the lumen (Lee et al., 2005). In agreement with this, an RNase inhibitor to IRE1α was 
shown to inhibit proper expansion of the ER in the AR42J pancreatic cell line (Cross et al., 
2012).   
Of relevance is the study carried out by the Brewer group, who used the transcriptionally 
active form of ATF6 to transfect CHO cells. They demonstrated that there was an XBP-1(s) 
independent ER expansion which also resulted in increased phospholipid production. In this 
case, it was the choline kinase (CK) enzyme (also part of the Kennedy pathway) whose 
activity was increased after ATF6 transduction (Bommiasamy et al., 2009). 
As it can be seen, most work conducted in this field does not directly address ER expansion 
during the unfolded protein response, but rather focuses on the inductive potential of either 
the XBP-1 or ATF6 transcription factors. Also, the publications concentrate mainly on the 
size and volume of the ER, rather than the shape and structural organisation. For these 
reasons, it was agreed it would be informative to closely analyse the changes in ER 
morphology and size in both the D711A-hIRE1α and K599A-hIRE1α mutants compared to 
the WT-hIRE1α. It was hypothesized that an expansion in the ER should be seen in WT-
hIRE1α and D711A-hIRE1α cells treated with tetracycline, as the PhD student Louise 
Sutcliffe showed that this treatment causes XBP-1 splicing independent of ER-stress. The 
K599A-hIRE1α cells may be able to expand their ER via the ATF6 route, if there is indeed 
some functional redundancy between these two transcription factors. 
5.2: Observations and results from TEM 
Prior to carrying out the TEM processing protocol, all three cell lines were incubated at 
37°C with EtOH or tetracycline for 24 h following a 24 h period over which they adhered to 
the surface of the 75 cm
2
 tissue culture flasks. The control cells treated with EtOH were then 
treated with 10 μl DMSO for a further 48 h, whereas the cells treated with tetracycline were 
treated with 100 ng/ml tunicamycin for 48 h. The media and treatments were replenished 
every 24 h. 
At least 100 electron micrographs were taken for each cell line and treatment. Most pictures 
were taken at a magnification of at least 15,000 to obtain a clear image of the ER, however, 
in some cases lower magnification images were collected to highlight the extent to which the 
ER filled the cytoplasm of a single cell. It was immediately apparent that there were large 
differences in ER physiology, in particular between the WT-hIRE1α tunicamycin treated 
cells and the mutant treated cells. The untreated WT-hIRE1α cells did not display any 
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notable abnormal characteristics. There was not a large amount of ER within these cells, and 
this was neither well-organised nor disorganised (Figure 5.2). Often areas of the cells 
completely devoid of ER were observed. In the untreated D711A-hIRE1α cells, the 
appearance was comparable, however at first glance, there did appear to be very slightly 
more ER which had a wider lumen. The untreated K599A-hIRE1α cells were very similar to 
the untreated D711A-hIRE1α cells, as can be seen in the figure below. None of the untreated 
cells displayed a continuous or extensive ER network. 
Figure 5.2: (A) denotes the untreated control WT-hIRE1α MEFs. (B) and (C) represent 
the untreated D711A-hIRE1α and K599A-hIRE1α MEF controls, respectively. The 
arrows mark typical ER. Magnification: (A): x25,000, (B): x25,000 and (C): x20,000. 
Scale bars represent a distance of 500 nm.  
Figure 5.3 highlights the fact that there were no notable differences between the cell three 
lines when treated with tetracycline only. Additionally, there did not seem to be any 
dramatic changes in ER physiology when compared to the untreated cells. 
Figure 5.3: (A) is representative of the tetracycline-only treated WT-hIRE1α MEFs, 
whereas (B) and (C) depict average D711A-hIRE1α and K599A-hIRE1α MEFs treated 
with the IRE1α-inducing drug. The arrows mark ER. Magnification: (A): x20,000, (B): 
x20,000 and (C): x25,000. Scale bars represent a distance of 500 nm. 
When the cells were treated with the ER stress inducing agent tunicamycin the physiology of 
the ER dramatically changed. In the WT-hIRE1α cells, the amount of ER increased 
significantly, with a large proportion of cells containing cytoplasm almost fully occupied by 
rough ER. This rough ER was generally not swollen and formed a very well organised 
network. There seemed to be an increase in the number of autophagosomes and/or 
(A) (B) (C)
(A) (B) (C)
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lysosomes, although through observation it was difficult to differentiate between these 
vacuolar structures within the cell. In some cases the ER was in close contact with these 
structures, as can be seen in Figure 5.4. It is possible that the ER was being directly 
degraded in an attempt to reduce the amount of unfolded proteins, or that the ER was 
‘donating’ a small proportion of its membrane towards the forming vesicle. 
Figure 5.4: (A) and (B) show how the ER was observed to be organised in the WT-
hIRE1α MEFs treated with tunicamycin. The arrows in (C) highlight the presence of 
lysosomal-like structures and how the ER network was seen to interact with them. 
Magnification: (A): x40,000, (B) x15,000 and (C) x40,000. Scale bars represent a distance 
of 500 nm. 
On the other hand, the response of D711A-hIRE1α to the same drug was quite different 
(Figure 5.5). As with the WT-hIRE1α treated cells, there was a large increase in the amount 
of ER produced, however this was much more swollen and distorted and seemed to consist 
of comparatively more smooth ER. This is similar to what was observed in the yeast study 
carried out by the Walter group in 2009. Rather than forming an organised network, a 
disorganised and more ‘fragmented’ ER formed. The swollen ER appeared to have a less 
dense lumen, as opposed to the appearance of the lumen found in most of the WT-hIRE1α 
treated cells. This is indicative of the ER becoming expanded due to osmotic stress (personal 
correspondence: Dr. M. Goldberg, 19/04/2013, meeting, and Wócjik et al., 2006). There was 
a strong correlation between this phenotype and the observation of a thin white outline 
around the nucleus, which looked as though the outer nuclear membrane was separating 
from the inner nuclear membrane. This may be expected since the ER is continuous with the 
outer nuclear membrane. In some of the dilated and ‘white-coloured’ ER, small grey circles 
can be visualised. It is possible that these could be protein aggregates forming as a result of 
ER stress inducing drug treatment, or they could be analogous to the unidentified granules 
observed by Lee et al., 2005. 
(A) (B) (C)
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Figure 5.5: (A) and (B) show swollen, disrupted ER and also the 'white' perinuclear space 
in the ER-stress D711A-hIRE1α MEFs (B) also verifies that the ER is continuous with 
the outer nuclear membrane. Magnification: (A): x20,000 and (B): x15,000. Scale bars 
represent a distance of 500 nm. 
 
In the K559A mutant, the level of ER expansion as a result of the stress response being 
activated was maybe very slightly less than the WT-hIRE1α and D711A-hIRE1α, but 
nonetheless was very badly formed. It lacked both structure and integrity, and was even less 
organised than the ER seen in the D711A-hIRE1α mutant. As above, there seemed to be 
some correlation with severely swollen ER and the white nuclear perimeter, however, this 
phenotype was observed less often than in the D711A-hIRE1α cells. 
 
Figure 5.6: (A) and (B) show disorganised and 'tangled' ER in the K599A-hIRE1α MEFs 
treated with tunicamycin. Magnification: (A): x30,000 and (B): x 20,000. Scale bars 
represent a distance of 500 nm. 
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5.3: Quantification of TEM results confirms the mutants have a dilated ER 
The online random number generator, random.org, was used to generate random numbers 
between 1 and the highest number of the photos taken for a specific cell line and treatment. 
For example, if 120 photos were taken for the D711A-hIRE1α mutant, random numbers 
were generated between 1 and 120. In total 20 random images were analysed for each cell 
line and treatment. Any picture taken below a magnification of 15,000 times was not 
quantified. This is because there would have been significant error when measuring the 
width of ER lumen, especially in the untreated and tetracycline-treated cells, where the ER 
was the most narrow. Omitting these photos would not have biased the results as only a very 
small proportion of pictures were taken at low magnification. 
The images taken were analysed using ImageJ software. First a randomly offset grid of 
crosses was overlaid onto the image. From this three areas of ER were randomly selected for 
measurement of the ER lumen width once the appropriate scale has been set. An average 
was taken for each image analysed, and then from this, the overall average for the cell line 
and treatment was calculated.  
Table 5.1: The width in nm of the ER lumen ± SE for each cell type and treatment. 
‘UNTR’ represents the untreated, control MEFs. ‘Tet’ indicates where only tetracycline 
has been added, whereas ‘Tet/Tn’ highlights cells treated with both tetracycline and 
tunicamycin. 
WT-hIRE1α D711A-hIRE1α K599A-hIRE1α 
UNTR Tet Tet/Tn UNTR Tet Tet/Tn UNTR Tet Tet/Tn 
88.8 ± 
4.5 
85.6 ± 
4.4 
88.7 ± 
8.9 
89.5 ± 
4.8 
105.5 
± 4.8  
239.9 ± 
27.8 
98.3 ± 
6.2 
86.6 ± 
3.3 
164.7 ± 
13.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7: Graphical representation of the data in table 5.1 depicting the variability 
between the samples.  
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An unpaired t-test was carried out to determine whether the differences between the samples 
were statistically significant. The confidence limits were set to 95% and Welch’s correction 
was used if the variances between the samples were significantly different in the original t-
test. There was no significant difference between any of the untreated cells. Tunicamycin 
treated D711A-hIRE1α and K599A-hIRE1α were both significantly different from one 
another (p = 0.02) and also the WT-hIRE1α treated cells (p < 0.0001).  
The values obtained for all three untreated cell lines are all quite similar to each other. Most 
importantly, all of these values fall within the limits of the average width of the ER lumen, 
between 60 and 120 nm (referenced in Klopfenstein et al., 2001). Interestingly, the 
measurement achieved for ER-stressed WT-hIRE1α cells also conforms with the average 
width, suggesting that the ER proliferates when under stress but provided there is normal 
UPR signalling, it does not become dilated and/or unstructured. The two mutants, however, 
show a dramatic increase in the ER width, with the most impressive increase being in the 
D711A-hIRE1α mutant. Combined with observations from the images taken, it would seem 
that the D711A-hIRE1α and K599A-hIRE1α mutants both show the capacity for ER 
proliferation but the organelle becomes more disorganised and presumably dysfunctional as 
the severity of the mutation increases from D711A-hIRE1α to K599A-hIRE1α. This would 
be consistent with the fact that phospholipid synthesis can be controlled by either XBP-1(s) 
or ATF6(f), but that specifically organising these phospholipids into sheets and/or tubules of 
ER requires hIRE1α kinase activity.  
For the D711A-hIRE1α mutant, random pictures were chosen in the same way as described 
above, to measure the distance between the outer and inner nuclear membrane. This 
measurement was easy to take as the white colour in the perinuclear space made it possible 
to distinguish the inner and outer membranes from the background. The average distance 
was calculated to be 77.2 nm, which is much greater than the normal perinuclear distance 
between 20 and 40 nm (Cohen et al., 2002). The interaction between SUN- and KASH-
domain proteins is thought to anchor the inner and outer nuclear membranes together 
(Padmakumar et al., 2005). Therefore, the electronmicrographs suggests that D711A-
hIRE1α may have abnormal or no SUN/KASH-domain interactions in the nuclear 
membrane. A random measurement of this distance could not be taken for the K599A-
hIRE1α mutant, as too few pictures depicted this phenotype and the lack of the ‘space’ 
between the two membranes would have made it too difficult to measure accurately. It is 
surprising that the latter mutant is more similar to the WT in terms of this perinuclear 
phenotype. For this reason, it would be useful to characterise  xbp-1
-/-
 or ire1
-/-
 cells, which 
have been reconstituted with a form of IRE1α which possesses kinase function, but lacks 
RNase activity. 
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5.4: ER-Tracker™ experiments validate the phenotype seen in TEM 
Using ER-tracker is a very powerful tool as it enables the user to visualise live cells. Having 
observed that ER proliferation occurred in each of the three cell lines upon induction of 
stress, it was decided to attempt to quantify the relative volume of ER. Therefore, these 
experiments were designed to determine whether the relative ER volume in each of the 
tunicamycin-treated cell lines was increased by the same amount compared to their untreated 
and tetracycline treated counterparts. If this were the case, it would demonstrate that the 
mutants were lacking the capacity to structurally organise their ER but that proliferation was 
normal. The use of ER-Tracker™ would also help determine whether or not IRE1α kinase 
activity plays a role in ER biogenesis alongside XBP-1(s) and ATF6(f).  
The time course of drug treatments was approximately 24 h shorter than that carried out for 
electron microscopy due to that fact that further into the treatment the cells start dying and 
detaching from the plate, making it difficult to visualise and take ‘live’ pictures in a short 
time-frame. These experiments confirmed what was seen in the electron microscopy, 
especially for the D711A-hIRE1α mutant. When the UPR was induced in this mutant, the 
dye was seen to highlight several swollen, oval-shaped fragments of ER, reinforcing that ER 
organisation is not maintained in this mutant. It could be seen that the ER did not form a 
smooth continuous network. There appeared to be some swollen ‘blebs’ of ER in the 
K599A-hIRE1α mutant, along with a disorganised network around the nucleus. 
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Figure 5.8: ER-tracker confocal microscopy images. (A), (C) and (E) represent 
tetracycline treated WT-hIRE1α, D711A-hIRE1α and K599A-hIRE1α MEFs, 
respectively. (B), (D) and (F) represent tunicamycin treated WT-hIRE1α, D711A-hIRE1α 
and K599A-hIRE1α MEFs respectively. The arrows in (D) indicate swollen areas of ER in 
the D711A-hIRE1α mutant, whereas the arrows in (F) show some smaller ‘blebs’ in the 
K599A-hIRE1α mutant. An image representing the untreated WT-hIRE1α can be found 
in the appendix. All scale bars represent a distance of 10 μm. 
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Despite the fact that the ER-tracker experiments validated the observations from TEM, it 
was not possible to obtain a value for the amount of ER. For measuring ER volume, a macro 
(Wojciechowicz et al., 2013) was modified for use on ImageJ, to quantify the ‘amount’ of 
red fluoresence. Theoretically, quantifying this fluorescence for each cell line and treatment 
should have given a ‘relative ER volume’ value. However, this could not be implemented 
due to that fact that there was some bias in the selection of cells imaged. How this bias arose 
is explained below. 
Having previously looked at some stained MEFs under the confocal microscope, the 
parameters were set to the following: 
 Scan speed: x6 
 Line average of 2 
 Laser intensity of 67.3 
 Detector gain of 676 
 HeNe lamp wavelength of 543 nm 
It was important to keep these settings fixed for each picture taken, as otherwise the 
brightness of the image would change depending on the scan speed and laser intensity 
chosen. This would have effectively deemed this experiment void, as in theory there should 
be a positive correlation between the amount of ER present in the cell, and the intensity of 
the fluorescence.  
Upon first observation, these settings seemed to be appropriate as none of the cells 
visualised were either too bright or too dim for the camera. Later however, it became 
apparent that some cells had taken up the dye much more effectively than others (as seen in 
Figure 5.8 below) and were indeed so bright that an image could not be taken. Thus, there 
was an immediate bias in the cohort of pictures taken and quantifying these would not have 
given a representative value for the volume of ER in the different cell types. 
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Figure 5.9: an example of K599A-hIRE1α tunicamycin treated MEFs highlighting the 
unequal uptake of the ER-tracker dye within a group of cells. 
In general, it seemed as though the cells closest to the centre of a clump were the most 
brightly stained. For future work, when repeating this experiment, the cells should be 
sonicated prior to being seeded for the time course. It might also be advantageous to place 
the glass-bottomed plates onto a rocker or shaker for the whole time they are being 
incubated with the ER-tracker dye.  
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5.5: Discussion 
It was established that XBP-1 splicing is very similar in both WT-hIRE1α and D711A-
hIRE1α cells, and was undetectable by RT-PCR in cDNA from K599A-hIRE1α cells 
(Figure A1.1). However, the fact that there is no visible increase in the amount of ER when 
each of the cell lines was treated with tetracycline suggests that XBP-1 splicing alone does 
not suffice to induce ER expansion, and that stress is also required. The reason this may not 
conform with experiments conducted by Sriburi et al., could be because their XBP-1(s) 
transduction may be responsible for producing much higher levels of protein. 
Since the treated K599A-hIRE1α cells show an increase in ER amount comparable to that 
seen in the WT-hIRE1α and D711A-hIRE1α cells, it suggests that other proteins apart from 
XBP-1(s), such as ATF6, might be sufficient to cause this effect in the absence of XBP-1 
splicing, as implied by Bommiasamy et al., 2009. Also, the difference in phenotype between 
the two mutant cell lines confirms that the distortions observed in both of them are not 
simply a result of cell death (personal correspondence: Dr. M. Goldberg, 19/04/2013, 
meeting). 
What is most intriguing about these results is the evident loss of control over ER 
organisation seen in both ER-stressed mutants. The kinase inactive mutants display a 
severely dilated ER, which is sometimes seen in the K599A-hIRE1α mutant along with a 
very distorted ER phenotype. This implies that the kinase domain plays a role in structuring 
the ER. The reason the organisation seems worse in the K599A-hIRE1α mutant could be due 
to loss of activity from both domains of IRE1α, with XBP-1 playing a smaller role in 
organising the ER. 
The results discussed argue that the kinase domain is required for proper organisation of the 
ER. If lack of kinase activity is partly responsible for structuring the ER, this helps answer 
why the D711A-hIRE1α cells die before the WT-hIRE1α cells, as suggested by the PARP-1 
and caspase-3 Western blots, and the MTT assay carried out by Dr.Sutcliffe. It is also 
possible that this mutation directly or indirectly caused the increased perinuclear distance 
observed in these stressed cells. Immunofluorescence was carried out in all three cell lines 
using antibodies against Sun-1 and Nesprin-2 as it was hypothesized that the localisation of 
these proteins may have been disturbed in the D711A-hIRE1α mutant, since they link the 
outer and inner nuclear membranes together (Padmakumar et al., 2005). Unfortunately, there 
were not enough cells left on the cover slips to make any observations, and therefore this 
experiment should be repeated using poly-L-lysine coated cover slips to help the cells adhere 
in place while the washes are being done (personal correspondence: Dr. I. Karakesisolou, 
26/06/13, meeting). 
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Ideally, the TEM and confocal work should be repeated making the above mentioned 
changes. Despite the fact that ‘ER-tracker’ dye has been used during activation of the UPR 
(Tan et al., 2006) it is possible that the sulphonylurea receptors that the dye binds to (Zhang 
et al., 2010) are not as abundant and/or equally distributed during ER stress compared to 
during homeostasis. Synthesis of these receptors during ER stress may also be compromised. 
Therefore stereological techniques should also be used in conjunction with confocal 
microscopy to measure the volume of the ER, provided that non-biased serial sections could 
be taken (personal correspondence: Dr. R. Banks, 23/04/2013, meeting). As mentioned in 
Chapter 4, the relationship between the kinase domain and ER physiology via the TRB3 
route could also provide useful information as to how the structure of the ER is maintained 
whilst it is proliferating to cope with ER stress. The kinase domain may indeed play a role in 
determining the expression of reticulons and Climp-63 – both of which are required to 
structure the ER into the classical tubular network (Shibata et al., 2010).  
It would also be very interesting to determine whether there is more smooth ER in relation to 
rough ER in either or both of the mutants compared to the WT-hIRE1α. This can be carried 
out by separating these two constituents by equilibrium centrifugation and then quantifying 
how much there is in each fraction (Alberts et al., 2002). 
Finally, it would be useful to show where the human IRE1α proteins are located within the 
ER membrane in the three different cell lines. This could be achieved by using 
immunofluoresecent labelling of IRE1α, or alternatively, immunogold labelling. In theory, 
upon tetracycline induction of each IRE1α form, the protein should become clustered in 
groups throughout the ER (Li et al., 2010). This would serve as a good control to prove there 
were no differences in the localisation of any of the three forms of human IRE1α. 
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Chapter 6 
 
Concluding remarks and future 
work  
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The principal objective of this project was to determine pathways via which the kinase 
activity of human IRE1α may play a role in cell survival downstream of ER stress. Although 
no significant changes in PARP-1 and caspase-3 cleavage were found when comparing 
D711A-hIRE1α cells to WT-hIRE1α cells, there was a large increase in CHOP expression. 
Since CHOP is implicated in cell death (Oyadomari and Mori, 2004) this indicates that the 
kinase domain is required as well as endoribonuclease activity for cell survival downstream 
of the unfolded protein response being activated.  
 
QPCR data showed that TRB3 expression was also elevated the most in the D711A-hIRE1α 
cells. In order to determine a mechanism as to how lack of kinase activity compromises the 
cell, it would be useful to investigate Akt activation and expression of proteins it interacts 
with using both qPCR and Western blotting. One of these proteins is VCP/p97, which Akt is 
known to inhibit (Vandermoere et al., 2006). As described in chapter 4, it was found that 
there was a relation between the knockdown of VCP and the phenotype of swollen ER 
(Wócjik et al., 2006). This is in agreement with the D711A-hIRE1α phenotype observed by 
TEM and confocal techniques in Chapter 5. These data all argue that there is a relationship 
between the IRE1α kinase and the TRB3-Akt axis, however further research is required to 
elucidate whether or not this relationship is direct. Analysing this pathway could give some 
insights into the role autophagy plays during ER stress in the three different cell lines, as 
TRB3 should lift the inhibition on this degradation pathway imposed by mTOR (Salazar et 
al., 2009). The LC3 plasmid, which was characterised and prepared for transfection, could 
be used to confirm these findings. 
 
qPCR analysis also revealed that certain genes upregulated in the stressed WT-hIRE1α cells 
were induced to much lower levels in both of the mutants (not just in the K599A-hIRE1α 
cells). ERO1L-α, ERDJ4, and HRD1 were essentially reduced to the same levels in 
tunicamycin-treated D711A-hIRE1α and K599A-hIRE1α cells, implying kinase function is 
required to ensure full expression of these genes encoding chaperones and ERAD proteins. 
These interesting differences support the idea that the D711A-hIRE1α mutant needs to be 
properly characterised using microarray and/or RNA sequencing. EDEM1 was also reduced 
in the D711A-hIRE1α mutant, however, not as much as in the K599A-hIRE1α. Loss of 
expression of HRD1 and EDEM suggest that the ERAD component of the UPR would also 
be less effective in the kinase-dead cells, providing another possible route of explanation as 
to why these cells are compromised. To confirm this theory, pulse-chase labelling to 
determine the rate of turnover of established ERAD substrates will have to be conducted. As 
with the LC3 construct, plasmids containing established ERAD substrates were validated 
and prepared for transfection, however time constraints did not allow functional experiments 
to be carried out.  
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The ATF6 reporter will need to be used to validate whether or not there is an upregulation of 
this UPR signal transducer. If there is, then this will explain the increased expression of 
certain genes detected by qPCR analysis in the K599A-hIRE1α mutant. It may also be useful 
to carry out ChIP assays to show ATF6 binds to the promoters of the genes upregulated in 
the latter mentioned mutant. However, one must not rule out the possibility that PERK may 
also play a role in changing the transcriptional outcome during ER stress, and therefore 
complimentary studies should be carried out using PERK
-/-
 MEFs.  
 
Images from microscopy implicate both kinase and RNase in controlling the width of the ER 
and structurally organising this organelle under ER stress. It did seem that stress was 
required for the ER to proliferate, and not just XBP-1 splicing as previously reported (Sriburi 
et al., 2004; Sriburi et al., 2007). Proliferation in the K599A-hIRE1α mutant did seem 
slightly less in comparison to the other two cell lines. This is in agreement with the BIP 
profile shown in Chapter 3, however Western blotting for a different ER-resident protein 
(not inducible by ER stress) would be required for evidence of ER volume, preferably 
alongside ER-tracker experiments.  
 
 
Figure 6.1: Summary of experimental findings.  
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Increased severity of human IRE1α mutation
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The results and future experiments discussed in this thesis should help to map cell decision 
pathways downstream of human IRE1α as part of the UPR. Since UPR-mediated cell death 
plays such an important role in health and disease (reviewed in Schröder and Kaufman, 
2005) this work will eventually help ascertain which areas can be targeted to either promote 
the survival signals, or dampen cell death massages. It is likely that the kinase can have both 
antiapoptotic and proapoptotic roles, depending on the precise cellular conditions. Since 
UPR-mediated death is attributed to cell loss in the brain and pancreas in Parkinsonism and 
diabetes, respectively, identifying exactly what determines the nature of this kinase activity 
has very important medical implications. 
 
As an extension of this work, it would also be informative to use kinase inhibitors, such as 
sunitinib (Ali et al., 2011, Korennykh et al., 2011), to question the mechanism of how these 
chemicals affect cell fate. Development of inhibitors specific only to IRE1α kinase could 
prove particularly useful for inducing death in cancer cells. These cells are believed to 
survive the high levels of ER stress caused by their hypoxic and nutrient-poor environment 
(Feldman et al., 2005). Elucidating the role of IRE1α kinase holds the key to discovering 
therapeutics strategies to combat an array of varying human diseases.  
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Figure A1.1: RT-PCR carried out by Louise Sutcliffe showing XBP-1 splicing in WT-
hIRE1α, D711A-hIRE1α and K599A-hIRE1α MEFs. Times indicate treatment with 1 
μg/ml tetracycline. Samples are one of three replicates (Sutcliffe, 2012). 
 
Figure A1.2: WB carried out by Louise Sutcliffe showing PARP-1 cleavage in WT-
hIRE1α, K599A-hIRE1α, and D711A-hIRE1α MEFs after induction of hIRE1α 
expression using tetracycline (Sutcliffe, 2012). The arrow represents the cleaved fragment. 
 
 
Figure A1.3: Results of an MTT assay carried out by Louise Sutcliffe, showing relative 
viabilities of WT-hIRE1α, K599A-hIRE1α, and D711A-hIRE1α MEFs after 0, 24, and 48 
h of 100 ng/ml tunicamycin treatment (Sutcliffe, 2012). 
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Figure A3.1: Western blot showing expression levels of IRE1α and its phospho-form from 
hIRE1α WT, D711A and K599A MEF lysates. – and + indicate absence or presence of the 
appropriate drug. Cells treated with tetracycline were harvested after 4 h, then after 6, 24 
and 48 h of combined tetracycline and DMSO treatment. ER-stressed cells were harvested 
after 6, 24, and 48 h of combined tetracycline and tunicamycin treatment. GAPDH was 
used as the loading control. 
 
Figure A3.2: Western blot showing levels of PARP-1 cleavage from hIRE1α WT, D711A 
and K599A MEF lysates. The arrow indicates the cleaved fragment. – and + indicate 
absence or presence of the appropriate drug. Cells treated with tetracycline were harvested 
after 4 h, then after 6, 24 and 48 h of combined tetracycline and DMSO treatment. ER-
stressed cells were harvested after 6, 24, and 48 h of combined tetracycline and 
tunicamycin treatment. GAPDH was used as the loading control. 
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Figure A3.3: Western blot showing expression levels of CHOP from hIRE1α WT, D711A 
and K599A MEF lysates. – and + indicate absence or presence of the appropriate drug. 
The time/h indicates how long the cells have been treated with tunicamycin. Untreated 
cells were harvested at the end of the time course. Cells treated with tetracycline were 
harvested after 48 h of treatment. GAPDH was used as the loading control. 
 
Figure A3.4: Western blot showing expression levels of total eIF2α and its phospho-form 
from hIRE1α WT, D711A and K599A MEF lysates. – and + indicate absence or presence 
of the appropriate drug. Cells treated with tetracycline were harvested after 4 h, then after 
6, 24 and 48 h of combined tetracycline and DMSO treatment. ER-stressed cells were 
harvested after 6, 24, and 48 h of combined tetracycline and tunicamycin treatment.  
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Figure A3.5: Graphical representation of the Western blot image in Figure A2.5. The 
bands were quantified using ImageJ and phospho-eIF2α/total eIF2α was calculated. 
 
Figure A3.6: Western blot showing expression levels of total JNK and its phospho-form 
from WT, D711A and K599A lysates. – and + indicate absence or presence of the 
appropriate drug. Cells treated with tetracycline were harvested after 4 h, then after 6, 24 
and 48 h of combined tetracycline and DMSO treatment. ER-stressed cells were harvested 
after 6, 24, and 48 h of combined tetracycline and tunicamycin treatment.  
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Figure A3.7: Western blot showing expression levels of LC3 from WT, D711A and K599A 
lysates. – and + indicate absence or presence of the appropriate drug. Cells treated with 
tetracycline were harvested after 4 h, then after 6, 24 and 48 h of combined tetracycline 
and DMSO treatment. ER-stressed cells were harvested after 6, 24, and 48 h of combined 
tetracycline and tunicamycin treatment. GAPDH was used as the loading control. 
 
 
Figure A4.1: Melt curve for the ACTB gene in triplicate. The y-axis represents the change 
in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
 
Figure A4.2: Melt curve for the BIP gene in triplicate. The y-axis represents the change in 
fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product.  
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Figure A4.3: Melt curve for the BLOS1 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
 
 
 
Figure A4.4: Melt curve for the CHOP gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product.  
 
Figure A4.5: Melt curve for the COL6 gene in triplicate. The y-axis represents the change 
in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
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Figure A4.6: Melt curve for the EDEM1 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product.  
 
Figure A4.7: Melt curve for the EPHRINB2 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
 
 
Figure A4.8: Melt curve for the ERDJ4 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
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Figure A4.9: Melt curve for the ERO1L-α gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product.  
 
 
Figure A4.10: Melt curve for the ERO1L-β gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product.  
 
Figure A4.11: Melt curve for the GADD34 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product.  
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Figure A4.12: Melt curve for the GALNT10 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
 
 
 
Figure A4.13: Melt curve for the GRP94 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product.  
 
Figure A4.14: Melt curve for the HEDJ gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
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Figure A4.15: Melt curve for the HERP gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
 
Figure A4.16: Melt curve for the HGSNAT gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
 
Figure A4.17: Melt curve for the HRD1 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
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Figure A4.18: Melt curve for the MAP7d1 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
 
Figure A4.19: Melt curve for the p58
IPK
 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product.  
 
Figure A4.20: Melt curve for the PDGFRB gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
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Figure A4.21: Melt curve for the PMP22 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
 
Figure A4.22: Melt curve for the RAMP4 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
 
Figure A4.23: Melt curve for the SRP20 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
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Figure A4.24: Melt curve for the TRB3 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product.  
 
 
 
Figure A.4.25: Melt curve for the TRIM16 gene in triplicate. The y-axis represents the 
change in fluorescence (F) over the change in temperature (T), and the x-axis shows the 
temperature in °C. The single peak represents the PCR product. 
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Figure A4.26: Qualitative repeat of the HRD1 expression profile determined by qPCR 
analysis using Rotor-Gene Q software. FAST 2xreal-time PCR MasterMix with SYBR 
Green was used. – and + indicate absence and presence of tetracycline and/or 
tunicamycin, respectively. Tetracycline-only treatment was for 48 h. The time is the 
number of hours that ER-stress was induced for. The average Ct value error was ± 0.48. 
 
Figure A4.27: BLOS1 expression profile determined by qPCR analysis using Rotor-
GeneQ software. 2xreal-time PCR MasterMix with SYBR Green was used. – and +  
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of hours that ER-stress 
was induced for. The average Ct value error was ± 0.13. 
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Figure A4.28: COL6 expression profile determined by qPCR analysis using Rotor-Gene 
Q software. 2xreal-time PCR MasterMix with SYBR Green was used. – and +  indicate 
absence and presence of tetracycline and/or tunicamycin, respectively. Tetracycline-only 
treatment was for 48 h. The time is the number of hours that ER-stress was induced for. 
The average Ct value error was ± 0.24. 
 
Figure A4.29: EPHRINB2 expression profile determined by qPCR analysis using Rotor-
Gene Q software. 2xreal-time PCR MasterMix with SYBR Green was used. – and +  
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of hours that ER-stress 
was induced for. The average Ct value error was ± 0.29. 
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Figure A4.30: GALNT10 expression profile determined by qPCR analysis using Rotor-
Gene Q software. 2xreal-time PCR MasterMix with SYBR Green was used. – and +  
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of hours that ER-stress 
was induced for. The average Ct value error was ± 0.24. 
 
Figure A4.31: MAP7d1 expression profile determined by qPCR analysis using Rotor-
Gene Q software. 2xreal-time PCR MasterMix with SYBR Green was used. – and + 
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of hours that ER-stress 
was induced for. The average Ct value error was ± 0.16. 
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Figure A4.32: PRDFRB expression profile determined by qPCR analysis using Rotor-
Gene Q software. 2xreal-time PCR MasterMix with SYBR Green was used. – and +  
indicate absence and presence of tetracycline and/or tunicamycin, respectively. 
Tetracycline-only treatment was for 48 h. The time is the number of hours that ER-stress 
was induced for. The average Ct value error was ± 0.27. 
 
Figure A4.33: Qualitative repeat of the SRP20 expression profile determined by qPCR 
analysis using Rotor-Gene Q software. FAST 2xreal-time PCR MasterMix with SYBR 
Green was used. – and +  indicate absence and presence of  tetracycline and/or  
tunicamycin, respectively. Tetracycline-only treatment was for 48 h. The time is the 
number of hours that ER-stress was induced for. The average Ct value error was ±0. 28. 
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Figure A5.1: Untreated hIRE1α WT MEF cells incubated with ER-tracker dye. This 
image represents all untreated cell lines. The scale bar represents a distance of 20 μm. 
 
 
151 
 
 
 
 
 
References 
 
  
152 
 
 Adachi, Y., Yamamoto, K., Okada, T., Yoshida, H., Harada, A., and Mori, K. 
(2008) ATF6 Is a Transcription Factor Specializing in the Regulation of Quality 
Control Proteins in the Endoplasmic Reticulum. Cell Structure and Function. 33:75-
89. 
 Alberts, B., Johnson, A., Lewis, J., Riff, M., Roberts, K. and Walter, P. (2002) 
Molecular Biology of the Cell. In Manipulating Proteins, DNA and RNA, pp. 501-
578. Garland Science, Abingdon. 
 Ali, M.M.U., Bagaratuni, T., Davenport, E.L., Nowak, P.R., Silva-Santisteban, 
M.C., Hardcastle, A., McAndwers, C., Rowlands, M.G., Morgan, G.J., Aherne, W., 
Collins, I., Davies, F.E., and Pearl, L.H. (2011) Structure of the Ire1 
autophosphrylation complex and implication for the unfolded protein response. 
European Molecular Organisation Journal. 30: 894-905. 
 Amanso, A. M, Debbas, V, and Laurindo, F.R. (2011) Proteasome inhibition 
represses unfolded protein response and Nox4, sensitizing vascular cells to 
endoplasmic reticulum stress-induced death. PLoS One. 6: e14591. 
 Aredia, F., Oriz, L.M.G., Giansanti, V., and Scovassi, A.I. (2012) Autophagy and 
Cancer. Cells. 1: 520-534. 
 Back, S.H., Schröder, M., Lee, K., Zhang, K, and Kaufman, R.J. (2005) ER stress 
signalling by regulated splicing: IRE1/HAC1/XBP1. Methods. 35: 395-416. 
 Badiola, N., Penas, C., Miñano-Molina, A., Barneda-Zahonero, B., Fadé, R., 
Sánchez-Opazo, G., Comella J. X., Sabriá, J., Zhu, C., Blomgran, K. and Rogríguez-
Alvarez, J. (2011) Induction of ER stress in response to oxygen-glucose deprivation 
of cortical cultures involves the activation of the PERK and IRE-1 pathways and of 
caspase-12. Cell Death and Disease. 2: e149. 
 Bassik, M.C., Scorrano, L., Oakes, S.A., Pozzan, T. and Korsemeyer, S.J. (2004) 
Phosphorylation of BCL-2 regulates ER Ca
2+
 homeostasis and apoptosis. The 
European Molecular Organisation Journal. 23: 1207-1216. 
 Bernasconi, R., Galli, C., Kokame, K., and Molinari, M. (2013) Autoadaptive ER-
Associated Degradation defines a Preemptive Unfolded Protein Response. 
Molecular Cell. 52: 1-11. 
 Bertolotti, A., Zhang, Y., Hendershot, L.M., Harding, H.P., and Ron, D. (2000) 
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein 
response. Nature Cell Biology. 2: 326-332. 
 Birnboim, H.C., and Doly, J. (1979) A rapid alkaline extraction procedure for 
screening recombinant plasmid DNA. Nucleic Acids Research. 7: 1513-1523. 
 Bommiasamy, H., Back, S.H., Fagone, P., Lee, K., Meshinchi, S., Vink, E., Sriburi, 
R., Matthew, F., Jackowski, Kaufman, R.J., and Brewer, J. (2009) ATF6α induces 
153 
 
XBP1-independant expansion of the endoplasmic reticulum. Journal of Cell 
Science.  122: 1626-1636. 
 Brush, M., Welser, D.C. and Shenolikar, S. (2003) Growth Arrest and DNA 
Damage-Inducible Protein GADD34 Targets Protein Phosphatase 1α to the 
Endoplasmic Reticulum and Promotes Dephosphorylation of the α Subunit of 
Eukaryotic Translation Initiation Factor 2. Molecular and Cellular Biology. 23: 
1292-1303.  
 Chawla, A., Chakrabarti, S., Ghosh, G., and Niwa, M. (2011) Attenuation of yeast 
UPR is essential for survival and is mediated by IRE1 kinase. The Journal of Cell 
Biology. 193: 41-50. 
 Chiang, W.C., Messah, C., and Lin, J.H. (2011) IRE1 directs proteasomal and 
lysosomal degradation of misfolded rhodopsin. Molecular Biology of the Cell. 
23:758-770. 
 Cohen, M., Tzur, Y.B., Neufeld, E., Feinstein, N., Delannoy, M.R., Wilson, K.L., 
and Greunbaum, Y. (2002) Transmission electron microscope studies of the nuclear 
envelope in Caenorhabditis elegans embryos. Journal of Structural Biology. 140: 
232-240. 
 Cox, J.S., and Walter, P. (1996) A Novel Mechanism for Regulating Activity of a 
Transcription Factor That Controls the Unfolded Protein Response. Cell. 87: 391-
404.  
 Cox, J.S., Shamu, C., and Walter, P. (1993). Transcriptional Induction of Genes 
Encoding Endoplasmic Reticulum Resident Proteins Requires a Transmembrane 
Protein Kinase. Cell. 73: 1197-1206. 
 Cross, B.C.S., Bond, P.J., Sadowski, P.G., Jha, B.K., Zak, J., Goodman, J.M., 
Silverman, R.H., Neubert, T.A., Baxendale, I.A., Ron, D., and Harding, H.P. (2012) 
The molecular basis for selective inhibition of unconventional mRNA splicing by an 
IRE1-binding small molecule. Proceedings of the National Academy of Sciences. 
E869-E878. 
 Davis, J.M. (2002) Basic Cell Culture: A Practical Approach. Oxford University 
Press, Oxford.  
 Dlugosz, P., Billen, L.P., Annis, M.G., Zhu, W., Zhang, Z., Lin, J., Leber, B., 
Andrews, D.W. (2006) Bcl-2 changes conformation to inhibit Bax oligomerisation. 
The European Molecular Biology Organisation Journal. 25: 2287-2296. 
 Du, K., Herzig, S., Kulkarni, R.N, and Montminy, M. (2003) TRB3: A tribbles 
Homolog that Inhibits Akt/PKB Activation by Insulin in Liver. Science. 300: 1574-
1577. 
154 
 
 Eskes, R., Desagher, S., Antonsson, B., and Martinou, J.C. (2000) Bid induced 
oligomerisation and insertion of Bax into the outer mitochondrial membrane. 
Molecular Cell Biology. 20: 929-935. 
 Feldman, D.E., Chauhan, V., and Koong, A.C. (2005) The Unfolded Protein 
Response: A Novel Compenent of the Hypoxic Stress Response in Tumours. 
Molecular Cancer Research. 3: 596-605. 
 Fomenko, D.E., and Galdyshev, V.N. (2003) Genomics Perspective on Disulphide 
Bond Formation. Antioxidants & Redox Signalling. 5: 397-402. 
 Fujita, N., Itoh, T., Omori, H., Fukuda, M., Noda, T., and Yoshimori, T. (2008) The 
Atg16L Complex Specifies the Site of LC3 Lipidation for Membrane Biogenesis in 
Autophagy. Molecular Biology of the Cell. 19: 2092-2100. 
 Gaddam, D., Stevens, N., and Hollien, J. (2012) Comparison of mRNA localisation 
and regulation during endoplasmic reticulum stress in Drosophila cells. Molecular 
Biology of the Cell. 24:14-20. 
 Gao, B., Lee, S.M., Chen, A., Zhang, J., Zhang, D.D., Kannan, K., Ortmann, R.A., 
and Fang, D. (2008) Synoviolin promotes IRE1 ubiquitination and degradation in 
synovial fibroblasts from mice with collagen-induced arthritis. European Molecular 
Biology Organisation. 9: 480-485. 
 Gardner, B.M., and Walter, P. (2011) Unfolded Proteins Are Ire1-Activating 
Ligands That Directly Induce the Unfolded Protein Response. Science. 333: 1891-
1894. 
 Giménez-Xavier, P., Francisco, R., Platini, F., Pérez, R., and Ambrosio, S. (2008) 
LC3-I conversion to LC3-II does not necessarily result in complete autophagy. 
International Journal of Molecular Medicine. 22: 781-785. 
 Gobeil, S., Boucher, C.C., Nadeau, D., and Poirnier, G.G. (2001) Characterisation of 
the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of 
lysosomal proteases. Cell Death & Differentiation. 8: 588-594. 
 Guo, F.J., Liu, Y., Zhou, J., Luo, S., Zhao, W., Li, X., and Liu, C. (2012) XBP1S 
protects cells from ER stress-induced apoptosis through Erk1/2 signalling pathways. 
Histochemistry and Cell Biology. 138: 447-460. 
 Gupta, S., Deepti, A., Deegan, S., Lisbona, F., Hetz, C., and Samali, A. (2010) 
HSP72 Protects Cells from ER Stress-induced Apoptosis via Enhancement of 
IRE1α-XBP1 Signaling through a Physical Interaction. PLoS Biology. 8: e1000410. 
 Han, D., Lerner, A.G., Vande walle, L., Upton, J., Xu, W., Hagen, A., Baces, B.J., 
Oakes, S.A., and Papa, F.R. (2009) IRE1α kinase Activation Modes Control 
Alternative Endoribonuclease Outputs to Determine Divergent Cell Fates. Cell. 138: 
562-575. 
155 
 
 Han, D., Upton, J.P., Hagen, A., Callahan, J., Oakes, S.A., and Papa, F.R (2008) A 
kinase inhibitor activates the IRE1α RNase to confer cytoprotection against ER 
stress. Biochemical and Biophysical Research Communications. 365: 777-783. 
 Harding, H.P., Novoa, I., Zhang, Y.H., Zeng, H.Q., Wek, R., Schapira, M., and Ron. 
D. (2000) Regulated translation initiation controls stress-induced gene expression in 
mammalian cells. Molecular Cell. 6: 1099-1108. 
 Hershko, A., and Ciechanover, A. (1998) The Ubiquitin System. Annual review of 
Biochemistry. 67: 425-479. 
 Hetz, C., Bernasconi, P., Fisher, J., Lee, A.H., Bassik, M.C., Antonsson, B., Brandt, 
G.S., Iwakoshi, N.N., Schinzel, A., Glimcher, L.H. and Korsemeyer, S.J. (2006) 
Proapoptotic BAX and BAK Modulate the Unfolded Protein Response by a Direct 
Interaction with Ire1α. Science. 312: 572-576. 
 Hetz, C., Thielen, P., Matus, S., Nassif, M., Court, F., Kiffin, R., Martinez, Gabriela, 
Cuervo, A.M., Brown, R.H., and Glimcher, L.H. (2009) XBP-1 deficiency in the 
nervous system protects against amyotrophic lateral sclerosis by increasing 
autophagy. Genes and Development. 23: 2294-2306. 
 Hodgson, D.R.W., and Schröder, M. (2011) Chemical approaches towards 
unravelling kinase-mediated signalling pathways. Chemical Society Reviews. 40: 
1211-1223. 
 Hollien, J., and Weissman, J.S. (2006) Decay of Endoplasmic Reticulum-localised 
mRNAs During the Unfolded Protein Response. Science. 313: 104-107. 
 Hollien, J., Lin, J.H., Li, H., Stevens, N., Walter, P., and Weissman, J.S. (2009) 
Regulated Ire1-dependant decay of messenger RNAs in mammalian cells. The 
Journal of Cell Biology. 186: 323-361. 
 Hussain, S.G. and Ramaiah, K.V.A. (2007) Endoplasmic Reticulum: Stress, 
signalling and apoptosis. Current Science. 93: 1684-1696.  
 Inoue, H,. Nojima, H., and Okayama, H. (1990) High efficiency transformation of 
Eschericia coli with plasmids. Gene. 96: 23-28. 
 Jin, Y., Zhuang, M., and Hendershot, L.M. (2009) ERdj3, a Luminal ER DnaJ 
Homologue, Binds Directly to Unfolded Proteins in the Mammalian ER: 
Identification of Critical Residues. Biochemistry. 48: 41-49. 
 Karlin, A., and Bartels, E. (1966) Effects of blocking sulfhydryl groups and of 
reducing disulphide bonds on the acetylcholine-activated permeability system of the 
electroplax. Biochimica et Biophysica Acta (BBA) - Biophysics including 
Photosynthesis. 126: 525-535. 
156 
 
 Kato, H., Nakajima, S., Saito, Y., Takahashi, S., Katoh, R., and Kitamura, M. (2012) 
mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-
JNK pathway. Cell Death and Differentiation. 19: 310-320. 
 Kichipudi, S.V., Tellabati, M., Nelli, R.K., White, G.A., Perez, B.B., Sebastian, S., 
Slomka, M.J., Brookes, S.M., Brown, I.H., Dunham, S.P., and Chang, K.C. (2012) 
18S rRNA is a reliable normalisation gene for real time PCR based on influenza 
virus infected cells. Virology Journal. 9: 230-237. 
 Kim, I., Xu, W., and Reed, J.C. (2008) Cell death and endoplasmic reticulum stress: 
disease relevance and therapeutic opportunities. Nature. 7: 1013-1030.  
 Kim, R., Emi, M., Tanabe, K., and Murakami, S. (2006) Role of the unfolded 
protein response in cell death. Apoptosis. 11: 5-13.  
 Kimmig, P., Diaz, M., Zheng, J., Williams, C.C., Lang, A., Aragón, T., Li, H., and 
Walter, P. (2012) The unfolded protein response in fission yeast modulates stability 
of select mRNAs to maintain protein homeostasis. eLife. 1: e0048. 
 Klopfenstein, D.R., Klumperman, J., Lustig, A., Kammerer, R.A., Oorschot, V., and 
Hauri, H.P. (2001) Subdomain-Specific Localization of Climp-63 (P63) in the 
Endoplasmic Reticulum Is Mediated by Its Luminal α-Helical Segment. The Journal 
of Cell Biology. 153: 1287-1300. 
 Korennykh, A., and Walter, P. (2012) Structural Basis of the Unfolded Protein 
Response. Annual Review of Cell and Developmental Biology. 28: 251-277. 
 Korennykh, A.V., Egea, P.F., Korostelev, A.A., Finer-Moore, J., Stroud, R.M., 
Zhang, C., Shokat, K.M., and Walter, P. (2011) Cofactor-mediated conformational 
control in the bifunctional kinase/RNase Ire1. BMC Biology. 9: 1-16. 
 Korennykh, A.V., Egea, P.F., Korostelev, A.A., Finer-Moore, J., Zhang, C., Shokat, 
K.M., Stroud, R.M., and Walter, P. (2009) The unfolded protein response signals 
through high-order assembly of Ire1. Nature. 457: 687-693. 
 Kozak, M. (2002) Pushing the limits of the scanning mechanism for initiation of 
translation. Gene. 299: 1-34. 
 Krysko, D.V., Bergh, T.V., Herde, K.D., and Vandenabeele, P. (2008) Apoptosis 
and necrosis: Detection, discrimination and phagocytosis. Methods. 4: 205-221.  
 Kundu, M., and Thompson, C.B. (2008) Autophagy: basic principles and relevance 
to disease. Aunnual Review of Pathology. 3:427-55. 
 Lai, E., Teodoro, T., and Volchuk, A. (2006) Endoplasmic Reticulum Stress: 
Signalling the Unfolded Protein Response. Physiology. 22: 193-201. 
 Lazebnik, Y.A., Kaufmann, S.H., Desnoyers, S., Poirier, G.G., and Earnshaw, W.C. 
(1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties 
like ICE. Nature. 371: 346-347. 
157 
 
 Lee, A.H., Chu, G.C., Iwakoshi, N.N., and Glimcher, L.H. (2005) XBP-1 is required 
for biogenesis of cellular secretory machinery of exocrine glands. The European 
Molecular Organisation Journal. 24: 4368-4380. 
 Lee, A.H., Iwakoshi, N.N., and Glimcher, L.H. (2003) XBP-1 regulates a Subset of 
Endoplasmic Reticulum Chaperone Genes in the Unfolded Protein Response. 
Molecular and Cellular Biology. 23: 7448-7459. 
 Lee, A.H., Iwakoshi, N.N., Anderson, K.C., and Glimcher, L.H. (2003) Proteasome 
inhibitors disrupt the unfolded protein response in myeloma cells. Proceedings of 
the National Academy of Sciences of the United States of America. 100: 9946-9951. 
 Lee, H., Noh, J.Y. ,Oh, Y., Kim, Y, Chang, J.W., Chung, C.W., Lee, S.T., Kim, M., 
Ryu, H., and Jung, Y.K. (2012) IRE1 plays an essential role in ER stress-mediated 
aggregation of mutant huntintin via the inhibition of autophagy flux. Human 
Molecular Genetics. 21: 101-114. 
 Lee, K.P.K., Dey, M., Neculai, D., Cao, C., Dever, T.E., Sicheri, F. (2008) Structure 
ofthe dual enzyme Ire1 reveals the basis for catalysis and regulation in non-
conventional RNA splicing. Cell. 132: 89-100. 
 Lei, K. and Davis, R. (2003) JNK phosphorylation of Bim-related members of the 
Bcl2 family induces Bax-dependent apoptosis. Proceedings of the National 
Academy of Sciences. 100: 2432-2437. 
 Lerner, A.G., Upton, J.P., Praveen, P.V.K., Ghosh, R., Nakagawa, Y., Igbaria, A., 
Shen, S., Ngugen, V., Nackes, B.J., Heiman, M., Heintz, N., Greengard, P., Hui, S., 
Tang, Q., Trusina, A., Oakes, S.A., and Papa, F.R. (2012) IRE1α Induces 
Thioredoxin-Interacting Protein to Activate the NLRP3 Inflammasome and Promote 
Programmed Cell Death under Irremediable ER Stress. Cell Metabolism. 16: 250-
264. 
 Li, H., Korennykh, A.V., Behrman, S.L., and Walter,P. (2010) Mammalian 
endoplasmic reticulum stress sensor IRE1 signals by dymanic clustering. 
Proceedings of the National Academy of Sciences. 107: 16113-16118. 
 Lin, J.H., Li, H., Yasumura, D., Cohen, H.R., Zhang, C., Panning, B., Shokat, K.M., 
LaVail M.M. and Walter, P. (2007) IRE1 Signalling Affects Cell Fate During the 
Unfolded Protein Response. Science. 318: 944-949.  
 Lin, J.H., Li, H., Zhang, Y., Ron, D., and Walter, P. (2009) Divergent Effects of 
PERK and IRE1 Signaling on Cell Viability. PLoS. 4(1): e4170. 
 Livak, K., and Schmittgen, T.D. (2001) Analysis of Relative Gene Expression Data 
Using Real-Time Quantitative PCR and the 2
-ΔΔC
t
 
 Method. Methods. 25: 402-408. 
  Lui, J., and Lin, A. (2005) Role of JNK activation in apoptosis: A double-edged 
sword. Cell Research. 15: 36-42.  
158 
 
 Luo, D., He, Y., Zhang, H., Yu, L., Chen, H., Xu, Z., Tang, S., Urano, F., and Min, 
W. (2008) AIP1 is Critical in Trnasducing IRE1-mediated Endoplasmic Reticulum 
Stress Response. Journal of Biological Chemistry. 283: 11905-11912.  
 Lykidis, A., and Jackowski, S. (2001). Regulation of mammalian cell membrane 
biosynthesis. Progress in nucleic acid research and moluecular biology. 65: 361-
393.  
 Lytton, J., Westlin, M., and Hanley, M.R. (1991) Thapsigargin inhibits the 
sarcoplasmic or endoplasmic Ca-ATPase family of calcium pumps. The Journal of 
Biological Chemistry. 266: 17067-17071. 
 Ma, J., Brewer, J.W., Dielh, A. and Hendershot, L.M. (2002) Two Distinct Stress 
Pathways Converge Upon the CHOP Promoter During the Mammalian Unfolded 
Protein Response. Journal of Molecular Biology. 318: 1351-1365. 
 Ma, Y., and Hendershot, L.M. (2004) Herp Is Dually Regualted by Both the 
Endoplasmic Reticulum Stress-specific Branch of the Unfolded Protein Response 
and a Branch That Is Shared with Other Cellular Reponses. The Journal of 
Biological Chemistry. 279: 13792-13799. 
 Ma, Y., and Hendershot, L.M. (2004) Herp Is Dually Regulated by Both the 
Endoplasmic Reticulum Stress-specific Branch of the Unfolded Protein Response 
and a Branch That Is Shared with Other Cellular Stress Pathways. The Journal of 
Biological Chemistry. 279: 13792-13799. 
 Marciniak, S.J., Yun, C.Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., 
Nagata, K., Harding, H.P., and Ron, D. (2004) CHOP induces death by promoting 
protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes and 
Development. 18: 3066-3077. 
 Mikhailov, V., Mikhailova, M., Pulkrabek, D.J., Dong, Z., Venkatachalam, M.A., 
Saikumar, P. (2001) Bcl-2 Prevents Bax Oligomerisation in the Outer Mitochondrial 
Membrane. The Journal of Biological Chemistry. 276: 18361-18374. 
 Mizushima, N., Kuma, A., Kobayashi, Y., Yamamoto, A., Matsubae, M., Takao, T., 
Natsume, T., Ohsumi, Y., and Yoshimori, T. (2003) Mouse Apg16L, a novel WD-
repeat protein, targets to the autophagic isolation membrane with he Apg12-Apg5 
conjugate. The Journal of Cell Science. 116: 1679-1688. 
 Mizushima, N., Yamamoto, A., Hatano, M., Kobayashi, Y., Kabeya, Y., Suzuki, K., 
Tokuhisa, T., Ohsumi, Y., and Yoshimori, T. (2001) Dissection of Autophagosome 
Formation Using Apg5-Deficient Mouse Embryonic Stem Cells. The Journal of Cell 
Biology. 152: 657-668. 
 Mori, K., Ma, W., Gething, M.J., and Sambrook, J. (1993) A transmembrane protein 
with a cdc2+/CDC28-related kinase activity is required for signaling from the ER to 
the nucleus. Cell. 74:743-756.  
159 
 
 Mori, K., Ogawa, N., Kawahara, T., Yanagi, H., and Yura, T. (2000) mRNA 
splicing-mediated C-terminal replacement of transcription factor Hac1p is required 
for efficient activation of the unfolded protein response. Proceedings of the National 
Academy of Sciences of the United States of America. 97: 4660-4665. 
 Morishima, N., Nakanishi, K., Takenouchi, H., Shibata, T. and Yasuhiko, Y. (2004) 
An Endoplasmic Reticulum Stress-specific Caspase Cascade in Apoptosis 
Cytochrome c-independent activation of caspase-9 by caspase-12. The Journal of 
Biological Chemistry. 277: 34287-34294. 
 Morris, J.A., Dorner, A.J., Edwards, C.A., Hendershot, L.M., and Kaufman, R.J. 
(1997) Immunoglobulin Binding Protein (BiP) Function Is Required to Protect Cells 
from Endopalsmic Reticulum Stress but Is Not Required for the Secretion of 
Selective Proteins. The Journal of Biological Chemistry. 272: 4237-4334. 
 Nataksukasa, K, and Brodsky, J.L. (2009) The Recognition and Retrotranslocation 
of Misfolded Proteins from the Endoplasmic Reticulum. Traffic.9: 861-870. 
 Neutzner, A., Neutzner, M., Benischke, A.S., Ryu, S.W., Frank, S., Youle, R.J., and 
Karbowski, M. (2011) A systematic search for endoplasmic reticulum (ER) 
membrane-associated RING finger proteins identifies Nixin/ZNRF4 as a regulator 
of calnexin stability and ER homeostasis. The Journal of Biological Chemistry. 286: 
8633-8643. 
 Nutt, L.K., Chandra, J., Pataer, A., Fang, B., Roth, J.A., Swisher, S.G., O’Neil, R.G. 
and McConkey, D.J. (2002) Bax-mediated Ca
2+
 Mobilisation Promotes Cytochrome 
c Release during Apoptosis. The Journal of Biological Chemistry. 277: 20301-
20308.  
 Ogata, M., Hino, S., Saito, A., Morikawa, K., Kondo, S., Kanemoto, S., Murakami, 
T., Taniguchi, M., Tanii, I., Yoshinaga, K., Shiosaka, S., Hammarback, J.A., Urano, 
F., and Imaizumi, K. (2006) Autophagy Is Activated for Cell Survival after 
Endoplasmic Reticulum Stress. Molecular and Cell Biology. 26: 9220-9231. 
 Ohoka, N., Yoshii, S., Hattori, T., Onozaki, K. and Hayashi, H. (2005) TRB3, a 
novel ER stress-inducible gene, is induced via the ATF4-CHOP pathway and is 
involved in cell death. The European Molecular Biology Organisation Journal. 24: 
1243-1255. 
 Okada, T., Yoshida, H., Akazawa, R., Negishi, M. and Mori, K. (2002) Distinct 
roles of activating transcription factor 6 (ATF6) and double-stranded RNA-activated 
protein kinase-like endoplasmic reticulum kinase (PERK) in transcription during the 
mammalian unfolded protein response. Biochemical Journal. 366: 585-594. 
 Okada, T., Yoshida, H., Akazawa, R., Negishi, M., and Mori, K. (2000) ATF6 
activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-
160 
 
acting element responsible for the mammalian unfolded protein response. Molecular 
and Cellular Biology. 1: 585-594.  
 Oliver, F.J., de la Rubia, G., Rolli, V., Ruiz-Ruiz, M.C., de Murcia, G., and 
Ménissier-de Murcia, J. (1998) Importance of poly(ADP-ribose) polymerase and its 
cleavage in apoptosis. Lesson from an uncleavable mutant. The Journal of 
Biological Chemistry. 273: 33533-33539. 
 Oyadomari, S., and Mori, M. (2004) Role of CHOP/GADD153 in endoplasmic 
reticulum stress. Cell Death and Differentiation. 11: 381-389. 
 Oyadomari, S., Yun, C., Fisher, E.A., Kreglinger, N., Kreibich, G., Oyadomari, M., 
Harding, H.P., Goodman, A.G., Harant, H., Garrison, J.L., Taunton, J., Kayze, 
M.G., and Ron, D. (2006) Cotranslational degradation Protects the Stressed 
Endoplasmic Reticulum from Protein Overload. Cell. 126: 727-739. 
 Padmakumar, V.C., Libotte, T., Lu, W., Zaim, H., Abraham, S., Noegel, A.A., 
Gotzmann, J., Foisner, R., and Karakesisoglou, I. (2005) The inner nuclear 
membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear 
envelope. Journal of Cell Science. 118: 3419-3430. 
 Papa, F.R., Zhang, C., Shokat, K., and Walter, P. (2003) Bypassing a kinase activity 
with an ATP-competitive drug. Science. 203: 1533-1537. 
 Paton, A.W., Beddoe, T., Thorpe, C.M., Whisstock, J.C., Wilce, M.C., Rossjohn, J., 
Talbot, U.M., and Paton, J.C. (2006) AB5 subtilase cytotoxin inactivates the 
endoplasmic reticulum chaperone BiP. Nature. 443: 548-552. 
 Pattingre, S., Tessa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M., 
Schneider, M.D., and Levine, B. (2005) Bcl-2 antiapoptotic proteins inhibit Beclin-1 
dependent autophagy. Cell. 122: 927-936. 
 Putcha, G.V., Le, S., Frank, S., Besirli, C.G., Clark, K., Chu, B., Axil, S., Youle, 
R.J., LaMarche, A., Maroney, A. and Johnson, Jr. E.M. (2003) JNK-Mediated BIM 
Phosphorylation Potentiates BAX-Dependent Apoptosis. Neuron. 38: 899-914. 
 Reed, R., Holmes, D., Weyers, J., and Jones, A. (2013) Practical Skills in 
Biomolecular Sciences. In Molecular genetics II – PCR and related applications, 
pp. 467-473. Pearson Education Limited, Essex. 
 Reich, E., Franklin, R.M., Shatkin, A.J., and Tatum, E.L. (1961) Effect of 
actinomycin D on cellular nucleic acid synthesis and virus production. Science. 134: 
556-557. 
 Reimold, A.M., Etkin, A., Clauss, I., Perkins, A., Friend, D.S., Zhang, J., Horton, 
H.F., Scott, A., Orkin, S.H., Byrne, M.C., Grusby, M.J., and Glimcher, L.H. An 
essential role in liver development for transcription factor XBP-1. Genes and 
Development. 14: 152-157. 
161 
 
 Reynold, E.S. (1963) The use of lead citrate at high pH as an electron-opaque stain 
in electron microscopy. The Journal of Cell Biology. 17: 208-212. 
 Ron, D. and Walter, P. (2007) Signal integration in the endoplasmic reticulum 
unfolded protein response. Nature. 8: 519-529.  
 Rubio, C., Pincus, D., Korennykh, A., Schuck, S., El-Samad, H., and Walter, P. 
(2011) Homeostatic adaptation to endoplasmic reticulum stress depends on Ire1 
kinase activity. The Journal of Cell Biology. 193: 171-184. 
 Sado, M., Yamasaki, Y., Iwanaga, T, Onaka, Y., Ibuki, T, Nishihara, S., Mizuguchi, 
H., Momota, H., Kishibuchi, R., Hashimoto, T., Wada, D., Kitagawa, H. and 
Watanabe, T.K. (2008) Protective effect against Parkinson’s disease-related insults 
though the activation of XBP-1. Brain Research. 1257: 16-24. 
 Salazar, M., Carracedo, A., Salanueva, I.J., Hernández-Tiedra, S., Lorente, M., Egia, 
A., Vázquez, P., Blázquez, C., Torres, S., García, S., Nowak, J., Fimia, G.M., 
Piacentini, M., Cecconi, F., Pandolfi, P.P., González-Feria, L., Iovanna, J.L., 
Guzmán, M., Boya, P., and Velasco, G. (2009) Cannabinoid action induces 
autophagy-mediated cell death through stimulation of ER-stress in human glioma 
cells. The Journal of Clinical Investigation. 119: 1359-1372. 
 Scheuner, D., and Kaufman, R.J. (2008) The Unfolded Protein Response: A 
Pathway That Links Insulin Demand with β-cell Failure and Diabetes. Endocrine 
Reviews. 29: 317-333. 
 Scheuner, D., Song, B., McEwen, E., Liu, C., Laybutt, R., Gillespie, P., Saunders, 
T., Bonner-Wier, S., and Kaufman, R.J. (2001) Translational Control Is Required for 
the Unfolded Protein Response and In Vivo Glucose Homeostasis. Molecular Cell. 
7: 1165-1176. 
 Schröder, M., Kaufman, R.J. (2005) The Mammalian Unfolded Protein Response. 
Annual review of Biochemistry. 74: 739-789. 
 Schuck, S., Prinz, W.A., Thorn, K.S., Voss, C., and Walter, P. (2009) Membrane 
expansion alleviated endoplasmic reticulum stress independently of the unfolded 
protein response. The Journal of Cell Biology. 187: 525-536. 
 Shamu, C.E., and Walter, P. (1996). Oligomerisation and phosphorylation of the 
Ire1p kinase during intracellular signalling from the endoplasmic reticulum to the 
nucleus. EMBO. 15: 3028-3039.  
 Shang, Y.Y., Zhong, M., Zhang, L.P., Guo, Z.X., Wang, Z.H., Zhang, Y., Deng, J.T. 
and Zhang, W. (2010)  Tribble 3, a novel oxidized low-density lipoprotein-inducible 
gene, is induced via the activating transcription factor 4-C/EBP homologous protein 
pathway. Clinical and Experimental Pharmacology and Physiology. 37: 51-55.  
162 
 
 Shibata, Y., Shemesh, T., Prinz, W.A., Palazzo, A.F., Kozlov, M.M., and Rapport, 
T.A. (2010) Mechanisms determining the morphology of the peripheral ER. Cell. 
143: 774-788. 
 Shoulders, M.D., Ryno, L.M., Genereux, J.C., Moresco, J.J., Tu, P.G., Wu, C., 
Yates III, J.R., Su, A.I., Kelly, J.W., and Weissman, L. (2013) Stress-Independent 
Activation of XBP1s and/or ATF6 Reveals Three Functionally Diverse ER 
Proteostasis Environments. Cell. 3: 1279-1292. 
 Sitia, R. and Braakman, I. (2003) Quality control in the endoplasmic reticulum 
protein factory. Nature. 426: 891–894. 
 Sriburi, R., Bommiasamy, H., Buldak, G.L., Robbins, G.R., Frank, M., Jackowski, 
S., and Brewer, J.S. (2007) Coordinate Regulation of Phospholipid Biosynthesis and 
Secretory Pathway Gene Expression in XBP-1(S)-induced Endoplasmic Reticulum 
Biogenesis. Journal of Biological Chemistry. 282: 7024-7034. 
 Sriburi, R., Jackowski, S., Mori, K., and Brewer, J. (2004) XBP1: a link between the 
unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic 
reticulum. The Journal of Cell Biology. 167: 35-41. 
 Sutcliffe, L.K. (2012) Chemical genetic dissection of efferent IRE1α signalling. 
Ph.D. Thesis. Durham University: UK. 
 Tabas, I., and Ron, D. (2011) Integrating the mechanisms of apoptosis induced by 
endoplasmic reticulum stress. Nature Cell Biology. 13: 184-190. 
 Takatsuki, A., Kohno, K., and Tamura, G. (1975) Inhibition of biosynthesis of 
polyisoprenol sugar in chick embryo microsomes by tunicamycin. Agricultural and 
Biological Chemistry. 39: 2089–2091. 
 Tan, Y., Dourdin, N., Wu, C., De Verya, T., Elce, J.S., and Greer, P.A. (2006) 
Ubiquitous Calpains Promote Caspase-12 and JNK Activation during Endoplasmic 
Reticulum Stress-induced Apoptosis. Journal of Biological Chemistry. 281: 16016-
16024.   
 Tirasophon, W., Lee, K., Callaghan, B., Welihinda, A., and Kaufman, R.J. (2000) 
The endoribonuclease activity of mammalian IRE1 autoregulated its mRNA and it 
required for the unfolded protein response. Genes and Development. 14: 2725-2736. 
 Tirasophon, W., Welihinda, A.A., and Kaufman, R.J. (1998) A stress response 
pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional 
protein kinase/endoribonuclease (Ire1p) in mammalian cells. Genes and 
Development. 12: 1812-1824. 
 Todd-Corlett, A., Jones, E., Seghers, C., and Gething, M.J. (2007) Lobe IB of the 
ATPase Domain of Kar2p/BiP Interacts with Ire1p to Negatively Regulate the 
163 
 
Unfolded Protein Response in Saccharomyces cerevisiae. The Journal of Molecular 
Biology. 367: 770-787. 
 Tooze, S.A., and Yoshimori, T. (2010) The origin of the autophagosomal 
membrane. Nature Cell Biology. 12: 831-835. 
 Travers, K.J., Patil, C.K., Wodicka, L., Lockhart, D.J., Weissmann, J.S., and Walter, 
P. (2000) Functional and Genomic Analyses reveal an Essential Coordination 
between the Unfolded Protein Response and ER-Associated Degradation. Cell. 101: 
249-258. 
 Upton, J.P., Wang, L., Han, D., Wang, E.S., Huskey, N.E., Lim, L., Truitt, M., 
McManus, M.T., Ruggero, D., Goga, A., Papa, F.R., and Oakes, S.A. (2012) IRE1α 
Cleaves Select microRNAs During ER Stress to Derepress Translation of 
Proapoptotic Caspase-2. Science. 338: 818-822. 
 Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H.P. and Ron, 
D. (2000) Coupling of Stress in the ER to Activation of JNK Protein Kinases by 
Transmembrane Protein Kinase IRE1. Science. 287: 646-666. 
 Vandermoere, F., Yazidi-Belkoura, I.E., Slomiamy, C., Demont, Y., Bidaux, G., 
Adriaenssens, E., Lemoine, J., and Hondermarck, H. (2006) The Valsolin-containing 
Protein (VCP) Is a Target of Akt Signaling Required for Cell Survival. The Journal 
of Biological Chemistry. 281: 14360-14313. 
 Vattem, K.M., and Wek, R.C. (2004). Reinitiation involving upstream ORFs 
regulates ATF4 mRNA translation in mammalian cells. Proceedings of the National 
Academy of Sciences. 101: 11269-11274. 
 Wang, X., Olberding, K.E., White, C., Li, C. (2011) Bcl-2 proteins regulate ER 
membrane permeability to luminal proteins during ER stress-induced apoptosis. Cell 
Death and Differentiation. 18: 38-47. 
 Wang, X.Z., and Ron, D. (1996) Stress-induced phosphorylation and activation of 
the transcription factor CHOP (Gadd153) by p38 MAK kinase. Science. 272: 1347-
1349. 
 Warburg, O., and Christian, W. (1942) Isolation and crystallisation of enolase. 
Biochemische Zeitschrift. 310: 384-421. 
 Wei, M.C., Lindsten, T., Mootha, V.K., Weiler, S., Gross, A., Ashiya, M., 
Thompson, C.B., and Korsemeyer, S.J. (2000) tBID, a membrane-targeted death 
ligand, oligomerises BAK to release cytochrome c. Genes and Development. 14: 
2060-2071. 
 Wei, M.C., Zong, W.X., Cheng, E.H.Y., Lidsten, T., Panoutsakopoulou, V., Ross, 
A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B. and Korsemeyer, S.J. (2001) 
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction 
and Death. Science. 292: 727-730. 
164 
 
 Wei, Y., Pattingre, S., Sinha, S., Bassik, M., and Levine, B. (2008) JNK1-Mediated 
Phosphorylation of Bcl-2 Regulates Starvation-Induced Autophagy. Molecular Cell. 
30: 678-688. 
 Williams, J.A., Hou, Y., Ni, H.M., and Ding, W.X. (2013) Role of intracellular 
calcium in proteasome inhibitor-induced endoplasmic reticulum stress, autophagy, 
and cell death. Pharmaceutical Research. 30: 2279-2289. 
 Wócjik, C., Rowicka, M., Kudlicki, A., Nowis, D., McConnell, E., Kujawa, M., and 
DeMartino, G.N. (2006) Valsolin-containing Protein (p97) Is a Regulator of 
Endoplasmic Reticulum Stress and of the degradation of N-End Rule and Ubiquitin-
Fusion degradation Pathway Substrates in Mammalian Cells. Molecular Biology of 
the Cell. 17: 4604-4618. 
 Wojciechowicz K, Gledhill K, Ambler CA, Manning CB, Jahoda CAB (2013) 
Development of the Mouse Dermal Adipose Layer Occurs Independently of 
Subcutaneous Adipose Tissue and Is Marked by Restricted Early Expression of 
FABP4. PLoS ONE 8: e59811. 
 Wójcik, C., Rowicka, M., Kudlicki, A., Nowis, D., McConnell, E., Kujawa, M., and 
DeMartino, N. (2006) Valsolin-containing Protein (p97) Is a Regulator of 
Endoplasmic Reticulum Stress and of the Degradation of N-End Rule and Ubiquitin-
Fusion Degradation Pathway Substrates in Mammalian Cells. The American Society 
for Cell Biology. 17: 4806-4618. 
 Xie, Z., Nair, U., and Klionsky, D.J. (2008) Atg8 Controls Phagophore Expansion 
during Autophagosome formation. Molecular Biology of the Cell. 19: 3290-3298. 
 Xu, P., Raden, D., Doyle III, F.J., and Robinson, A.S. (2005) Analysis of unfolded 
protein response during single-chain antibody expression in Saccharomyces 
cerevisiae reveals different roles for BiP and PDI in folding. Metabolic Engineering. 
7: 269-279. 
 Yamamoto, K., Ichijo, H., and Korsemeyer, S.J. (1999) BCL-2 Is Phosphorylated 
and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally 
Activated at G2/M. Molecular and Cellular Biology. 19: 8469-8478. 
 Yamamoto, K., Sato, T., Matsui, T., Sato, M., Okada, T., Yoshida, H., Harada, A., 
and Mori, K. (2007) Transcriptional Induction of Mammalian ER Quality Control 
Proteins Is Mediated by Single or Combined Action of ATF6α and XBP1. 
Developmental Cell. 13: 365-376. 
 Yoneda, T, Imaizumi, K., Oono, K., Yui, D., Gomi, F., Katayama, T. and Tohyama, 
M. (2001) Activation of Caspase-12, an Endoplamic Reticulum (ER) Resident 
Caspase, thought Tumor Necrosis Factor Receptor-associated Factor 2-dependent 
Mechanism in Response to the ER Stress. The Journal of Biological Chemistry. 276: 
13935-13940. 
165 
 
 Yoshida, H., Matsui, T., Hosokawa, N., Kaufman, R.J., Nagata, K., and Mori, K. 
(2003) A Time-Dependent Phase Shift in the Mammalian Unfolded Protein 
Response. Developmental Cell. 4: 265-271. 
 Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., and Mori, K. (2001) XBP1 
mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to 
Produce a Highly Active Transcription Factor. Cell. 107: 881-891. 
 Yu, C., Minemoto, Y., Zhang, J., Liu, J., Tang, F., Bui, T.N., Xiang, J. and Lin, A.  
(2004) JNK Suppresses Apoptosis via Phosphorylation of the Proapoptotic Bcl-2 
Family Protein BAD. Molecular Cell. 13: 329-340.  
 Zhang, B., Shozu, M., Okada, M., Ishikawa, H., Kasai, T., Murakami, K., Nomura, 
K., Harada, N., and Inoue, M. (2010) Insulin-Like Growth Factor I Enhances the 
Expression of Aromatose P450 by Inhibiting Autophagy. Endocrinology. 151: 4949-
4958. 
 Zinszner, H, Kuroda, M., Wang, X.Z., Batchvarova, N., Lightfoot, R.T., Remotti, 
H., Stevens, J.L., and Ron, D. (1998) CHOP is implicated in programmed cell death 
in response to impaired function of the endoplasmic reticulum. Genes and 
Development. 12: 982-995.  
 Zong, W.X., Li, C., Hatzivassiliou, G., Lindsten, T., Yu, Q.C., Yuan, J. and 
Thompson, C.B. (2003) Bax and Bak can localise to the endoplasmic reticulum to 
initiate apoptosis. The Journal of Cell Biology. 162: 59-69. 
 
 
